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ABSTRACT 
RNA cleavage by metal ion-independent endoribonucleases and self-cleaving 
ribozymes produces RNA fragments with 5´-hydroxyl (5´-OH) and 2´,3´-cyclic phosphate 
termini. However, RNAs with 5´-OH termini (5´-OH RNAs) are not detected by 
conventional sequencing methods, and 5´-OH RNAs cannot be directly degraded by 
canonical 5´-phosphate-dependent 5´→3´ exoribonucleases. 
To identify new 5´-OH RNA fragments, I exploited the unique ligation mechanism 
of E. coli RtcB RNA ligase to develop 5OH-seq, a novel method to capture and sequence 
5´-OH RNAs. I applied 5OH-seq to budding yeast and captured known 5´-OH fragments 
produced by tRNA Splicing Endonuclease (SEN) during processing of intron-containing 
pre-tRNAs and by ribonuclease Rny1 during stress-induced cleavage of tRNA anti-codon 
loops. I identified numerous novel 5´-OH fragments derived from mRNAs: some 5´-OH 
mRNA fragments were derived from single, localized cleavages, while others were likely 
produced by multiple, distributed cleavages. Many 5´-OH mRNA fragments were 
produced upstream of codons for highly electrostatic peptides, suggesting that the 
fragments may be generated by co-translational mRNA decay, such as no-go decay (NGD). 
5´-OH RNAs must be phosphorylated to become substrates for 5´-phosphate-
dependent 5´→3´ exoribonucleases, a process I term “kinase-mediated decay” (KMD). 
During the unfolded protein response (UPR), the ER-localized Ire1 endoribonuclease 
cleaves HAC1 mRNA, yielding 2´,3´-cyclic phosphate and 5´-OH RNA fragments that are 
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ligated by Trl1 tRNA ligase to produce mature HAC1 mRNA and activate downstream 
target genes. The HAC1 fragments cleaved by Ire1 have previously been identified with 
5´-phosphate (5-PO4) termini in vivo in xrn1∆ yeast, suggesting the HAC1 fragments are 
KMD substrates. I found that HAC1 3´-exons accumulate with 5´-PO4 termini in xrn1∆ 
yeast when Trl1 is present, but not kinase-dead Trl1-D425N or RtcB ligase, suggesting that 
Trl1 phosphorylates the HAC1 3´-exon for decay by Xrn1. Failure to degrade the HAC1 
3´-exon promotes aberrant splicing and UPR activation without stimulus. 
In summary, this thesis describes a method to directly capture and sequence 5´-OH 
RNAs (5OH-seq), a comprehensive analysis of 5´-OH RNAs in budding yeast, and 
evidence for a unified theory of 5´-OH RNA degradation by kinase-mediated decay 
(KMD). I also present preliminary data on the abundance of 5´-OH RNAs in mammalian 
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 RNA is a diverse molecule comprising the majority of nucleic acid content in a given 
cell. It can act as the messenger encoding protein sequence (mRNA), the molecule 
decoding the sequence and carrying amino acids during protein translation (tRNA), and a 
structural and catalytic component of the ribosome (rRNA). The constant production of 
this essential molecule necessitates robust decay mechanisms to break down RNA and 
recycle nucleotides. For instance, the canonical Xrn1 and exosome decay pathways in yeast 
maintain cytosolic homeostatsis by processive mRNA degradation. However, little is 
known about RNAs which exist outside of the known decay pathways. What happens when 
an RNA is cleaved and the resulting RNA terminus is immune to degradation by known 
exoribonucleases? 
 This dissertation seeks to address this question by employing both broad, 
transcriptome-wide analyses of RNAs with 5´-hydroxyl termini (5´-OH RNAs) as well as 
a focused study of the molecular mechanism of kinase-mediated decay (KMD) for specific 
5´-OH RNAs within the unfolded protein response (UPR) and the no-go decay (NGD) 
pathway. This chapter provides an overview of RNA modifications, the generation and 
regulation of 5´-OH RNAs, the known RNA decay mechanisms, and the current methods 
of terminal RNA modification detection by next-generation sequencing. In Chapter II, I 
discuss the development and validation of the novel 5OH-seq method, which combines the 
unique ligation specificity of E. coli RtcB with massively parallel next-generation 
sequencing to directly capture and sequence 5´-OH RNAs. I describe the findings of the 
first transcriptome-wide analysis of 5´-OH RNAs in Saccharomyces cerevisiae, including 
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the enrichment of 5´-OH RNAs upstream of regions encoding polycharged amino acids 
and 5´-OH RNAs cleaved during UPR induction. In Chapter III, I further explore the 
5OH-seq results in yeast.  I demonstrate the molecular mechanism of the decay of two 5´-
OH RNAs: the 3´-exon fragment of HAC1 mRNA generated by Ire1 cleavage and the 3´-
exon fragment of a no-go decay (NGD) reporter construct. I term these and other related 
processes “kinase-mediated decay” (KMD). In Chapter IV, I apply the 5OH-seq method 
to mammalian RNA samples and describe results of a preliminary analysis of 5´-OH RNAs 
in mouse spinal cords, human cell lines, and human patient-derived fibroblasts with 
compromised 5´-OH kinase activity. In Chapter V, I summarize the collective findings 
and describe future directions and applications to RNA decay, including extensions to 
human disease. Together, these chapters provide a comprehensive overview of 5´-OH 
RNAs in eukaryotes and define the molecular mechanism of their degradation by KMD. 
 
Overview of RNA Modifications 
 Modification of nucleobases and ribose sugars drastically increases the information 
coding potential of RNA, creating a “combinatorial chemistry playground” (Jackman and 
Alfonzo 2013).  The first glimpse of RNA modification arose when the hydrolyses of yeast 
RNA with a phosphodiesterase and 5´ nucleotidase yielded inorganic phosphate, 
suggesting that some phosphoryl groups were attached to C5 of the ribose (Gulland and 
Jackson 1938). Since this early discovery of what is now known as the 5´-phosphate 
terminal modification (5´-PO4), over 100 RNA modifications, both terminal and internal, 
have been identified on all major RNA types (tRNA, rRNA, and mRNA) and several minor 
RNA subspecies (snRNA and miRNA) in all domains of life (Machnicka et al. 2012). 
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 tRNA provides a stunning example of internal RNA modifications. In 1957, Davis 
and Allen described an abundant “fifth nucleotide” that comprised 4% of yeast tRNA 
nucleotides (Davis and Allen 1957). The chemical structure and properties of this 
pseudouridine (Ψ) nucleotide, the C5-glycoside isomer of uridine, were revealed shortly 
thereafter (Cohn 1960). Over the next half century, dozens of tRNA modifications were 
discovered (Reviews: Hopper 2013; Jackman and Alfonzo 2013; Helm and Alfonzo 2014). 
An analysis of 561 sequenced tRNA molecules from a variety of species found 11.9% of 
the all nucleotides differed from the canonical bases and 16.4% of nucleotides in 34 
sequenced yeast cytoplasmic tRNAs are modified (Sprinzl and Vassilenko 2005; Phizicky 
and Alfonzo 2010). Though the role of most tRNA modifications is not well-understood, 
it is abundantly clear that many RNA modifications are required for normal cellular 
functioning. Over 200 diseases have been linked to tRNA hypomodification, including 
cancers, asthma, diabetes, and neurological diseases (Torres et al. 2014; Abbott et al. 2014). 
 In addition to modifications of the internal nucleotides, the 5´ and 3´ termini of RNA 
can be covalently modified. The nature of these termini can inhibit or promote recognition 
by enzymes that modify the end chemistry by phosphorylation, cyclic phosphate diesterase 
activity, adenylation, guanylation, ligation, and so on. Perhaps the most well-studied 
example of a regulated 5´-terminal RNA modification is the 7-methylguanosine (m
7
G) cap 
on the 5´ terminus of mRNA. In the mid 1970s, a series of publications demonstrated the 
presence of the m
7
G cap on the 5´ terminus of mRNAs from viruses, slime mold, yeast, 
and mammals (Shatkin 1976). During transcription, nascent pre-mRNA is 
dephosphorylated by RNA triphosphatase Cet1 (Tsukamoto et al. 1997). A guanine 
nucleotide is transferred to the resulting 5´-bisphosphate mRNA by mRNA 
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guanylyltransferase Ceg1 creating a 5´-to-5´ triphosphate linkage. Methylation of the 
guanine by mRNA (guanine-N7-)-methyltransferase Abd1 yields a m
7
G-mRNA (Mao et 
al. 1995). The m
7
G cap recruits eukaryotic initiation factor 4E (eIF4E) to promote 
translation (Sonenberg et al. 1979), and it also promotes 5´ proximal intron excision (Ohno 
et al. 1987). Importantly, the m
7
G cap prevents recognition by 5´→3´ exoribonuclease 
Xrn1, and must first be removed by Dcp1/Dcp2 to promote decay of the mRNA (discussed 
further in the “RNA Decay” section). 
 In this dissertation, I seek to characterize another terminal RNA modification: the 5´-
hydroxyl terminus. I consider the 5´-OH terminus a “hidden” terminus for two reasons. 
First, 5´-OH RNAs have evaded extensive characterization due to their incompatibility 
with sequencing methods that rely on 5´-phosphate-dependent chemistries. Therefore, in 
order to comprehensively identify 5´-OH RNAs with precise resolution, I needed to 
develop a new method to specifically capture and map this previously “hidden” RNA 
species (Chapter II and Chapter IV). The second reason is that, similar to the m
7
G capped 
mRNAs, 5´-OH RNAs cannot be recognized or degraded by 5´-phosphate-dependent 
5´→3´ exoribonucleases. In Chapter III, I describe how the “hidden” 5´-OH terminus can 
be phosphorylated, creating a competent substrate for 5´→3´ RNA decay. 
 
Generation of RNAs with 5´-hydroxyl Termini 
 Within this section, I introduce three key processes generating 5´-OH RNAs: intrinsic 
cleavage, self-cleaving ribozymes, and metal-ion independent endoribonucleases. 
Cleavages by several metal-ion independent endoribonucleases are of particular interest in  
 
	 5 
regulated pathways, which are further described in the subsequent section, “5´-OH RNAs 
in biological systems”. 
 
Intrinsic RNA cleavage 
 RNA can assume a conformation promoting sequence-independent cleavage. This 
intrinsic RNA cleavage likely proceeds via an in-line SN2-like reaction that requires an 
initial deprotonation of the 2´-OH of the upstream ribose. Following deprotonation, the  
2´-O functions as the nucleophile and attacks the neighboring 3´-5´ bridging phosphate 
prompting the 5´-O of the downstream ribose to act as a leaving group. Intrinsic RNA 
cleavage yields a 5´ RNA fragment with a 2´,3´-cyclic phosphate terminus and a 3´ RNA 
fragment with a 5´-OH terminus. The cleavage is relatively non-specific and likely 
accounts for a significant portion of in vitro RNA fragmentation.   
 Certain metal ions can enhance intrinsic RNA cleavage. Metal ions promote RNA 
cleavage by acting as Brönsted bases and abstracting a proton from the 2´-OH (Brown et 
al. 1985). Indeed, acceleration of RNA cleavage by divalent lead cations was first shown 
over 65 years ago (Dimroth et al. 1950). Other divalent cations Mg
2+
 and and Zn
2+
 also 







 are even more efficient catalysts, accelerating the rate of dinucleotide 
cleavage 3-4 orders of magnitude (Breslow and Huang 1991). 
 Intrinsic RNA cleavage is important for many RNA sequencing methods. Single-
stranded RNA cleaves at a rate ~100 times higher than double-stranded RNA (Soukoup 
and Beaker, 1999), enabling partial mapping of RNA structure by differential cleavage in 
the presence of metal cations (Forconi and Herschlag 2009). Intentional RNA 
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fragmentation is a critical step in the optimization of various sequencing library 
preparations, including the 5OH-seq method described within this thesis. 
 
Self-cleaving ribozymes 
 Though the potential for enzymatic activity of RNA had been suggested by Carl 
Woese, Francis Crick, and Leslie Orgel in 1967, the experimental evidence for the 
necessity of RNA in catalysis came a decade later. While investigating the mechanism of 
ribonuclease P (RNase P) in the sequence-independent generation of 5´ termini of E. coli 
tRNAs, Sidney Altman’s group showed that purified RNase P contained a single protein 
and a single nucleic acid component. Treatment of purified RNase P with micrococcal 
nuclease (MN) or RNase A inhibited cleavage of a tRNA
Tyr
 precursor, and addition of total 
cellular RNA after MN treatment partially restored the enzymatic activity, suggesting that 
the RNA component was required for enzymatic function (Stark et al. 1978). Separately, 
Tom Cech’s group was investigating the removal mechanism of a 413 bp intervening 
sequence (IVS) from the 26S pre-rRNA in Tetrahymena thermophila. They initially 
purified an active form of 26S pre-rRNA that completed IVS excision and circularization 
even following extensive measures to inactivate potential protein contaminants including 
SDS-phenol extraction, boiling in SDS, and treatment with proteases (Cech et al. 1981). 
These results suggested, but did not definitely prove, that excision was not performed by a 
protein. In a follow up study, in vitro transcription of purified plasmid rDNA with a 
minimal E. coli RNA polymerase system yielded a pre-rRNA independently capable of 
autoexcision and autocyclization of the IVS (Kruger et al. 1982). This seminal publication 
also coined the term “ribozyme” for RNA with enzymatic properties. Shortly thereafter, 
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Altman’s group definitively showed that RNA was the catalyitic subunit of RNase P 
(Guerrier-Takada et al. 1983). For these discoveries, Thomas Cech and Sidney Altman 
were awarded the Nobel Prize in Chemistry in 1989. 
 Self-cleaving ribozymes are a subset of short ribozymes that achieve RNA cleavage 
and ligation at specific sites. Examples of such ribozymes include: hammerhead (Prody et 
al. 1986), hairpin (Buzayan et al. 1986), hepatitis delta virus (HDV) (Sharmeen et al. 1988), 
Varkud satellite (VS) (Saville and Collins 1990), glmS (Winkler et al. 2004), and twister 
(Roth et al. 2014) ribozymes. Though it was initially thought that all ribozymes were 
metalloenzymes that required coordination of divalent metal ions to achieve catalysis, 
analysis of the hammerhead, hairpin, and VS ribozymes in the absence of metal ions 
revealed that RNA cleavage rates were unaffected (Murray et al. 1998). Instead, self-
cleaving ribozymes employ a site-specific internal transesterfication reaction (Das and 
Piccirilli 2005), which is similar to the mechanism of intrinsic RNA cleavage described 
above and yields final products with 2´,3´-cyclic phosphate and 5´-OH termini.  
 
Metal ion-independent endoribonucleases 
 Endoribonucleases can be divided into two distinct categories based on their reliance 
on divalent cations, their mechanism of action, and the terminal chemistry of the resulting 
RNA cleavage fragments (Figure 1.1) (Yang 2011). In general, metal ion-dependent 
endoribonucleases use a conserved aspartic acid residue to coordinate two divalent metal 
cations, usually Mg
2+
, and the non-bridging oxygens of the scissile phosphate. One of these 
divalent metal cations facilitates the deprotonation of a water molecule, creating a 
hydroxide that acts as nucleophile to attack the phosphate. The 3´-O of the 5´-ribose acts 
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as the leaving group and is deprotonated by a general acid. The cleavage occurs 5´ of the 
scissile phosphate and yields a 5´ RNA fragment with a 3´-OH terminus and a 3´ RNA 
fragment with a 5´-PO4 terminus (Figure 1.1A) (Steitz and Steitz 1993). Because 
generation and attack of the nucleophile is relatively independent of nucleic acid 
conformation, metal ion-dependent endoribonucleases are able to cleave ssRNA, dsRNA, 
and DNA:RNA hybrids. Endoribonucleases in this category include RNases H, P, and Z, 
as well as Dicer and Drosha, and are relegated to a minor role in this document (Yang 
2011). 
 In contrast, metal ion-independent endoribonucleases coordinate amino acids to 
promote acid-base catalysis. For instance, residue His12 of RNase A deprotonates the  
2´-O creating the attacking nucleophile. His119 serves as a general acid catalyst and 
protonates the 5´-O leaving group. The chemistry of metal ion-independent 
endoribonucleases ensures a break 3´ of the scissile phosphate and generates a 5´ RNA 
fragment with a 2´,3´-cyclic phosphate terminus and a 3´ RNA fragment with a 5´-OH 
terminus (Figure 1.1B) (Raines 1998; Fedor and Williamson 2005). Metal ion-independent 
endoribonucleases require accessibility of the 2´-OH, and therefore almost exclusively 
cleave ssRNA. 
 Though mammals have evolved over a dozen metal ion-dependent 
endoribonucleases, I focus on several well-characterized endoribonucleases that are 
conserved from yeast through humans (Table 1.1). In the next section, I describe regulatory 
pathways involving four metal ion-independent endonucleases (Sen2, Sen34, 
Rny1/Angiogenin, and Ire1). The role of Las1 in rRNA biogenesis is explored in the 





Figure 1.1. Two distinct mechanisms of endoribonuclease cleavage. 
A. Metal ion-dependent endoribonucleases (e.g., RNase H, RNase P, RNase Z) coordinate 
a metal ion to initiate cleavage of the scissile phosphate in ssRNA, dsRNA, and DNA:RNA 
hybrids. Cleavage generates a 5´-fragment with a 3´-OH terminus and a 3´-fragment with 
a 5´-PO4 terminus. 
B. Metal ion-independent endoribonucleases (e.g., Sen2, Sen34, Ire1, Rny1) use amino 
acid residues to promote catalysis in the absence of a metal ion. Cleavage generates a 5´-
fragment with a 2´,3´-cyclic phosphate terminus and a 3´-fragment with a 5´-OH terminus. 























































































5´-OH RNAs in Biological Systems 
 Although a transcriptome-wide identification of 5´-OH RNAs via a direct 
sequencing method had never been performed prior to my work, there are numerous well-
studied examples of 5´-OH RNAs in regulated pathways of RNA cleavage. In this section, 
I discuss the generation of 5´-OH RNAs in three pertinent examples: processing of intron-
containing tRNAs by the tRNA splicing endonuclease (TSEN), cleavage of tRNAs by 
Rny1/Angiogenin to yield stress-induced tRNA fragments (tiRNAs), and the cleavage of 
HAC1/XBP1 mRNA by inositol-requiring enzyme 1 (IRE1). The regulated decay of these 
fragments are further described in the “Kinase-Mediated Decay” section. 
 
TSEN: Processing of intron-containing tRNAs 
 Of the predicted 295 tRNAs encoded in the yeast genome, 59 tRNAs representing 
10 codons contain an intron that must be removed following transcription (Lowe and Eddy 
1997). The first intron-containing tRNA in yeast was discovered in 1977 when DNA 
sequencing of SUP4 revealed a 14 bp intervening sequence adjacent to the 3´ end of the 
anticodon triplet in tRNA
Tyr
 (Goodman et al. 1977). An intron of ~18 bp was found 3´ of 
the anticodon loop in tRNA
Phe
  the following year (Valenzuela et al. 1978). Though the 
functional purpose of tRNA introns remains mysterious, the processing of intron-
containing tRNAs is now well-understood (Figure 1.2A).  
 The first step in maturation of intron-containing tRNAs is processing by the tRNA 
Splicing Endonuclease (TSEN). Intron-containing tRNAs are transcribed in the nucleus, 
then exported to the cytoplasm where they are cleaved by the TSEN complex to remove 
the intron. Sen2 cleaves on the 5´ end of the intron and Sen34 cleaves on the 3´ end of the 
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Table 1.1 Functions of several eukaryotic metal ion-independent endoribonucleases. 
 
Protein Name 
Yeast             Human 
Function References 
Sen2 TSEN2 Processing of intron-
containing tRNAs 




anticodon loop cleavage 
(Yamasaki et al. 2009; 




(Cox and Walter 1996; 
Hollien et al. 2009) 
Las1 LAS1L 
ITS2 cleavage in rRNA 
processing 
(Schillewaert et al. 2012; 
Butterfield et al. 2014) 
 
UPR: Unfolded Protein Response; RIDD: Regulated IRE1-Dependent Decay of mRNA; 
ITS2: Internal Transcribed Spacer 2 
* Rny1 and Angiogenin are not homologous but perform an analogous function. See text 
in the “5´-OH RNAs in Biological Systems” section for additional explanation. 
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intron (Ho et al. 1990). The enzymes generate a 5´ fragment with a 2´,3´-cyclic phosphate 
terminus and a 3´ fragment with 5´-OH terminus (Peebles et al. 1983; Knapp et al. 1979). 
 T-RNA Ligase 1 (Trl1) – also known as RNA Ligase 1 (Rlg1) – resolves the termini 
and ligates the two tRNA exons. Trl1 was first purified and shown to perform tRNA 
splicing in 1986 (Phizicky et al. 1986). The specific molecular mechanism was worked out 
in the late 1980s and early 1990s via a series of experiments primarily from John Abelson’s 
and Craig Greer’s groups. In brief, Trl1 ligates the 5´ and 3´ tRNA halves via key three 
enzymatic activities (Greer et al. 1983; Phizicky et al. 1986), each performed by a separate 
modular domain: (i) hydrolysis of the 2´,3´-cyclic phosphate terminus of the 5´ tRNA half 
to a 2´-phosphate terminus by the 2´,3´-cyclic phosphodiesterase (CPDase) domain; (ii) 
phosphorylation of the 5´-OH terminus of the 3´ tRNA half by the NTP-dependent 
polyribonucleotide kinase domain; and (iii) adenylation of the 5´-phosphate terminus to 
form an RNA-adenylate intermediate which is attacked by the 3´-OH terminus to ligate the 
ends via a phosphodiester bond (Xu et al. 1990; Apostol et al. 1991). The three domains 
(CPDase, kinase, and adenylyltransferase/ligase) are all essential for tRNA splicing and 
yeast viability, but can function independently and perhaps arose from gene fusion events 
(Sawaya 2003). The ligation produces a 2´-phosphate at the splice junction. For the tRNA 
to be functional, this phosphate must be removed by the essential 2´-phosphotransferase 
Tpt1, which transfers the 2´-phosphate to NAD+, forming ADP-ribose 1´,2´-cyclic 
phosphate and nicotinamide (Culver et al. 1993; 1997; Spinelli et al. 1997) (Figure 1.2A). 
Following splicing, some tRNAs also undergo retrograde transport to the nucleus where 
they are further modified (Shaheen and Hopper 2005; Takano 2005).  Decay of the tRNA 
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intron, which also carries 5´-OH and 2´,3´-cyclic phosphate termini is further described in 
the “Kinase-Mediated Decay” section (Wu and Hopper 2014). 
In humans, intron-containing tRNAs are cleaved by conserved TSEN complex 
members TSEN2 and TSEN34, but the resulting 3´ and 5´ tRNA exons are ligated via a 
different mechanism than yeast. It had been speculated since the 1970s that the tRNA exons 
were joined by a direct ligation pathway that differed from the yeast system described 
above; however, the responsible enzyme was not identified until 2011. Popow et. al 
followed the ligation of a 3´-PO4 dsRNA over three chromatographic purification steps and 
identified 91 potential proteins by MS/MS  (Popow et al. 2011). One of the proteins, 
HSPC117, is the human homolog of E. coli RtcB. Due to its genetic proximity to RNA 3´-
terminal cyclase RtcA, the E. coli RtcB was thought to be an RNA repair enzyme 
(Genschik et al. 1998; Galperin and Koonin 2004). Depletion of human RTCB by RNAi 
reduced ligation of tRNA halves in vivo, and mutation of a conserved cytosine residue for 
metal ion coordination (Cys
122→Ala122) abolished tRNA ligation in vitro, thus 
demonstrating that RTCB is the mammalian tRNA ligase (Popow et al. 2011). (Additional 
functions of RTCB and consequences of mutation are discussed in the “IRE1α: non-
canonical splicing of XBP1 mRNA and RIDD” section.) 
Almost simultaneously, two groups showed that archaeal (Pyrobaculum 
aerophilum) RtcB and bacterial (E. coli) RtcB also perform ligation of 2´,3´-cyclic 
phosphate RNAs and 5´-OH RNAs (Englert et al. 2011; Tanaka and Shuman 2011). Further 
biochemical studies by Shuman’s group demonstrated RtcB joins the ends by a multi-step 
mechanism: i) resolution of the 2´,3´-cyclic phosphate using cyclic phosphate diesterase 
(CPDase) activity, ii) formation of a covalent RtcB-GMP intermediate on His337, iii) 
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guanylation of the 3´-PO4 RNA terminus to form a (3′)pp(5′)G intermediate, and iv) attack 
of the 5´-OH terminus on the (3′)pp(5′)G to form the ligation junction (Chakravarty et al. 
2012; Chakravarty and Shuman 2012) (Figure 1.2B). The mechanism of RtcB represents 
a novel method of RNA ligation. I take advantage of the unique enzyme specificity of E. 
coli RtcB to ligate 5´-OH RNAs to a 3´-PO4 RNA/DNA oligonucleotide in the initial step 
of the 5OH-seq method (Chapter II). 
 
Rny1/Angiogenin: Stress-induced tRNA fragments 
 A growing body of literature is dedicated to understanding the generation and 
consequences of tRNA cleavage (Review: Saikia and Hatzoglou 2015). Presently, two 
major categories of tRNA fragments have been demonstrated in eukaryotic cells: stress-
induced tRNA fragments (tiRNAs) and tRNA-derived fragments (tRFs). This discussion 
will focus on tiRNAs, as they are the most well-studied tRNA fragments and have 5´-OH 
termini. 
In both prokaryotes and eukaryotes, tRNAs are cleaved in the anticodon loop during 
specific cellular stress conditions to yield 3´ and 5´ halves termed tiRNAs. The 3´-tiRNAs 
are produced with 5´-OH termini, and the 5´-tiRNAs have 2´,3´-cyclic phosphate termini. 
Studies in E. coli were the first to identify a mechanism for in vivo tiRNA generation. In 
response to bacteriophage T4 infection, the PrrC nuclease cleaves tRNA
Lys
 in the anticodon 
loop (Levitz et al. 1990). Another study showed that colicin E5 cleaved 3´ of a queuine 
wobble base in tRNAs for Tyr, His, Asn, and Asp (Ogawa et al. 1999). In contrast to 






Figure 1.2. Yeast and human pathways for processing of intron-containing tRNAs. 
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Figure 1.2. Yeast and human pathways for processing of intron-containing tRNAs. 
A. Yeast pathway for cleavage and ligation. (1) The TSEN complex cleaves intron-
containing tRNAs, yielding a 5´-half with a 2´,3´-cyclic phosphate terminus and a 3´-half 
with a 5´-OH terminus. (2) Trl1 resolves the 2´,3´-cyclic phosphate terminus to a 2´-PO4, 
(3) phosphorylates the 5´-OH terminus, and (4) adenylates the new 5´-PO4 terminus. (5) 
The 3´-OH attacks the adenylated intermediate. (6) Tpt1 removes the 2´-PO4 at the splicing 
junction. 
B. Human pathway for cleavage and ligation. (1) The TSEN complex cleaves intron-
containing tRNAs as in A. (2) RTCB resolves the 2´,3´-cyclic phosphate terminus to a 3´-




prokaryotic stress response shuts down translation by cleaving a large percentage of the 
pool (Thompson and Parker 2009a). 
Although tRNA fragments had been identified in the the urine and sera of cancer 
patients in the late 1970s, evidence of in vivo eukaryotic tRNA cleavage came much later. 
The first study demonstrating in vivo eukaryotic tRNA cleavage showed that starvation by 
amino acid deprivation of Tetrahymena induced anticodon loop cleavage in asparagine, 
glycine, and threonine tRNAs (Lee and Collins 2005). In 2009, RNase T2 family member 
Rny1 was identified as the endoribonuclease responsible for tiRNA generation in yeast 
under oxidative stress conditions (Thompson and Parker 2009b). Yeast tiRNAs are also 
produced in numerous other stress conditions, including: nitrogen starvation, methionine 
starvation, heat shock, and entrance into stationary phase (Thompson et al. 2008). Rny1 is 
normally sequestered in the vacuole or secreted, and is only released into the cytoplasm in 
the presence of cellular stressors (Thompson and Parker 2009b) (Figure 1.3A). 
In mammals, Angiogenin is an endoribonuclease that cleaves tRNA anticodon 
loops under stress conditions. Though Angiogenin shares this common function with Rny1, 
it is not a homolog, and the mammalian Rny1 homolog RNASET2 does not cleave tRNAs 
(Yamasaki et al. 2009). Angiogenin is a secreted ribonuclease of the RNase A superfamily 
that was initially discovered as an angiogenic factor in conditioned medium of HT-29 colon 
adenocarcinoma cells (Fett et al. 1985). While it was known that Angiogenin hydrolyzes 
tRNAs when injected into Xenopus oocytes (Saxena et al. 1992), it was not until 2009 that 
Angiogenin was shown to generate tiRNAs in human fetus hepatic tissue and human 
osteosarcoma cells (U2OS) (Fu et al. 2009; Yamasaki et al. 2009). To become activated, 
Angiogenenin must translocate from the nucleus to the cytoplasm and dissociate from 
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Ribonuclease/Angiogenin Inhibitor 1 (RNH1) (Thompson and Parker 2009a). Once active 
in the cytoplasm, Angiogenin cleaves tRNAs near the anti-codon loop to yield 3´ and 5´ 
tiRNAs (Figure 1.3B). Angiogenin is downregulated in several neurodegenerative 
diseases, and loss of function mutations have been identified in patients with amyotrophic 
lateral sclerosis (ALS) (Greenway et al. 2004), and Parkinson’s disease (PD) (van Es et al. 
2011). However, Angiogenin can also promote cellular growth and is upregulated in many 
solid tumors including the colorectal, prostate, and breast cancers (Shimoyama et al. 1999; 
Katona et al. 2005; Montero et al. 1998). 
Several studies have implicated tiRNAs in inhibition of both translation and 
apoptosis.  Transfection of 5´-tiRNAs, but not 3´-tiRNAs, promotes stress granule 
formation and moderately inhibits protein synthesis, independent of eIF2α 
phosphorylation state (Emara et al. 2010). Synthetic 5´-tiRNAs can also displace eIF4G/A 
from mRNAs to inhibit translation in rabbit reticulocyte lysate (Ivanov et al. 2011). tiRNAs 
can saturate the Dicer binding pocket, decreasing cleavage of dsRNA substrates (Durdevic 
et al. 2013). Finally, both 5´-tiRNAs and 3´-tiRNAs can bind cytochrome c, competitively 
inhibiting the binding of apoptotic protease-activating factor 1 (APAF1), thus suppressing 
apoptosis (Saikia et al. 2014). 
 
Ire1: non-canonical splicing of HAC1 mRNA 
The unfolded protein response (UPR) is a conserved eukaryotic intracellular 
signaling pathway activated in response to endoplasmic reticulum (ER) stress (Walter and 




Figure 1.3. Rny1 (yeast) and Angiogenin (humans) cleave the anticodon loops of 
tRNAs under stress conditions. 
A. In yeast, Rny1 is normally sequestered in the vacuole or secreted. Following certain 
stress conditions, Rny1 is released to the cytoplasm. Rny1 cleaves tRNAs in the anticodon 
loop, generating a 5´-tiRNA with a 2´,3´-cyclic phosphate terminus and 3´-tiRNA with a 
5´-OH terminus. Does Rny1 target other RNAs? 
B. In humans, Angiogenin (Ang) is usually localized to the nucleus or secreted. During 
cellular stress, Ang enters the cytoplasm and dissociates from Ribonuclease/Angiogenin 
Inhibitor 1 (RNH1). Ang generates the same tiRNAs as Rny1 in A. These tiRNAs may 
interact with several downstream pathways. Does Angiogenin target other RNAs? 
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the UPR is triggered, resulting in upregulation of protein-folding machinery (Kozutsumi et 
al. 1988). The net result is an increase in the size and folding-capacity of the ER and a 
resolution of the unfolded protein burden (Schuck et al. 2009). The UPR is naturally 
triggered by a multitude of environmental stimuli, diseases, and developmental processes 
including: oxidative stress; viral infection (Bechill et al. 2006; 2008); inherited diseases of 
protein misfolding, such as cystic fibrosis and retinitis pigmentosa; and the development 
of antibody-secreting plasma cells (Gass et al. 2002; Iwakoshi et al. 2003) or pancreatic ß-
cells (Harding et al. 2001; Zhang et al. 2002). The UPR is commonly chemically induced 
by tunicamycin, an inhibitor of N-linked glycosylation of proteins, which decreases protein 
stability. Dithiothreitol (DTT), which reduces disulfide bonds and thus results in decreased 
protein stability, can also be used to induce the UPR. 
In budding yeast, the UPR is mediated by a single pathway controlling the non-
canonical cytosolic splicing of HAC1 mRNA, which encodes a transcription factor that 
resolves ER stress by upregulating key protein folding machinery and chaperones.  This 
unexpected and unprecedented means of RNA regulation was revealed by a series of 
elegant experiments conducted independently by Peter Walter at UCSF and Kazutoshi 
Mori at UT Southwestern and Kyoto University in the early 1990s, for which they were 
jointly awarded the Lasker Award in 2012. 
Several early studies suggested the existence of a regulated system for increasing 
protein expression under specific cellular stress conditions. The first of these studies 
showed that the mRNA levels of two glucose regulated proteins (GRPs) p4A3 and p3C5 
increased under conditions of glucose starvation in the hamster K12 cell line (Lee et al. 
1983). While it was initially thought that induction of GRPs was due to defective 
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glycosylation caused by glucose depletion, induction of GRPs by amino acid analogues 
argued against this theory (Kelley and Schlesinger 1978). Impaired protein folding was 
also shown to regulate the expression of GRPs. In simian CV-1 cells, expression of a 
misfolded influenza virus haemagglutinin (HA) but not wildtype HA induced GRP78 and 
GRP94/HSP90 (Kozutsumi et al. 1988). GRP78 was later renamed BiP and is encoded by 
the KAR2 gene in yeast (Normington et al. 1989). 
The discovery of Ire1 and Hac1 in the molecular regulation of the UPR was spurred 
by the identification of a 22 nt conserved sequence in the KAR2 promoter. This conserved 
UPR element (UPRE) is required for induction of yeast BiP in response to tunicamycin 
(Mori et al. 1992; Kohno et al. 1993). Independently, Walter and Mori expressed the UPRE 
upstream of the E. coli ß-galactosidase gene (lacZ) creating a colorimetric system for 
screening yeast genomic libraries and ultimately identifying Ire1/Ern1, a putative protein 
kinase (Nikawa and Yamashita 1992), as a required gene for upregulation of KAR2 
expression following treatment with tunicamycin (Cox et al. 1993; Mori et al. 1993). 
Further studies revealed Ire1 spans the ER membrane due to an N-terminal ER signal 
adjacent to a hydrophobic region and contains a C-terminal cytosolic kinase domain whose 
enzymatic activity is essential for complementation of temperature sensitive ern1-1 
mutants (Mori et al. 1993). The initial presumption was that Ire1 would phosphorylate and 
activate a transcription factor that would subsequently recognize the UPREs upstream of 
target genes. Indeed, using an adapted yeast in vivo one-hybrid screening system (Mori et 
al. 1996) or an overexpression system (Cox and Walter 1996), Mori and Walter each 
identified Hac1/Ern4 as the transcription factor responsible for binding the UPRE and 
upregulating expression of target genes. 
	 22 
Peter Walter’s group then proceeded to make the revolutionary discovery that Hac1 
signaling was not regulated by phosphorylation, but by non-canonical cytosolic mRNA 
splicing, publishing two essential studies in the same issue of Cell. In one publication, they 
showed that HA-Hac1 was undetectable by immunofluorescence with an α–HA antibody 
under normal growth conditions, but was detected in the nucleus when cells were induced 
with tunicamycin. Northern analysis demonstrated that the HAC1 mRNA shortened in an 
Ire1-dependent manner following treatment with tunicamycin, and sequencing revealed the 
excision of a 252 nt intervening sequence (IVS) and splice junctions of the mRNA that 
differed from consensus spliceosome recognition sequences (Cox and Walter 1996). The 
second study used a sectoring screen in a kar2-∆HDEL yeast stain to identify Trl1/Rlg1 as 
the HAC1 mRNA ligase (Sidrauski et al. 1996). The following year, Walter’s group 
demonstrated that Ire1 cleaves at a conserved 5´-CN|CNNG-3´ motif in stem loops at the 
3´ and 5´ splice junctions (Sidrauski and Walter 1997). 
The series of experiments described above unveiled the first and only known 
example of a signaling pathway that is regulated by the cytosolic splicing of an mRNA. 
Ire1 oligomerizes upon sensing unfolded proteins via its luminal domain (Gardner and 
Walter 2011).  This oligomerization promotes the activation of the Ire1 cytosolic 
endoribonuclease domain. When the Ire1 endoribonuclease domain is activated, it cleaves 
HAC1 mRNA at two locations on either side of the excised intron at sequence-specific 
recognition motifs (Kawahara et al. 1998), generating fragments with 2´,3´-cyclic 
phosphate and 5´-OH termini (Gonzalez et al. 1999). Non-canonical cytosolic splicing of 
the exons is then carried out by tRNA ligase Trl1 via the three distinct enzymatic activities 
previously described in “TSEN: Processing of intron-containing tRNAs.” Following 
	 23 
removal of this phosphate by Tpt1 (Spinelli et al. 1997), spliced HAC1 mRNA is translated, 
yielding a functional transcription factor that upregulates approximately 7% of yeast genes 
to modulate the ER stress response (Travers et al. 2000), including key UPR markers 
KAR2, EUG1 (Tachibana and Stevens 1992), and  PDI1 (Cox et al. 1993). While the UPR 
is non-essential for growth in the absence of cellular stress, HAC1 and IRE1 null mutants 
grow slowly compared to wild type yeast and both are required under UPR-inducing 
conditions (Figure 1.4). 
Key publications in the 2000s further extended this complex model of HAC1 
mRNA splicing and resolved two unanswered questions by attributing regulatory 
significance to both the intron and the 5´- and 3´-UTRs. Previous experiments had revealed 
curious findings of unspliced HAC1 mRNA (HAC1
U
): In situ hybridization experiments 
localized HAC1
U
 to the cytoplasm (Chapman and Walter 1997), and large portions of 
HAC1
U
 comigrated with polyribosomes on sucrose gradients (Cox and Walter 1996). This 
suggested that Hac1
U
 is partially translated by ribosomes that subsequently stall on the 
HAC1
U
 mRNA. These findings were resolved by demonstrating that translational 
attenuation is mediated by a long-range 16 nucleotide base-pairing interaction between the 
intron and the 5’ UTR (Rüegsegger et al. 2001). There still remained the question of what 
might promote the colocalization of HAC1 mRNA and Ire1 prior to cleavage. Mutational 
probing of the HAC1 3´-UTR revealed a prominent, extended stem-loop with a conserved 
bipartite element (3´ BE) which targets HAC1 mRNA to Ire1 foci to promote cleavage 
during ER stress (Aragón et al. 2008) (Figure 1.4). 
Given these latest examples of UPR regulation by the mRNA transcript itself, I was 
particularly curious about the findings of a recent study that captured HAC1 3´-exons with 
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5´-PO4 termini in dcp2∆ xrn1∆ yeast (these genes are discussed in the “RNA Decay 
Pathways” section) (Harigaya and Parker 2012). The existence of HAC1 3´-exons with  
5´-PO4 termini is perplexing because HAC1 mRNA is cleaved by metal ion-independent 
endoribonuclease Ire1, and the 3´-exon should therefore be generated with a 5´-OH 
terminus (Figure 1.4). If the HAC1 3´-exon can exist with a 5´-PO4 terminus, it must be 
phosphorylated after Ire1 cleavage. Furthermore, because the HAC1 3´-exon with a 5´-PO4 
terminus accumulates when Xrn1 is deleted, Xrn1 must be required for the degradation of 
this exon. In Chapter II, I use 5OH-seq to replicate the capture of HAC1 3´-exons with  
5´-PO4 termini in xrn1∆ yeast. This finding sets up the experimentation in Chapter III, 
where I investigate the phosphorylation and decay of the HAC1 3´-exon intermediate. 
 
IREα: non-canonical splicing of XBP1 mRNA and RIDD 
 In contrast to the single UPR pathway found in yeast, the human UPR is mediated 
via three branches: PERK, ATF6, and IREα (Walter and Ron 2011).  (This discussion will 
be limited to the IRE1α pathway, as it is the only pathway conserved with yeast and the 
only pathway regulated by mRNA splicing.) Similar to yeast, the IREα branch signals via 
the non-canonical cytosolic splicing of XBP1 mRNA, the human ortholog of yeast HAC1. 
In contrast to yeast HAC1 mRNA, XBP1 mRNA is targeted to the ER membrane by the 
nascent peptide of the partially translated Xbp1 protein (Yanagitani et al. 2009; 2011), and 
the two conserved recognition motifs that are cleaved by IRE1α excise a 26 nt intron 
following UPR activation (Figure 1.5). 
Until 2014, there was debate as to the primary mammalian pathways for XBP1 
mRNA ligation following IRE1α-mediated cleavage: a yeast-like pathway and a direct-  
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Figure 1.4. The unfolded protein response (UPR) in yeast is primarily regulated by 
the non-canonical cytosolic splicing of HAC1 mRNA. 
(1) HAC1 mRNA is targeted to the ER membrane by a bipartite element (BE) in the 3´-
UTR. (2) Translation of HAC1 is attenuated by long-range base-pairing of the intron and 
the 5´-UTR. (3) During ER stress, unfolded proteins are sensed by Ire1, which promotes 
oligomerization, autophosphorylation, and activation of the endoribonuclease domain.  
(4) Active Ire1 cleaves HAC1 mRNA in two conserved stem loops, generating a 5´-exon 
with a 2´,3´-cyclic phosphate terminus and 3´-exon with a 5´-OH terminus. (5) Trl1 ligates 
the exons, and (6) Tpt1 removes a 2´-PO4 at the splicing junction. (7) Spliced HAC1 mRNA 
is translated to Hac1 protein, (8) which translocates to the nucleus, binds UPR elements 
(UPREs), and upregulates expression of ~7% of the yeast genome. Inset: (?) Ire1 cleavage 
produces HAC1 3´-exon mRNA intermediates with 5´-OH termini. In dcp2∆ xrn1∆ yeast 
strains, these intermediates accumulate with 5´-PO4 termini. Does phosphorylation of the 
HAC1 3´-exon by Trl1 promote decay by Xrn1? 
	 26 
ligation pathway. In the hypothetical yeast-like pathway, the three enzymatic roles of yeast 
Trl1 would be carried out by analogous but non-homologous human counterparts: CNP, a 
cyclic phosphodiesterase; CLP1, a polynucleotide kinase (discussed in further detail in the 
“Kinase-Mediated Decay” section); and an unknown ligase. TRPT1, a phosphodiesterase 
homologous to the yeast Tpt1, would be a likely candidate for 2´-PO4 removal. However, 
CNP and TRPT1 are non-essential in mice, and TRPT1-null mice have intact XBP1 
splicing (Harding et al. 2007). Rather than resolve the 2´,3´-cyclic phosphate and 5´-OH 
termini, ligate, and remove the 2´-PO4 via four enzymes, the direct ligation pathway would 
join these ends with a single enzyme (Schwer et al. 2008). As previously discussed in the 
“5´-OH RNAs in Biological Systems” section, RTCB performs such a direct ligation 
during processing of intron-containing tRNAs in humans (Popow et al. 2011). RTCB can 
also ligate Ire1-cleaved HAC1 mRNA in a yeast trl1∆ strain (Tanaka et al. 2011). However, 
a report demonstrating that XBP1 mRNA ligation was not impaired when RTCB was 
depleted by RNAi in HeLa cells (Iwawaki and Tokuda 2011) argued against RTCB as the 
ligase for XBP1 mRNA. 
In late 2014, a series of three publications revealed that RTCB is the mammalian 
UPR ligase (Lu et al. 2014; Kosmaczewski et al. 2014; Jurkin et al. 2014) (Figure 1.5).  
The first created a synthetic circuit wherein an XBP1 splicing-dependent 4-OHT-regulated 
Cre sensor activates Bim expression to generate a robust apoptotic response in SNL cells 
(Lu et al. 2014). This clever biological engineering approach enabled an unbiased screen 
that identified RTCB as the requisite XBP1 mRNA ligase. Kosmaczewski et al. bypassed 





 in vivo. They were able to demonstrate  impaired XBP1 
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mRNA splicing of endogenous intron-containing tRNAs in RtcB null worms 
(Kosmaczewski et al. 2014). (We employ a similar strategy in Chapter III to evaluate the 
requirement of Trl1 in the phosphorylation of the 3´ cleavage product of HAC1 mRNA in 
the yeast UPR.) The final publication showed that simultaneous depletion of  RTCB and 
its Archease cofactor by Dox-inducible shRNAs abolishes XBP1 mRNA splicing in HeLa 
cells (Jurkin et al. 2014). 
Recent studies have linked RTCB ligase activity to several essential processes. The 
RTCB-mediated splicing of XBP1 is required for secretion of antibodies in human plasma 
cells (Jurkin et al. 2014). In the orthologous C. elegans system, RTCB-1 splicing of xbp-1 
protects neurons from degeneration induced by human α–synuclein, which is a hallmark 
of Parkinson’s disease (Ray et al. 2014). RtcB also localizes to the site of neuronal injuries 
in C. elegans and inhibits axon regeneration independent of xbp-1 ligation, tRNA ligation, 
and cofactor Archease (Kosmaczewski et al. 2015). 
In many eukaryotes, activated IRE1 broadly cleaves mRNA in a process termed 
Regulated Ire1-Dependent Decay (RIDD) (Hollien and Weissman 2006) (Figure 1.5). 
During RIDD, Ire1 cleaves mRNAs that are colocalized to the ER, generating RNA 
fragments with 2´,3´-cyclic phosphate and 5´-OH termini. RIDD was first identified by 
microarray studies of Drosophila S2 cells depleted of either IRE1 or XBP-1 by RNAi and 
induced with DTT.  A population of mRNAs were differentially repressed in IRE1-depleted 
cells but not XBP-1-depleted cells, and this was shown to be the result of mRNA cleavage 
performed by IRE1 that was dependent on co-translational ER-localization of the mRNA 
(Hollien and Weissman 2006). Subsequent studies have extended RIDD to plants (Hayashi 
et al. 2012), fission yeast (Kimmig et al. 2012), and mammals (Hollien et al. 2009). While  
	 28 
 
Figure 1.5. Human IRE1α cleaves XBP1 and ER-proximal mRNAs. 
(1) The nascent peptide of partially translated XBP1 targets the mRNA to the ER. (2) 
During ER stress, IRE1α oligomerizes, promoting autophosphorylation and activation of 
the endonuclease domain. (3) Active IRE1α cleaves XBP1, generating a 5´-exon with a 
2´,3´-cyclic phosphate terminus and a 3´-exon with a 5´-OH terminus. (4) RTCB ligates 
the exons. (5) Spliced XBP1 mRNA is translated to XBP1
S
 protein and upregulates 
expression of protein chaperones and folding machinery. (6) Active IRE1α also cleaves 
ER-proximal mRNAs in a process termed Regulated IRE1-Dependent Decay (RIDD). 
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RIDD has not been demonstrated in budding yeast, the conservation of Ire1 and the 
HAC1/XBP1 pathway in eukaryotes suggests a similar pathway may be present, and I 
investigate this further in Chapter II. Importantly, although the 3´ mRNA fragments have 
5´-OH termini following cleavage by IRE1, the initial RIDD paper demonstrated that these 
species accumulate in XRN1-depleted cells (Hollien and Weissman 2006). This 
discrepancy is not addressed and RIDD-substrates are prime candidates for “kinase-
mediated decay”, which is explained later in this chapter and discussed in Chapter III.   
At the time of this dissertation, hundreds of publications have purported a UPR  
phenotype in human disease, comprising an extensive breadth of syndromes. In 1999, a 
group in Osaka, Japan was the first to implicate the UPR in a specific disease, early-onset 
familial Alzheimer’s disease (FAD). Their study demonstrated that missense-mutations in 
the human presenilin-1 (PS1) gene – the most common autosomal dominant cause of early-
onset FAD – increased sensitivity of neuroblastoma cells to tunicamycin and inhibited 
induction of GRP78/BIP mRNA (Katayama et al. 1999).  Since this initial study, aberrant 
regulation of the UPR has been linked to multiple disease processes, including: i) protein 
misfolding (e.g., proinsulin 2 in ß-cell death and procollagen in osteogenesis imperfecta); 
ii) polyglutamate expansions, such as Machado-Joseph disease; iii) cancers, including 
myeloma, breast cancer, many others; and iv) neurodegenerative diseases, specifically 
Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis (Reviews: 
(Kaufman 2002; Lee and Ozcan 2014)). While description of the causes and implications 
of UPR misregulation in each of these diseases is beyond the scope of this thesis, such 
extensive connections between UPR and disease demonstrates the paramount importance 
of understanding the molecular mechanisms modulating this ubiquitous stress response. 
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RNA Decay Pathways 
 Within this section, I provide an overview of RNA decay. I outline the known 
primary cytosolic mRNA degradation pathways of Xrn1 and the exosome.  I also describe 
several degradation pathways for defective mRNAs: nonsense-mediated decay (NMD), 
non-stop decay (NSD), and no-go decay (NGD).  Finally, I introduce previously 
unaddressed questions of 5´-OH RNA decay. 
 
5´→3´ degradation by 5´-phosphate-dependent exoribonucleases 
 The constant production of mRNAs necessitates robust mechanisms of regulated 
mRNA turnover. In the late 1970s, studies of the 5´ mRNA cap structure in Xenopus, wheat 
germ, and mouse L cells suggested that a 5´→3´ decay process might hydrolyze uncapped 
mRNAs (Furuichi et al. 1977; Shimotohno et al. 1977). Shortly thereafter, Audrey Stevens 
purified an exoribonuclease from yeast and demonstrated that it performed 5´ hydrolysis 
of radiolabelled RNA with a 5´-PO4 termini (Stevens 1980). This protein was named 
eXoRiboNuclease 1 (Xrn1) (Larimer and Stevens 1990), and subsequently shown to 
degrade mRNA by processive 5´-phosphate–dependent 5´→3´ hydrolysis (Hsu and 
Stevens 1993; Muhlrad et al. 1994; Stevens 2001). 
Most 5´-capped mRNAs are deadenylated and decapped prior to degradation. The 
first step of decay is deadenylation by the Ccr4/Pop2/Not complex (Brown and Sachs 1998; 
Tucker et al. 2001) or a secondary Pan2/Pan3 complex (Boeck et al. 1996). Deadenylation 
is regulated by several RNA binding proteins (RBPs), particularly the poly-A binding 
protein (Pab1), which binds the polyadenylated mRNA and inhibits the Ccr4 deadenylase 
(Caponigro and Parker 1995). Decapping proteins 1 and 2 (Dcp1/Dcp2) subsequently 
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remove the 7-methylguanylate caps of the deadenylated transcripts (van Dijk et al. 2002); 
however, decapping proceeds independently of deadenylation for a subset of mRNA 
transcripts (Muhlrad and Parker 2005). As with deadenylation, decapping is a highly 
regulated process, and likely predominantly regulated by Pat1/Lsm1-7 mediated 
recruitment of Dcp1/Dcp2 (Review: Parker 2012). 
The final product of most mRNA decapping events is a deadenylated mRNA with 
a 5´-PO4 terminus that Xrn1 recognizes and degrades (Figure 1.6). Xrn1 is non-essential 
in yeast, presumably due to secondary pathways of degradation; however, xrn1∆ strains 
have a decreased rate of mRNA decay, which varies between a 1.5 to 6-fold reduction 
depending on the mRNA transcript (Cao and Parker 2001). In contrast, Xrn1/Pacman 
knockdowns in higher-order eukaryotes C. elegans and Drosophila confer either 
developmental failures or lethality, confirming that 3´→5´ decay pathways cannot 
compensate for defective 5´→3´ decay (Newbury and Woollard 2004; Jones et al. 2012).  
In addition to Xrn1, there are two other known 5´-phosphate-dependent 5´→3´ 
exoribonucleases in yeast. The most well-studied of these is Rat1, known as Xrn2 in 
higher-order eukaryotes. The essential RAT1 gene was initially identified in a screen for 
defective poly(A) mRNA transport from the nucleus (thus its name: Ribonucleic Acid 
Trafficking 1), and encodes an exoribonuclease similar to Xrn1 (Amberg et al. 1992; 
Kenna et al. 1993). Rat1 is predominantly expressed in the nucleus, and overexpression of 
wild-type RAT1 can only partially restore growth defects in xrn1∆ yeast (Poole and Stevens 
1995). However, expression of RAT1 with mutations that increase cytosolic localization 
can fully complement xrn1∆ yeast. Similarly, Xrn1 is primarily located in the cytoplasm, 
but XRN1 tagged with a nuclear localization signal (NLS) can rescue temperature-sensitive 
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rat1-1 yeast (Johnson 1997). Thus, Xrn1 and Rat1 are functionally interchangeable 
exoribonucleases, but are restricted to the cytoplasm and nucleus, respectively.  Rat1 is 
required for pre-rRNA trimming (Henry et al. 1994) (described in the “Kinase-Mediated 
Decay” section), snoRNA processing (Petfalski et al. 1998), and mRNA transcription 
termination (Kim et al. 2004; Ghazal et al. 2009). 
Functional studies of a Rai1 homolog Ydr3706 recently revealed a third 5´-
phosphate-dependent 5´→3´ exoribonuclease in yeast. Though initially evaluating the 
effects of Ydr3706 on decapping, a group at Columbia discovered the protein had 
distributed 5´→3´ exoribonuclease activity and proposed the new name Decapping 
eXOnuclease 1 (Dxo1). The study showed that Dxo1 can degrade 5´-PO4 RNA, but cannot 
proceed through a RNA-DNA heteroduplex, suggesting that Dxo1 is weaker than Xrn1 and 
more prone to stalling (Chang et al. 2012). The mammalian homolog DXO is restricted to 
the nucleus and acts as a 5´ end quality control mechanism to detect and degrade 
incompletely 5´ end-capped pre-mRNAs (Jiao et al. 2013); however, it is not known what 
role cytosolic yeast Dxo1 might play in cytosolic mRNA decay. 
 
3´→5´ degradation by the exosome 
A secondary pathway for RNA degradation following deadenylation is 3´→5´ 
degradation by the exosome (Figure 1.6). The exosome was first discovered when 
immunoprecipitation of Ribosomal RNA Processing 4 (Rrp4), a  protein required for 
3´→5´ exonuclease activity on 5.8S rRNA, revealed that it was part of a much larger 
complex (Mitchell et al. 1997). Mass spectrometry analysis enabled identification of four 
associated proteins – thereafter named Rrp41, Rrp42, Rrp43, and Rrp44 – each of which is 
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required for 5.8S rRNA 3´ end formation (Mitchell et al. 1997). Studies over the subsequent 
decade demonstrated that the exosome is a complex comprised of 10 key proteins: the 
exonuclease and endonuclease domain-containing Rrp44/Dis3 protein and a nine-member 
ring structure formed by six RNase PH proteins (Rrp41, Rrp42, Mtr3, Rrp43, Rrp46, 
Rrp45) and three small RNA-binding proteins (Rrp4, Rrp40, and Csl4) analogous to 
bacterial PNPase (Allmang et al. 1999; Liu et al. 2006). While the core exosome complex 
is present in both the nucleus and the cytoplasm, the exosome requires four Ski proteins 
(Ski2, Ski3, Ski7, and Ski8) for cytoplasmic mRNA decay (Anderson and Parker 1998; 
van Hoof et al. 2000b). The Ski2 protein is an ATPase that may act as an RNA helicase to 
unwind structured RNAs and remove bound proteins; a related protein, Mtr4, may perform 
the same activity when associated with the nuclear exosome (Lykke-Andersen et al. 2009). 
Deadenylation occurs prior to 3´→5´ exosomal decay of mRNAs, possibly due to removal 
of factors bound to the poly(A) tail that would otherwise inhibit the exosome (Parker 2012). 
In contrast to the 5´-PO4 terminus requirement of Xrn1, the effect of RNA 3´ terminal 
modifications on recognition and degradation by the exosome is unknown.  
The components of the exosome are well-conserved in humans, and mutations can 
greatly compromise neurodevelopment. For example, a recent study that sequenced the 
exomes of patients with pontocerebellar hypoplasia type 1 (PCH1) revealed recessive 
mutations in EXOSC3, the human homolog of yeast RRP40 (Wan et al. 2012). A 
morpholino knockdown of exosc3 mRNA in zebrafish conferred maldevelopment 





Figure 1.6. Canonical cytosolic mRNA decay pathways: Xrn1 and the exosome. 
(1) The first step in cytosolic mRNA decay is deadenylation by the Ccr4/Pop2/Not complex 
or the Pan2/Pan3 complex. (2) Dcp1 and Dcp2 are recruited to the 5´ terminus and Dcp2 
removes the m
7
G cap, leaving a 5´-PO4 terminus. (3) Xrn1-mediated degradation of 
decapped 5´-PO4 mRNA proceeds 5´→3´. The cytosolic exosome is comprised of a 
9-member ring structure and the Rrp44 nuclease. (4) Degradation of deadenylated mRNA 




Decay pathways for defective mRNAs 
In addition to the major Xrn1 and exosome decay pathways, three other minor 
pathways for mRNA quality control have been described in yeast: nonsense-mediated 
decay (NMD), non-stop decay (NSD), and no-go decay (NGD) (Figure 1.7). The most  
well-studied of these mRNA quality control mechanism, NMD, was first suggested in 1979 
when amber nonsense mutations introduced into the yeast URA3 gene decreased mRNA 
stability (Losson and Lacroute 1979). Other than mRNAs with the nominal nonsense 
mutations, NMD acts on a broad array of substrates with anomalous translation 
termination, as well as a subset of “normal” mRNAs (Parker 2012). These defective 
mRNAs are marked by Upf1, Upf2, and Upf3 interaction and are subject to rapid 
deadenylation-independent decapping followed by 5´-phosphate-dependent degradation 
by Xrn1 (Baker and Parker 2004) (Figure 1.7A). NMD is conserved in Drosophila 
(Gatfield et al. 2003) and mammals (Lejeune et al. 2003); however, metazoans have 
additional mechanisms for mediating NMD, including SMG6, an endonucleolytic 
component that cleaves mRNA at premature translation termination codons (PTCs) 
(Huntzinger et al. 2008). SMG6-mediated cleavage allows cytosolic decay by XRN1 and 
the exosome to proceed from the site of PTC in the 5´→3´ and 3´→5´ directions, 
respectively (Stevens et al. 2002). 
Nonstop decay (NSD) occurs when a translating ribosome reaches the 3´ end of an 
mRNA without reaching a stop codon (Figure 1.7B). The stalled ribosome is recycled by 
Dom34/Hbs1 (discussed in more detail below) and triggers rapid 3´→5´ Ski-dependent 
degradation of the mRNA by the exosome (Frischmeyer 2002; van Hoof et al. 2002; Tsuboi 
et al. 2012). NSD of the mRNA occurs concomitantly with rapid proteasome-mediated 
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decay of the nascent peptide promoted by Ltn1 (Wilson et al. 2007) or Not4 (Dimitrova et 
al. 2009). NSD can be differentiated from canonical exosomal decay by its requirement of 
the GTPase domain of Ski7 (van Hoof et al. 2002). Though NSD is primarily a 3´→5´ 
decay process, decapping by Dcp1 and 5´→3´ decay by Xrn1 does play a minor role in 
degrading mRNAs without stop codons (Frischmeyer 2002). 
No-go decay (NGD) refers to endonucleolytic cleavage of mRNA that occurs when 
a translating ribosome stalls, followed by degradation of the cleavage fragments (Figure 
1.7C). NGD was first demonstrated in yeast expressing a PGK1 reporter with a stable stem-
loop insertion in the coding region (PGK1-sL). Deletion of XRN1 leads to accumulation of 
fragments 3´ of the stem loop, and cytosolic exosome mutant strains ski2∆, ski3∆, and 
ski7∆ accrue fragments 5´ of the stem loop (Doma and Parker 2006). Rare codons, runs of 
polylysine and polyarginine, depurination sites, and possibly frameshift sites can also 
trigger NGD (Parker 2012). 
Dom34 is required for the accumulation of NGD fragments for certain NGD 
triggers (Doma and Parker 2006), but is dispensable for others (Kuroha et al. 2010; Passos 
et al. 2009; Chen et al. 2010). Dom34 is structurally similar to translation termination factor 
eRF1 and interacts with Hbs1, a protein related to eRF3. A cryo-EM structure of the 
Dom34-Hbs1 complex bound to a stalled ribosome showed that the N-terminal domain 
(NTD) of Dom34 reached deep into the A-site (Becker et al. 2011). This association may 
disrupt the mRNA stabilizing network, leading to dissociation of the nascent peptide and 
rescue of the ribosome. Dom34 is thought to recycle ribosomes at the 3´-ends of truncated 




Figure 1.7. Decay pathways for defective mRNAs: nonsense-mediated decay (NMD), 
non-stop decay (NSD), and no-go decay (NGD). 
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Figure 1.7. Decay pathways for defective mRNAs: nonsense-mediated decay (NMD), 
non-stop decay (NSD), and no-go decay (NGD). 
A. Mechanism of nonsense-mediated decay (NMD). (1) A translating ribosome encounters 
a premature stop codon. (2) The mRNA is rapidly decapped by Dcp1/Dcp2. (3) Xrn1 
performs rapid 5´→3´ degradation of the 5-PO4 mRNA. 
B. Mechanism of nonstop decay (NSD). (1) A translating ribosome reaches the end of an 
mRNA without encountering a stop codon. (2) Dom34/Hbs1 rescue the stalled ribosome, 
and (3) the truncated mRNA is rapidly degraded 3´→5´ by the exosome. 
C. Mechanism of no-go decay (NGD). (1) A translating ribosome stalls due to a strong 
secondary structure, polycharged bases, etc. (2) An unidentified endoribonuclease cleaves 
upstream of the stall, and (3) Dom34/Hbs1 rescue the stalled ribosome. (4) The exosome 
degrades the 5´-NGD fragment, and (5) Xrn1 degrades the 3´-NGD fragment. Inset: (?) 
Does the NGD cleavage produce a 3´-fragment with a 5´-PO4 or a 5´-OH that must be 
phosphorylated prior to decay? 
Adapted from (Parker 2012; Shoemaker and Green 2012) 
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Although targets of NGD have not been specifically identified in higher-order 
eukaryotes, the Dom34 homolog Pelota is highly conserved. Pelota is required for mitotic 
and meiotic cell division in Drosophila (Eberhart and Wasserman 1995), and homozygous 
Pelota deficient mice fail to develop past embryogenesis day 7.5 (E7.5) (Adham et al. 
2003). In mice with a CNS-specific tRNA
Arg
UCU SNP,  loss of Pelota binding partner 
GTPBP2 induces ribosome stalling and neurodegeneration, indicating the potential 
importance of Pelota in mammalian NSD/NGD (Ishimura et al. 2014). 
The endonuclease responsible for cleavage in NGD decay remains unknown, and 
this is a key gap in understanding NGD. Early reports suggested that Dom34 and the 
Dom34 archaea ortholog had RNA nuclease activity (Lee et al. 2007), but subsequent 
studies could not reproduce these results (Passos et al. 2009). Importantly, as the nuclease 
has still not been identified, the ends generated after cleavage remain ambiguous. If the 
cleavage is performed by a metal ion-dependent endonuclease, the 3´ fragment would have 
a 5´-PO4 terminus. However, if the cleavage is performed by a metal ion-independent 
endonuclease or in-line cleavage, the 3´ fragment would have a 5´-OH terminus. In this 
latter case of cleavage chemistry, the 3´ fragment with a 5´-OH terminus would require 
phosphorylation prior to decay by Xrn1. 
 
5´→3´ decay pathways do not account for 5´-OH RNAs 
The RNA decay field does not currently address the 5´→3´ degradation of 5´-OH 
RNAs. Three known 5´→3´ exoribonucleases Xrn1, Rat1, and Dxo1 (XRN1, XRN2, and 
DXO in mammals) require an RNA substrate with a 5´-PO4 terminus (Stevens 2001). The 
NSD and NGD pathways for cytosolic decay of defective mRNAs both propose a final step 
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in 5´ end degradation that requires 5´-phosphate-dependent degradation by Xrn1. The  
5´-OH termini generated by metal-ion independent endoribonucleases, such as the HAC1 
mRNA intermediates produced by yeast Ire1 cleavage during the UPR, are immune to 
decay by these known 5´→3´ exoribonucleases. Therefore, 5´-OH RNAs cannot be 
substrates for degradation by Xrn1 or Rat1 without phosphorylation of the 5´ terminus. 
Similarly, if the 3´ cleavage products of NGD are generated with a 5´-OH rather than a 5´-
PO4, they would also require phosphorylation to become competent for 5´→3´ decay. 
 
Kinase-Mediated Decay 
Throughout this thesis, I use the term “kinase-mediated decay” (KMD) to refer to 
any decay process where a 5´-OH RNA is phosphorylated prior to decay by a 5´-phosphate-
dependent 5´→3´ ribonuclease. On the following pages, I describe KMD in three 
previously published examples: T4 phage infection of E. coli, tRNA intron processing in 
yeast, and pre-rRNA processing in yeast. Prior to this dissertation, these three disparate 
examples have not been united by a common theory of regulated RNA decay. 
 
Kinase-mediated decay of T4 bacteriophage mRNA 
 E. coli lack the 5´→3´ exoribonucleases found in eukaryotes, and instead 
accomplish mRNA degradation primarily via multiple endoribonucleolytic cleavages 
promoting 3´→5´ decay. The initial step in mRNA decay is conversion of the 5´-
triphosphate mRNA terminus to a 5´-PO4 terminus by RNA pyrophosphohydrolase (RppH) 
(Celesnik et al. 2007). RNase E and its homolog RNase G recognize the 5´-PO4 terminus 
of mRNA and cleave downstream, creating a 3´-fragment with a 5´-PO4 terminus that itself 
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can be recognized for additional cleavages (Mackie 1998; Spickler et al. 2001). The result 
of these cleavages is several smaller mRNA fragments, which are degraded by one of three 
3´→5´exoribonucleases – polynucleotide phosphorylase (PNPase), RNase R, and RNase 
II – and oligoribonuclease (Review: Andrade et al. 2009)). 
 Bacteriophage T4 infects E. coli and must coordinate expression of “early” and 
“late” genes during the infection. RegB is a unique sequence-specific endoribonuclease 
encoded by the T4 phage genome that cleaves primarily at tetranucleotide GGAG in the 
Shine-Dalgarno sequence of “early” genes (Uzan et al. 1988; Sanson et al. 2000; Saïda et 
al. 2003). As a metal ion-independent endoribonuclease, RegB leaves a 5´-OH terminus on 
the 3´ cleavage fragment (Uzan et al. 1988; Saïda et al. 2003). This 5´-OH terminus was 
initially confusing, because E. coli RNases E and G require a 5´-PO4 terminus to promote 
rapid RNA turnover by creating entry sites for PNPase, RNase R, and RNase II. Durand et 
al. solved the quandary when they showed that T4 polynucleotide kinase (PNK) 
phosphorylates the 5´terminus, creating a substrate competent for decay by the endogenous 
RNases E and G (Durand et al. 2012) (Figure 1.8A). 
 In this system of KMD, the T4 phage uses its own kinase (PNK) to phosphorylate 
5´-OH RNAs for decay by the E. coli host ribonucleases (RNases E and G) (Durand et al. 
2012). Because RegB specifically cleaves “early” phage mRNAs, the T4 phage can turn 
off expression of “early” genes by promoting their turnover. This joint viral-host KMD is 
the first known example of phosphorylation of 5´-OH RNAs by an RNA kinase prior to 




Kinase-mediated decay of yeast tRNA introns 
In addition to cleavage of pre-tRNA by TSEN and ligation of tRNA exons by 
TRL1, intron-containing tRNAs are also processed by KMD. As described in the “5´-OH 
RNAs in Biological Systems” section, cleavage of the pre-tRNA by TSEN liberates the 
tRNA intron with 5´-OH and 2´,3´-cyclic phosphate termini (Knapp et al. 1979). The fate 
of this tRNA intron was recently uncovered following the identification of Xrn1 in a 
genome-wide screen for tRNA processing defects (Wu et al. 2015). Deletion of the XRN1 





tRNAProUGG introns with 5´-PO4 termini, which suggested that tRNA introns are 
phosphorylated prior to 5´-phosphate-dependent decay by Xrn1 (Wu and Hopper 2014). 
Using temperature-sensitive Trl1 mutants rlg1-4 and rlg1-10 (Phizicky et al. 1992), Wu 
and Hopper demonstrated that the phosphorylation of the 5´-OH terminus of tRNA introns 
is greatly diminished when Trl1 function is impaired (Wu and Hopper 2014). Thus in this 
example of KMD, the 5´-OH tRNA intron is phosphorylated by Trl1, which promotes 
5´→3´ degradation by Xrn1 (Figure 1.8B). 
While kinase-mediated decay of tRNA introns has not yet been demonstrated in 
mammals, Cleavage and Polyadenylation factor 1 subunit 1 (CLP1) is likely the 
mammalian kinase of tRNA introns. CLP1 is one of two known polyribonucleotide 5´-OH 
kinases in humans. The activity was first identified by Weitzer and Martinez by following 
siRNA-kinase activity over eight biochemical purification steps and analyzing the final 
fraction by mass spectrometry (Weitzer and Martinez 2007b). While endogenously-
produced miRNAs have 5´-PO4 termini (Nykänen et al. 2001), siRNAs introduced for 
experimental knockdown of mRNAs have 5´-OH termini and are phosphorylated by CLP1 
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in the cytoplasm to become RISC substrates (Weitzer and Martinez 2007b). In the same 
study, Weitzer and Martinez demonstrated that both tRNA introns and tRNA 3´-exons are 
phosphorylated on their 5´-termini in vitro in the presence of purified or 
immunoprecipitated CLP1-TSEN complex. This activity is abolished by single-site 
mutations (either S128A or K127A) that impair the catalytic activity of CLP1 (Weitzer and 
Martinez 2007a). 
Three recent studies have demonstrated the importance of CLP1 in maintaining 
specific neuronal populations and have linked CLP1 to tRNA processing in vivo. Mice 
homozygous for a kinase-dead CLP1
K127A
 mutation develop progressive spinal motor 
neuron loss, similar to SOD1 mouse models of acute lateral sclerosis (Hanada et al. 2013). 
Humans with a rare recessive homozygous kinase-defective CLP1
R140H
 mutation display 
pontocerebellar hypoplasia and progressive neurodegenerative features (Schaffer et al. 
2014; Karaca et al. 2014). In all three studies, aberrantly processed tRNA fragments from 
intron-containing tRNAs accumulate in cells with CLP1 mutations. In the human patient-
derived fibroblasts, these include tRNA introns (Karaca et al. 2014) and tRNA 3´-exons 
(Schaffer et al. 2014), which accumulate with 5´-OH termini. It is not known whether these 
fragments are causative of disease, though transfection of the tRNA 3´-exon with a 5´-OH 
terminus increased cellular death of CLP1 mutant cells during oxidative stress (Schaffer et 
al. 2014). Taken together, these results suggest that CLP1 could potentially function in a 
role analogous to Trl1 in the decay of tRNA intermediates, and that the kinase activity of 




Kinase-mediated decay of yeast pre-rRNA 
A second example of kinase-mediated decay in yeast was recently demonstrated in 
rRNA processing (Gasse et al. 2015). Eukaryotic rRNA processing was first described in 
the early 1960s. In Jim Darnell’s lab at MIT, Klaus Scherrer showed that “giant” RNA 
accumulated in the rapidly-sedimenting 45S fraction of a sucrose gradient when HeLa cells 
were labelled for a short time with uridine-2-C
14
, and that increasing the labelling time 
resulted in RNA accumulating in the 35S, and then the 28S and 16S fractions (Scherrer 
and Darnell 1962; Scherrer et al. 1963; Scherrer 2003). At the Fox Chase Cancer Center, 
Bob Perry published similar results (Perry 1962; Perry et al. 1964). Thus, it was proposed 
that 45S “giant” RNA was the precursor to ribosomal RNA. 
Surprisingly, the molecular details of the complex processing pathway of ribosomal 
RNA have still not been completely solved over half a century later.  In yeast, rRNA is 
encoded by 150 genomic copies of rDNA repeat units in a tandem array on chromosome 
XII (Fernández-Pevida et al. 2015).  The 5S pre-rRNA is transcribed as a single RNA pol 
III transcript and Rex1 performs a rapid, non-essential maturation step, trimming 12 nt 
from the 3´ end (van Hoof et al. 2000a).  In contrast to this simple maturation pathway, the 
maturation of the 25S, 18S, and 5.8SS/L rRNAs from the RNA Pol I 35S pre-rRNA 
transcript requires 8 endonucleolytic cleavages (A0, A1, A2, A3, B0, B1L, C2, and D) and 8 
“trimming” steps (B1S, B2, C1´, C1, and 4 steps between 7SS/L to 5.8SS/L) (Reviews: 
Woolford and Baserga 2013; Fernández-Pevida et al. 2015). While the enzymes and 
complexes responsible for the trimming steps have been identified, the source of four of 
the endonucleolytic cleavages (A0, A1, B1L, and C2) have remained elusive. 
 
	 45 
In 2015, the long-sought-after endonuclease performing the C2 cleavage was 
identified. It was already known that internal transcribed spacer 2 (ITS2) between the 5.8S 
and 25S rRNAs is cleaved from 27SB pre-rRNA, and these rRNAs are further matured by 
several exoribonucleases (Veldman et al. 1981).  Importantly, 25S rRNA was known to be 
primarily trimmed by Rat1 in 5´-phosphate-dependent 5´→3´ decay (Geerlings et al. 2000).  
Gasse et al. demonstrated that Las1, a metal ion-independent endonuclease, cleaves the 
ITS2 spacer, generating a 26S pre-rRNA with a 5´-OH terminus. They further show that 
phosphorylation of the 26S pre-rRNA by the RNA/DNA 5´-kinase Grc3 initiates decay by 
the nuclear 5´→3´ exonuclease Rat1 to produce 25S´ rRNA (Gasse et al. 2015) (Figure 
1.8C).  
The components of the yeast KMD ribosomal rRNA processing system are 
conserved through humans.  LAS1L performs the 3´ and 5´ cleavage of ITS2 in human 45S 
pre-rRNA (Schillewaert et al. 2012). Then Nol9, the human nucleolar RNA 5´-kinase, 
likely phosphorylates the 5´ end of the 26S pre-rRNA followed by trimming by the nuclear 
5´-phosphate-dependent 5´→3´ exoribonuclease XRN2, the Rat1 homolog (Heindl and 
Martinez 2010). KMD of 26S pre-rRNA may be required for normal mammalian 
development as a LAS1L mutation was recently found in patients with spinal muscle 
atrophy with respiratory distress (SMARD) (Butterfield et al. 2014). 
 
Extensions of kinase-mediated decay 
The preceding examples of eukaryotic KMD support two key conclusions. First, 
given that grc3∆ yeast are inviable and single amino acid substitutions impairing Gcr3 








Figure 1.8. Examples of kinase-mediated decay (KMD). 
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Figure 1.8. Examples of kinase-mediated decay (KMD). 
A. KMD of T4 phage mRNA. (1) Bacteriophage T4 infects E. coli. (2) T4-encoded 
RegB, a sequence-specific endonuclease, cleaves “early” T4 genes in the Shine Delgarno 
(SD) sequence, generating 3´-fragments with 5´-OH termini. (3) T4 PNK phosphorylates 
the 5´-OH termini. (4) E. coli RNases E and G cleave the 5´-PO4 RNAs to create entry 
points for 3´→5´ decay (Durand et al. 2012). T4 factors are displayed in red, and E. coli 
factors in blue. 
B. KMD of yeast tRNA introns. (1) Sen2 and Sen34 cleave an intron-containing pre-
tRNA, leaving a 5´-OH terminus and a 2´,3´-cyclic phosphate terminus. (2) Trl1 
phosphorylates the 5´-OH terminus, creating a 5´-PO4 substrate for degradation by Xrn1 
(3) (Wu and Hopper 2014). 
C. KMD of yeast pre-rRNA. (1) Las1 cleaves the ITS2 spacer in 27SB pre-rRNA, 
generating 26S pre-rRNA with a 5´-OH terminus. (2) Grc3 phosphorylates this terminus, 
(3) promoting decay by Rat1 to produce 25S´ rRNA (Gasse et al. 2015). 
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may be an essential process in eukaryotes. Second, KMD is probably a wide-spread 
phenomenon. It has already been shown to occur in both the cytoplasm and the nucleus, 
with each of the known 5´-OH kinases (Trl1 and Grc3) and two 5´→3´ exoribonucleases 
(Xrn1 and Rat1). In this dissertation, particularly in Chapter III, I show that KMD is 
required for regulation of the yeast UPR, and I present evidence that KMD may function 
broadly in mRNA surveillance to degrade 5´-OH cleavage products. 
 
Methods for Global Mapping of RNA Modifications 
Next-generation sequencing allows for massively parallel sequencing of DNA 
using clustered amplification and iterative addition of reversibly terminated, fluorescently 
labeled nucleotides. Though initially developed as a tool for genomic sequencing, next-
generation sequencing technology was creatively harnessed to map RNA by using 
degenerate or oligo-dT primers to reverse transcribe cDNA. In 2008, a series of high-
profile papers applied this new “RNA-seq” method to analyze the transcriptomes of 
Saccharomyces cerevisiae, Schizosaccharomyces pombe, Prunus persica, Arabidopsis 
thaliana, mouse and human cells (Wang et al. 2009). RNA-seq was rapidly combined with 
ingenious modified linkers and unique ligation chemistries to specifically capture and 
sequence a variety of RNA modifications. Below, I describe several such methods: Cap 
Analysis Gene Expression (CAGE) (Shiraki et al. 2003; Kodzius et al. 2006), 5´ phosphate 
sequencing (German et al. 2008; Harigaya and Parker 2012; Pelechano et al. 2016), and 
2´,3´-cyclic phosphate sequencing (Schutz et al. 2010; Honda et al. 2015). Despite these 
and other methods to capture and sequence RNA terminal chemistries, 5´-OH RNAs had 
never been directly mapped prior to my work. 
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Cap Analysis Gene Expression (CAGE) 
Two of the key limitations of RNA-seq are the resolution of 5´ and 3´ termini of 
RNA transcripts and the difficulties in isolating specific populations of interest, such as 
mRNA.  The Cap Analysis Gene Expression (CAGE) method was pioneered to specifically 
capture m
7
G capped RNAs, allowing the precise mapping of the 5´ end as well as a 
quantitative measure for gene expression comparison (Shiraki et al. 2003; Kodzius et al. 
2006). In brief, the diol residue of the mRNA cap is chemically biotinylated, allowing for 
specific purification of capped RNA hybridized to a single strand of reverse-transcribed 
DNA using streptavidin. T4 RNA Ligase is then used to attach a linker with an Mme1 
recognition motif, and subsequent treatment with Mme1 restriction enzyme results in 
cleavage of 20 or 21 nucleotides downstream of the original capsite. The resulting 
fragments can then be concatenated and sequenced. The initial study using the CAGE 
method revealed tissue-specific alternative transcription starting points (TSPs) for a subset 
of genes (Shiraki et al. 2003). Application of a related cap-based sequencing method, 
RAMPAGE (RNA Annotation and Mapping of Promoters for the Analysis of Gene 
Expression), to 36 stages of Drosophila development found at least two promoters in more 
than 40% of developmentally expressed genes (Batut et al. 2013). 
 
5´-phosphate sequencing 
miRNA-directed cleavage by Argonaute yields an mRNA fragment with a 5´-
phosphate terminus.  To identify miRNA targets on a massive scale, Pam Green’s lab 
pioneered a method to specifically capture and sequence RNAs with 5´-PO4 termini 
(German et al. 2008). An RNA oligonucleotide with a Mme1 recognition motif is directly 
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ligated to RNAs with 5´-PO4 termini. The RNA is reverse transcribed with an oligo-dT 
primer, followed by second strand synthesis. Digestion with Mme1 shortens the 3´ 
terminus to 20 or 21 nts from the original 5´-PO4. Finally, a DNA adapter is ligated to the 
3´ terminus, and the library is PCR amplified and sequenced. Once sequencing reads are 
trimmed of the initial 5´ RNA oligonucleotide, the 5´ ends of reads map to 5´ phosphate 
cleavage fragments. This method in conjunction with Paired Analysis of RNA Ends 
(PARE) successfully identified hundreds of miRNA-target RNA pairs in Arabidopsis, 
including nearly 100 previously validated miRNAs (German et al. 2008). The 5´-phosphate 
sequencing method has also been applied to yeast to demonstrate a novel discard pathway 
for debranched lariat-intermediates and identify introns in genes previously thought to be 
intron-less (Harigaya and Parker 2012). Importantly, the surprising capture of HAC1 3´-
exon mRNA cleavage fragments by 5´-phosphate cloning in dcp2∆ xrn1∆ yeast cells 
suggests a stable phosphorylated intermediate in the HAC1 mRNA ligation pathway 
(Harigaya and Parker 2012). This finding provides essential motivation for the studies 
described in Chapter III. Another group recently developed a nearly identical method to 
sequence 5´-PO4 RNA, which they termed “5P-seq” (Pelechano et al. 2016). 
 
Sequencing of RNAs with 2´,3´-cyclic phosphate termini 
Our lab has extensive experience in the preparation of 2´,3´-cyclic phosphate 
libraries (Schutz et al. 2010). In this method, A. thaliana tRNA ligase is used to attach a 
linker to RNAs terminating in 2´,3´-cyclic phosphates. Yeast Tpt1 is then used to 
dephosphorylate the 2´ phosphate at the ligation junction. Following reverse transcription 
with a primer complementary to the linker, cDNA is purified and sequenced.  The first 
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2´,3´-cyclic phosphate sequencing study captured the 3´ terminus of the U6 snRNA as well 
as cleavages in the anti-codon loop of 5 tRNA species (Glu-CTC, Glu-TTC, Lys-CTT, 
Lys-TTT, His-GTG) consistent with Rny1 cleavage (Schutz et al. 2010). This method has 
subsequently been used to identify sites of RNase L cleavage in poliovirus (Cooper et al. 
2014) and influenza A infected cells (Cooper et al. 2015), and to identify targets of Ire1 
cleavage in fission yeast (Kimmig et al. 2012). A similar protocol to specifically sequence 
cyclic phosphate RNAs – “cP-RNA-seq” – identified a novel category of angiogenin 
cleavage products termed 5´ Sex HOrmone-dependent TRNA-derived RNAs (SHOT-
RNAs) in breast and prostate cancer cell lines (Honda et al. 2015). 
   
Towards 5´-OH sequencing 
Although other methods can partially infer 5´-OH RNA mappings, there are key 
limitations. For instance, although in vitro phosphorylation prior to 5´-PO4 sequencing 
would in principle capture 5´-OH RNAs, this population would be a mixed population with 
in vivo 5´- PO4 RNAs. A figure in the most recent 5PSeq paper suggested 5´-OH RNAs 
might be captured following 5´-P RNA removal by Terminator followed by 
phosphorylation with PNK; however, this approach was not performed and was not 
discussed within the text (Pelechano et al. 2016). Cyclic phosphate cloning theoretically 
captures all 5´ fragments at 5´-OH RNA cleavage sites generated by a single 
endoribonucleolytic cleavage; however, in practice, the signal generated by this method is 
overwhelmingly derived from ncRNAs including rRNAs, tRNAs, and snRNAs. In 
contrast, a method specifically capturing 5´-OH RNA allows for advantageous use of the 
polyA tail to easily enrich for polyadenylated species, including mRNA populations. 
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In Chapter II, I describe a novel method to directly capture and sequence 5´-OH 
RNA.  In my initial analysis, I show how the method enables new inquiries into this 
unexplored RNA modification, and in Chapter IV, I apply 5OH-seq to mammalian 
samples. Given the adoption of other RNA modification sequencing protocols and their 
widespread applications, I anticipate that the 5OH-Seq method will be used by other labs 










 Metal ion-independent endoribonucleases including the tRNA splicing 
endonuclease (Trotta et al. 1997), Ire1 (Sidrauski and Walter 1997) and the ribonucleases 
T2 (Luhtala and Parker 2010) and L (Cooper et al. 2014) create cleavage products with 5´-
hydroxyl (5´-OH) and 2´,3´-cyclic phosphate termini, as do self-cleaving ribozymes like 
the hammerhead, HDV, VS, hairpin and twister ribozymes (Ferré-D'Amaré and Scott 
2010). In addition, accelerated RNA cleavage by intramolecular phosphoester transfer at 
structurally distorted phosphodiester bonds generates 5´-OH and 2´,3´-cyclic phosphate 
products (Soukup and Breaker 1999). However, products of RNA cleavage with 5´-OH 
and 2´,3´-cyclic phosphate termini are not typically identified in global surveys of RNA 
populations, and thus their frequency and role in RNA metabolism remain unknown. 
 Methods for studying RNAs with specific termini can shed light on RNA 
transcription initiation, processing, and decay pathways. Several methods have been 
developed for the global study of mRNA 5´-termini, but most of these do not capture 5´-
OH termini, or do so indirectly via a 5´-PO4 intermediate. In a recent example, 5´-OH 
termini were indirectly inferred from cloning of 5´-PO4 termini created upon 
phosphorylation of 5´-OH termini (Schifano et al. 2014), but this method requires several 
enzymatic manipulations prior to the ligation step. Similarly, the Parallel Analysis of RNA 
                                                   
1
 Portions of this chapter were reused with permission from Peach et al., 2015. 
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Ends (PARE) method (German et al. 2009) begins with ligation of an RNA adapter to the 
5´-PO4 terminus of an RNA substrate with T4 RNA ligase, and thus this method does not 
capture 5´-OH termini. Other methods compare signals among different enzymatic 
manipulations of 5´ mRNA cap structures to enable specific detection of mRNA 5´-termini 
(Gu et al. 2012), but these methods are unable to capture 5´-OH termini. 
  A method was previously developed to identify RNA fragments with 2´,3´-cyclic 
phosphate and 2´-PO4/3´-OH termini using the A. thaliana tRNA ligase (Schutz et al. 
2010). Recent studies used this method to discover virus and host targets of Ribonuclease 
L cleavage (Cooper et al. 2014), and to identify the Gas2 mRNA as a novel target of the 
Ire1 endonuclease in the S. pombe unfolded protein response (UPR) (Kimmig et al. 2012). 
Fungal and plant tRNA ligases join RNAs with 5´-OH and 2´,3´-cyclic phosphate termini 
via 5´-PO4 and 5´-adenylate intermediates (Greer et al. 1983), and thus the method 
employing A. thaliana tRNA ligase does not distinguish between 5´-OH and 5´-PO4 RNA 
termini. In addition, libraries produced by this method typically contain high levels of 
ribosomal RNA fragments with cyclic-phosphate termini, which may mask signals from 
lower abundance fragments from mRNA. Therefore I was motivated to develop a new 
method to capture the other products of RNA cleavage – 5´-OH RNA fragments – that also 
allows mRNAs to be enriched via oligo-dT selection of their polyadenylate tails. 
E. coli RtcB RNA ligase catalyzes a unique chemistry involving the attack of a 3´-
guanylylate intermediate by a 5´-OH nucleophile, yielding a 3´-5´ phosphodiester bond and 
GMP (Tanaka et al. 2011). As noted previously (Desai and Raines 2012; Tanaka et al. 
2011), RtcB RNA ligase therefore represents a unique reagent for direct capture of 5´-OH 
RNAs. In this chapter, I describe the development of the “5OH-seq” method using the E. 
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coli RtcB RNA ligase to globally identify 5´-OH RNA fragments in complex RNA 
populations. I apply the 5OH-seq method to study 5´-OH RNA fragments in budding yeast. 
 
Materials and Methods 
 
Expression and purification of E. coli RtcB RNA ligase 
The E. coli rtcB gene was PCR amplified, recombined into pDONR221 (Gateway 
BP, Invitrogen) and Sanger sequenced to confirm lack of mutations in the open reading 
frame. The rtcB ORF was recombined into pET-53-DEST (creating an N-terminal 6xHis 
tag; Gateway LR, Invitrogen) and transformed into BL21 (DE3) RIPL cells (Stratagene). 
The pET-53-RtcB expression construct is available from Addgene (Plasmid 51282). For 
RtcB protein expression, cells were grown from a single colony in 1 L terrific broth with 
selective antibiotics (50 µg/mL ampicillin and 34 µg/mL chloramphenicol) at 37˚C to an 
OD600 of 0.6 and then chilled on ice for 30 min. Ethanol was added to 2%, expression was 
induced with 0.1 mM IPTG and cultures were grown 16 hours at 17˚ C. Cells were 
harvested by centrifugation and lysed for 1 hour at 4˚C in Buffer A (50 mM Tris pH 7.4, 
250 mM NaCl, 10% sucrose) with 0.2 mg/mL lysozyme. Triton X-100 was added to a final 
concentration of 0.1%, and the cells were sonicated briefly to reduce viscosity. Following 
clarification by centrifugation at 10,000 x g, the supernatant was incubated for 1 hour at 
4˚C with 3 mL of pre-washed Nickel-NTA beads (Qiagen). The beads were washed with 
25 mL of Buffer A, then loaded onto a column and washed twice with 25 mL Buffer E (50 
mM Tris-HCl (pH 7.4), 10% glycerol, 250 mM NaCl) containing 15 mM imidazole. The 
column was eluted with 3 mL each of Buffer E with 50, 150 and 300 mM imidazole. Peak 
fractions were identified by SDS-PAGE and were pooled and diluted to 50 mM NaCl with 
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Buffer D (50 mM Tris-HCl (pH 7.4), 10% glycerol, 5 mM DTT. 1 mM EDTA). RtcB 
protein was further purified on a 1 mL HiTrap Heparin HP column (GE Healthcare Life 
Sciences), washed with Buffer D containing 50 mM NaCl, and eluted with 3 mL each of 
Buffer D containing 150 mM, 300 mM and 500 mM NaCl. RtcB protein eluted 
predominantly in the 150-300 mM NaCl fractions, with a typical yield of 2 mg / L culture. 
Peak fractions were pooled, quantitated by Bradford assay, snap frozen in liquid nitrogen 
and stored at -80˚C. 
 
RtcB ligation assay 
Oligonucleotides used in this study are listed in Table 2.1. Ligation assays were 
used to confirm recombinant RtcB function. A linker oligonucleotide with a 3´-phosphate 
was incubated at equimolar concentration (200 pM) with another oligonucleotide with a 
5´-OH terminus in the presence of 1.25 µM RtcB in buffer (1 mM GTP, 50 mM MOPS pH 
7.4, 2 mM MnCl2) for 1 hour at 37˚C. The reaction was quenched with stop dye (95% 
formamide, 5 mM EDTA pH 8.0, 0.01% xylene cyanol and bromophenol blue), denatured 
at 70˚C for 3 minutes, and electrophoresed on 10% TBE-Urea polyacrylamide gel and 
stained with SYBR Gold (Invitrogen) prior to visualization.  
 
Yeast strains and culturing 
Yeast strains used in this study are listed in Table 2.2. Single colonies were 
inoculated in YEPD and incubated at 30˚C overnight with rotation. Cultures were diluted 
to OD600 of 0.1 in YEPD. In untreated conditions, yeast cells were harvested in mid-log 
phase. To induce the UPR, yeast were grown to mid-log phase, then treated for 2 hours 
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Table 2.1. Oligonucleotides 
 
Ligation Assay RNA 
Oligonucleotides Sequence 
M13-Linker 
5′ Amino – rGrUrUrUrUrCrCrCrArGrUrCrA 
rCrGrArC – 3′ phosphate 
RPS31-5OH 
5′ OH – rArArGrArArGrArGrArArArGrArArG 





5′ desthiobiotin – ACACTCTTTCCCTACACGACGC 
TCTTCCGATCTrNrNrNrNrNrNrNrN  –  3′ phosphate 
5OH-RT-amino 
5´ Amino – GTGACTGGAGTTCAGACGTGTG 
CTCTTCCGATCTNNNNNNNNN – 3´ 
  
Validation Primers  
M13-F 5′ GTTTTCCCAGTCACGAC 
RPS31-F 5′ CCCTGGAAGTTGAATCTTCTG 
RPS31-R 5′ GCGTTAACCTTGTAGACGGAAT 
 
 
Table 2.2. Yeast strains 
 
Strain Genotype 
XRN1 (BY4742) MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 










with tunicamycin (final concentration of 2.5 µg/mL, Sigma-Aldrich). Cells were harvested 
by centrifugation and total RNA was isolated by hot acid phenol extraction and treated 
with TURBO DNase (Ambion) to remove genomic DNA. 
 
5´-hydroxyl RNA library construction and sequencing 
Total RNA from budding yeast (15 µg) was enriched for a polyadenylated mRNA 
fraction using oligo-dT magnetic beads (Ambion). PolyA-enriched RNA was incubated 
with 1.1 µM RtcB in buffer (1 mM GTP, 50 mM MOPS pH 7.4, 2 mM MnCl2), 20 units 
RNase Inhibitor (Enzymatics) and 10 µM 5OH-Biotin-Linker at 37 ˚C for 1 hour. 
Following phenol/chloroform extraction and ethanol precipitation, RNA was fragmented 
with Ambion Fragmentation Reagent for 15 minutes at 70 ˚C, and the reaction was 
quenched with the addition of EDTA. Samples were denatured in stop dye (95% 
formamide, 0.01% xylene cyanol / bromophenol blue), heated to 65 ˚C for 5 minutes and 
separated on a 10% acrylamide TBE-Urea gel. Following staining with SYBR Gold 
(Invitrogen), the gel was visualized by blue light transillumination and a gel slice 
containing RNA above 80 nt was excised and pulverized. RNA was eluted from the gel by 
2-hour incubation at 40˚C in 0.3 M sodium acetate, pH 5.2, 1 mM EDTA, pH 8.0 and 
precipitated with 2.5 volumes of ethanol. cDNA was prepared using an Illumina-
compatible primer with a 9 nt degenerate region (oligonucleotide 5OH-RT-amino) and 
Protoscript II RT (NEB), and was purified using Agencourt RNAClean XP Beads 
(Beckman Coulter). Second strand synthesis was performed with RNase H, E. coli DNA 
Polymerase, and E. coli Ligase (Enzymatics). Double-stranded DNA products were 
purified using magnetic Streptavidin beads (Invitrogen), eluted with 25 mM biotin in 
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elution buffer (Omega Bio-Tek) and PCR amplified with Illumina TruSeq primers and 
Phusion DNA polymerase. PCR reactions were purified with SPRI Size Select Beads 
(Beckman Coulter). Indexed libraries were quantified by Qubit (Invitrogen), mixed to a 
final concentration of 1-10 nM and sequenced on an Illumina MiSeq in a 50 cycle run. Raw 
and processed sequencing data are available at NCBI GEO under accession number 
GSE61527. 
 
Analysis of DNA sequencing data 
Sequences in FASTQ format were preprocessed to remove molecular indexes using 
umitools (https://github.com/brwnj/umitools). Processed reads were aligned to the S. 
cerevisiae genome (sacCer1) with Bowtie (Langmead et al. 2009) and visualized in the 
UCSC Genome Browser (Karolchik et al. 2014). Coverage signals in bedGraph format 
were generated, normalized to UMI-corrected Counts Per Million reads mapped (CPM), 
and analyzed with BEDTools (Quinlan and Hall 2010) and custom scripts. Studies of 
mRNA cleavage focused on the collection of 5´-OH fragments in the upper decile of the 
CPM distribution (i.e., the most abundant 10%) that were reproducible in 5OH-seq libraries 
prepared from two independent cultures. Significant discrete 5´-OH signals within mRNAs 
were identified as previously described (Harigaya and Parker 2012). Briefly, the CPM 
values for each nucleotide of a given mRNA were fit to a transcript-specific negative 
binomial distribution, and P values were computed for each site against the background 
distribution. P values for all sites in all mRNAs were combined and adjusted using the 
Benjamini-Hochberg false discovery rate (FDR) (<0.05). Clustered hits were determined 
by identifying regions of high 5´-OH signal density using the Model-based Analysis of 
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ChIP-Seq (MACS) algorithm (Zhang et al. 2008), selecting regions longer than 100 bp, 
and discarding regions included in the list of mRNAs with single fragments. Additional 
workflow and analysis scripts are available at https://github.com/hesselberthlab/5OH. 
Processed data can be visualized on the UCSC Genome Browser in the track hub at 
https://github.com/hesselberthlab/trackhub. 
 
Validation of 5´-hydroxyl RNA fragments by RtcB ligation and RT-PCR 
5´-OH RNA fragments were verified by RtcB-mediated ligation of an 
oligonucleotide linker, followed by reverse transcription and gene-specific PCR. Total 
RNA (5 µg) was ligated to an RNA oligonucleotide with a 5´-amino group and a 3´-
phosphate (M13-Linker-RNA) with RtcB. Reactions were phenol-chloroform extracted, 
ethanol precipitated, and reverse transcribed with Superscript III RT (Invitrogen) and gene-
specific primers. cDNA was PCR amplified using primer pairs that hybridize to full length 
mRNA or the linker-ligated 5´-OH RNA fragment. PCR products were resolved on 10% 




Development of a method for capture of 5´-hydroxyl RNAs  
To demonstrate the utility of RtcB RNA ligase as a reagent for global capture of 
5´-OH RNA, I first asked whether RtcB could ligate unrelated oligonucleotide substrates 
– a prerequisite for global capture of 5´-OH molecules. I overexpressed and purified E. coli 
RtcB ligase (Figure 2.1A) and used the enzyme to perform ligations with 
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oligoribonucleotide substrates with 2´-OH/3´-PO4 and 5´-OH termini with minimal 
predicted base pairing (Figure 2.1B). I found that RtcB could ligate these substrates in a 
bimolecular ligation with ~25% efficiency, confirming previous studies of RtcB 
intermolecular ligation (Das et al. 2013) and suggesting that RtcB could be used in global 
profiling of cellular RNAs with 5´-OH termini. 
I next established a general protocol to capture 5´-OH RNA from complex RNA 
populations using the RtcB ligase (Figure 2.2). I began by chemically fragmenting total 
RNA from budding yeast, producing many RNA fragments with 5´-OH and 2´,3´-cyclic 
phosphate termini. RNA fragments with 5´-OH termini were ligated to an oligonucleotide 
with 5´-desthiobiotin and 3´-PO4 groups using E. coli RtcB ligase. This oligonucleotide 
linker contains an 8-base random sequence at its 3´ end that serves as a molecular index 
during sequence analysis, enabling quantitation of unique ligation events and estimation of 
relative amounts of 5´-OH fragments in the initial RNA population (Kivioja et al. 2012). 
After gel purification to remove excess unligated linker, RNA was reverse transcribed with 
a second oligonucleotide primer containing an Illumina primer binding site and nine 
randomized bases at the 3´ end to facilitate random priming to RNA templates. Double-
stranded RNA:DNA hybrids were converted to double stranded DNA by second-strand 
synthesis, and double-stranded DNA fragments containing the desthiobition linker were 
purified on immobilized streptavidin and eluted with free biotin. Purified double-stranded 
DNA fragments were PCR amplified with primers that incorporate library-specific indexes 





Figure 2.1. Purified E. coli RtcB ligates RNA substrates with 3´-PO4 and 5´-OH 
termini 
A. SDS-PAGE analysis of E. coli RtcB protein. Recombinant RtcB protein (10 µg) was 
electrophoresed through a 10% SDS-PAGE gel and stained with Coomassie blue.  
B. RtcB-mediated bimolecular ligation of RNA substrates with 3´-PO4 and 5´-OH termini 
was analyzed by polyacrylamide gel electrophoresis. The ligation product at 50 nt was 





Figure 2.2. Schematic of method to clone and sequence RNAs with 5´-OH termini 
(5OH-seq). 
RNA cleavage generates a 5´-fragment with a 2´,3´-cyclic phosphate terminus and a 5´-
fragment with a 5´-OH terminus. An adaptor with a 5´-desthiobiotin and 3´-phosphate is 
ligated to the 5´-OH RNA fragment with E. coli RtcB ligase. This adaptor has 8 randomized 
positions at its 3´ end which serve as a molecular index to uniquely identify individual 
ligation events upon sequencing (Kivioja et al. 2012). Following ligation, excess adaptor 
is removed by gel purification. A primer with a 3´ random hexamer region is used for 
reverse transcription to create cDNA, followed by second-strand synthesis to generated 
double-stranded DNA products. After streptavidin isolation, DNA fragments are PCR 
amplified and analyzed by Illumina sequencing. 
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Global analysis of 5´-hydroxyl RNAs in budding yeast 
I used this library construction protocol to identify 5´-OH RNA fragments in the 
budding yeast S. cerevisiae. I prepared libraries from oligo-dT enriched yeast total RNA, 
in order to increase signals that might be present on polyadenylated mRNA fragments. 
These libraries were sequenced on the Illumina MiSeq platform with 50 bp single reads to 
identify 5´-OH RNA fragments. The 5OH-seq libraries had an average of 2.7 million reads 
per sample, with an average of 23% of the reads aligning uniquely to the yeast genome and 
an additional 30% of reads aligning multiple times. The majority of unaligned reads were 
due to Illumina primer sequence amplification. I examined the distribution of uniquely 
aligning reads within existing RNA annotations, and found that in polyA-enriched samples, 
21% mapped to mRNA regions, 0.4% mapped to abundant non-coding RNA species 
(tRNA, snoRNA, and snRNA), and 65% of the reads were derived from ribosomal RNA. 
Using these sequences, I also assessed whether RtcB exhibited a bias for specific sequences 
at the ligation junction. I found that the base composition of each position downstream of 
the ligation site (i.e., the 5´-OH terminus) mirrored budding yeast A/T content (62%), 
suggesting that RtcB does not have strong preference for 5´-OH RNAs with specific 
sequences. The 8 nt molecular index in ligated adaptors (Figure 2.2 and Table 2.1) allowed 
me to examine base composition upstream of the ligation site, and I found that RtcB 
preferred adaptors with an adenosine at their 3´ terminus, which was present in 42% of 
sequences, while the remaining 7 positions had more random composition. Because the 
molecular index is trimmed from reads prior to alignment, this ligation bias has no effect 
on sequence alignment, but does limit the diversity of possible molecular indexes. 
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To validate the protocol, I analyzed the capture of 5´-OH termini generated in vitro 
and in vivo. Ribosomal RNAs have 5´-PO4 termini produced by endonucleolytic (Venema 
et al. 1995) and exonucleolytic processing (Geerlings et al. 2000). These ends should be 
underrepresented in 5´-OH libraries, but I would expect to recover these termini in 5´-OH 
libraries prepared from RNA samples that had been dephosphorylated in vitro (Figure 
2.3A). Therefore, I compared libraries prepared from total RNA samples that were treated 
or not with recombinant shrimp alkaline phosphatase (rSAP) to convert 5´-PO4 RNAs in 
the samples to 5´-OH groups. An average of 2574 reads aligned to the 5´ end of 5.8S rRNA 
in the dephosphorylated sample compared to an average of 358 5´-OH fragments aligned 
to the same position in the untreated samples, (Figure 2.3B), representing a 7-fold 
enrichment of reads at the 5´ end of this RNA upon phosphatase treatment and confirming 
that the method captures 5´-OH RNAs and discriminates against 5´-PO4 RNAs. 
The levels of ribosomal RNA fragments found in the poly(A)-enriched library 
suggested that oligo-dT capture of polyadenylated mRNA is not sufficient to deplete 
ribosomal RNA signals from libraries, and that other strategies for ribosomal RNA 
depletion might be used to further reduce signals from ribosomal RNA. I prepared libraries 
from an RNA sample following treatment with a commercial strategy to remove ribosomal 
RNA by hybridization to antisense probes (Sigurgeirsson et al. 2014). I found that signals 
from ribosomal RNAs were ~10-fold less abundant in these libraries compared to libraries 
prepared from oligo-dT selected RNA, but also unexpectedly found that the commercial 
kit contained a phosphatase activity that converted the 5´-PO4 termini of ribosomal RNAs 
to 5´-OH groups, leading to their capture by 5OH-seq independent of additional 
phosphatase treatment (data not shown). 
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Similar to rRNA, some small nucleolar RNAs (snoRNAs) are produced from 
endonucleolytic and exonucleolytic processing of precursor RNA molecules and have 5´-
monophosphate termini (Petfalski et al. 1998). Dephosphorylation of the 5´-PO4 termini of 
these snoRNAs would produce 5´-OH termini, and I found abundant signals for these in 
5´-OH libraries following rSAP treatment. For example, the 5´-end of the box C/D snoRNA 
U18, which is produced by Rnt1 and Rat1 processing of the EFB1 pre-mRNA (Giorgi et 
al. 2001), was 6-fold more abundant in the dephosphorylated sample compared to the 
untreated sample (Figure 2.3C). Overall I identified six snoRNAs (snR18, 24, 55, 57, 61, 
64) with 5´-PO4 termini that were captured by 5OH-seq after in vitro phosphatase 
treatment. 
Cleavage of pre-tRNA molecules by the tRNA splicing endonuclease (SEN) creates 
intron and 3´-exon products with 5´-OH groups (Trotta et al. 1997) (Figure 2.4A). Yeast 
pre-tRNA molecules range from 71 to 133 nt and processed tRNAs from 71 to 87 nt. 
Sequences in my libraries have an effective read length of 42 nt, and thus my libraries can 
be used to quantify cleavages within ~30-40 nt of the 5´-end of processed tRNA molecules, 
depending on variable loop length. I analyzed signals from tRNAs in the 5´-OH library 
prepared from rRNA-depleted total RNA. The presence of 5´-OH fragments corresponding 
to the 5´-terminus of the 3´-exon of the intron-containing tRNA
Leu
CAA (Figure 2.4B, top 
panel) confirms that 5OH-seq can capture known 5´-OH termini generated in vivo. I also 
identified products of cleavage in the anticodon loop of tRNA
Ser
AGA (Figure 2.4B, middle 
panel), consistent with 2´,3´-cyclic phosphate capture of anticodon loop cleavage (Schutz 
et al. 2010). Finally, I identified high levels of 5´-OH fragments that mapped to the D arm 




Figure 2.3. 5OH-seq captures RNAs with 5´-PO4 termini after in vitro 
dephosphorylation. 
A. Schematic of RtcB-mediated ligation to a 5´-OH RNA substrate produced by 
phosphatase-mediated removal of a 5´-PO4 group. 
B. Abundance of 5´-OH fragments (per-site, UMI-corrected Counts Per Million reads 
mapped, CPM) mapped to 5.8S rRNA (157 nt). In an untreated sample (top), 5´-OH signal 
was uniformly low across the body of the 5.8S rRNA. 5´-OH RNA fragments cloned from 
total RNA treated with shrimp alkaline phosphatase (bottom) mapped to the 5´-end of 5.8S 
rRNA (grey arrows), indicating conversion of the 5´-PO4 to a 5´-OH group  
C. Abundance of 5´-OH fragments (CPM) in the snR18 locus show that the 5´-PO4 of 
snR18, produced by Rnt1-mediated processing of the EFB1 pre-mRNA (Petfalski et al. 






Figure 2.4. Cleavages in tRNA in introns, anticodon loops, and D arm and loop 
A. Schematics of tRNAs. On the left, a mature tRNA with the CCA terminator and the D, 
anticodon, variable, and TΨC loops. On the right, a portion of an intron-containing pre-
tRNA with cleavage sites recognized by tRNA Splicing Endonuclease (SEN) represented 
by black lines. Sites within tRNAs that were captured abundantly by 5OH-seq are shaded. 
Arrows indicate the most abundant fragment in each tRNA shown in B. 
B. Examples of tRNA fragments captured by 5OH-seq in rRNA-depleted total RNA.  
Fragments from tRNA
Leu
CAA mapped to the 5´-terminus of the 3´ exon (top panel). Anti-
codon loop cleavages were found in tRNA
Ser
AGA (middle panel).  tRNA
Asp
GUC was the most 
abundant species captured by 5OH-seq and primarily showed D-arm and loop cleavage 
(bottom panel). Arrows indicate the most abundant fragment in each tRNA and correspond 
to the arrows in A. Key regions of the tRNA are indicated by solid bars labeled as Intron, 
Anticodon loop, and D arm & loop. 
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fragments in tRNAs to a previous study of 5´-PO4 RNA fragments (Harigaya and Parker 
2012), and found that 5´-PO4 signals were localized mainly to the 5´ ends of tRNA, 
indicating that the 5´-OH fragments represent a distinct pattern of tRNA cleavage 
fragments (data not shown). I did not identify the 5´-OH intron products of SEN 
cleavage, presumably because they are phosphorylated by Trl1 and degraded by Xrn1 
(Wu and Hopper 2014). 
 
mRNA decay events identified with 5´-hydroxyl RNA capture 
 In order to focus on 5´-OH fragments present in mRNA, I collected sequence reads 
from libraries prepared from poly(A)-enriched RNA that mapped uniquely within 
annotated mRNA transcripts (Nagalakshmi et al. 2008), and found 710 mRNAs that had 
significant signals in two replicate samples (35% overlap among mRNAs). I examined the 
distribution of 5´-OH fragments within these mRNAs (Figure 2.5A), and found that 76.7% 
of 5´-OH fragments mapped within open reading frames, 9.9% were in 5´ untranslated 
regions (UTRs) and 13.4% were in 3´ UTRs. I found 81 mRNAs with 5´-OH fragments 
that mapped exclusively to the 5´ and 3´ UTRs, and 551 mRNAs with 5´-OH fragments 
exclusively in their open reading frames. The remaining 78 mRNAs contained fragments 
distributed throughout the mRNA. Many 5´-OH fragments were biased toward the 3´-end 
of mRNAs, possibly reflecting a bias imposed by poly(A) purification prior to 5OH-seq 
(Figure 2.5A). 
 I identified a subset of mRNAs with 5´-OH signals that also were expressed under 
similar conditions as measured by a previous RNA-seq experiment (Levin et al. 2010). For 
each of these 629 mRNAs, I calculated a summary statistic by dividing the sum of its CPM 
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values by the length of the mRNA in kilobases (Counts Per Kilobase per Million reads 
mapped; CPKM), and compared mRNA CPKM values to their expression levels in Reads 
Per Kilobase per Million mapped (RPKM) (Levin et al. 2010). There was a modest but 
significant correlation between levels of 5´-OH fragments and mRNA abundance (Pearson 
R = 0.31; p < 10
-16
), indicating that 5´-OH fragment abundance is partly a reflection of 
mRNA abundance (Figure 2.5B). I also evaluated whether these fragments were associated 
with intrinsic structural properties of RNAs. I compared 5´-OH fragment levels to previous 
measures of global RNA structures using Ribonuclease S1 and V1 mapping (Kertesz et al. 
2010), and found minimal correlation between these data sets (Pearson R = -0.04; p < 
0.048). This suggests that 5´-OH sites may be uniformly distributed among RNA secondary 
structure elements (i.e., single and double-strand regions).  
 There were unique patterns of 5´-OH fragment distribution within mRNAs. I 
identified 187 mRNAs with multiple fragments mapping to localized regions within the 
gene body, and these 5´-OH fragments clustered within a mean distance of 191 nt. For 
example, the IMH1, RPN2, and YEF3 mRNAs had clustered 5´-OH fragments within their 
coding regions, and the SAC1 mRNA had clustered fragments within its 3´ UTR (Figure 
2.6A). The pattern of clustered 5´-OH fragments suggests that a localized process cleaves 
these specific mRNAs in multiple locations within a defined region. 
I found 17 mRNAs that each had a single predominant 5´-OH fragment (FDR < 
0.05). For example, the ADH1 and YNK1 mRNAs had single sites of cleavage in their open 
reading frames, CYS4 had a predominant cleavage in its 3´ UTR, and a predominant 
cleavage in the MDH1 mRNA is 8 nt downstream of its stop codon (Figure 2.6B). I also 





Figure 2.5. Analysis of mRNAs captured by 5OH-seq. 
A. 5´-OH fragments are found in numerous mRNAs. Each of 710 mRNAs was divided into 
proportionally sized bins for the 5´ and 3´ UTR regions (2 bins each, left and right of the 
solid vertical lines), and the open reading frame (ORF; 20 bins). 5´-OH fragment 
abundance (CPM) in each bin was summed, and mRNAs were sorted by their maximum 
bin value from 5´ to 3´. Each mRNA is displayed in a row. A total of 11 mRNAs have 
signal exclusively within their 5´ UTRs (top) and 69 mRNAs have signal exclusively in 
their 3´ UTRs (bottom). The grey center line marks the middle of the ORF region; 5´-OH 
signal was predominantly in the 5´ portion of 143 mRNAs (above horizontal dashed line), 
while remaining mRNAs had signals mainly localized toward their 3´ ends. 
B. Comparison of signals in mRNAs in 5´-OH and RNA-seq libraries. There was a 
significant correlation (Pearson R = 0.31; p < 10
-16
) between 5´-OH signals (counts per 
million reads per kilobase; CPKM) and RNA-seq (FPKM) (Levin et al. 2010) for 629 
mRNAs (a subset of the mRNAs in A. Dotted lines indicate median RNA-seq FPKM and 




Figure 2.6. 5´-OH RNAs exist in regions of clustered or discrete cleavage. 
A. Plots of 5´-OH abundance (CPM) versus position (bp) for four representative mRNAs 
(of 187 total) with multiple, distributed 5´-OH fragments. All mRNAs are plotted from 5´ 
to 3´, with UTR regions in grey, and ORF regions in black. 5´-OH fragments in the IMH1, 
RPN2, and YEF3 mRNAs were predominantly localized to their coding regions, and 5´-
OH fragments in the SAC1 mRNA were restricted to its 3´ UTR. 
B. Three representative mRNAs (of 17 total) with single, predominant 5´-OH fragments. 
The ADH1 and YNK1 mRNAs each contained a single predominant 5´-OH fragment in 
their ORF regions, and the CYS4 mRNA contained a single 5´-OH fragment in its 3´ UTR. 
The MDH1 mRNA had a predominant 5´-OH fragment 8 nt downstream of its stop codon. 
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fusion of ubiquitin to the S31 protein of the ribosomal small subunit (Finley et al. 1989). 
The 5´-OH fragment mapped 3 nt downstream of the codons for the Arg Gly-Gly (RGG) 
terminus of ubiquitin, suggesting that this fragment might be generated during translation 
and ubiquitin processing (Lacombe et al. 2009) (Figure 2.7A). However, another mRNA 
encoding a ubiquitin-ribosomal protein, RPL40A, had significant levels of 5´-OH 
fragments located farther downstream of the codons encoding the ubiquitin C-terminus, 
suggesting that ubiquitin processing is not responsible for RPS31 mRNA cleavage (Figure 
2.7B). 
In the RPS31 mRNA, the 7 codons following the Arg-Gly-Gly residues – and at the 
site of the 5´-OH fragment – are AAA and AAG codons that encode Lys and Arg residues, 
which are known to trigger co-translational mRNA cleavage (Tsuboi et al. 2012). In 
addition, a similar fragment from the RPS31 mRNA was previously identified in ribosomal 
profiling experiments (Guydosh and Green 2014) (Figure 2.7C), suggesting that this 
fragment is associated with ribosomes. I validated the RPS31 mRNA fragment by RtcB-
mediated linker ligation followed by reverse transcription and PCR, yielding product sizes 
consistent with 5OH-seq (Figure 2.7D). Based on this amplification, I estimate that these 
fragments are <1% of the abundance of full length RPS31 mRNA. 
Given that the RPS31 5´-OH fragment mapped upstream of a region of six 
consecutive basic residues, I analyzed the global relationship between 5´-OH fragments 
and nearby codon content. I first examined annotated open reading frames to identify 
sequences encoding amino acid sequences of at least five consecutive identical or related 
residues (e.g., five or more consecutive lysine residues, or a mix of five consecutive lysine 




Figure 2.7. Single cleavage in RPS31 mRNA is validated by link-RT-PCR. 
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Figure 2.7. Single cleavage in RPS31 mRNA is validated by link-RT-PCR. 
A. A single predominant 5´-OH RNA fragment (grey arrow) maps to the RPS31 mRNA, 
encoding the ubiquitin-Rps31 fusion protein. The fragment maps to a position 3 nt 
downstream of the codons for Arg-Gly-Gly (RGG) residues (vertical black arrow), which 
signal ubiquitin removal by deubiquitinases (Lacombe et al. 2009). 
B. Multiple, distributed 5´-OH signals are further downstream of RGG codons (vertical 
black arrow) in the RPL40A mRNA, which encodes the ubiquitin-Rpl40a fusion protein. 
C. An abundant RNA fragment recovered in ribosome profiling experiments (Guydosh and 
Green 2014) maps to the same position in the RPS31 mRNA as the 5´-OH fragment in A. 
This fragment was present in all samples, but was most abundant in ribosome profiling 
done in cells treated with the non-hydrolysable GTP analog GMP-PNP (shown). 
D. The 5´-OH fragment in RPS31 was validated by RtcB ligation-mediated RT-PCR (“link-
RT-PCR”). 5´-OH fragments in total RNA were incubated with an RtcB substrate (a 
synthetic oligonucleotide with a 3´-phosphate) in the presence or absence of RtcB ligase. 
These reactions were divided and reverse transcribed with a primer specific for RPS31 that 
hybridizes downstream of the 5´-OH terminus. cDNA products of reverse transcription 
were PCR amplified with primers that hybridize to RPS31 up- and downstream of the 5´-
OH terminus and analyzed by gel electrophoresis, yielding abundant fragments at the 
appropriate size (415 bp), independent of RtcB ligation (left panel). A second PCR was 
performed with a 5´ primer that hybridizes to the RtcB substrate, and analysis of these 
products showed ligation-dependent PCR products at the expected sizes (major 5´-OH 





upstream and 75 nt downstream from the start of these regions (Figure 2.8A). I analyzed 
5´-OH fragments cloned from rRNA-depleted RNA, and found that 5´-OH fragments 
accumulated upstream of the 240 instances of consecutive basic residues composed of both 
lysine and arginine codons (Figure 2.8B). This relationship was more pronounced than the 
accumulation of 5´-OH fragments upstream of regions with consecutive lysine or arginine 
residues alone (Figure 2.8B). I also found high levels of 5´-OH fragments upstream of the 
105 instances of consecutive glutamate residues, but this signal was diminished when I 
considered consecutive acidic residues composed of aspartate alone (n=102) or regions 
composed of both glutamate and aspartate (n=642) (Figure 2.8B). The highest levels of 
5´-OH fragments were upstream of regions composed of a mixture of acidic and basic 
residues, particularly the combination of Lys and Glu (Figure 2.8C). The levels of 5´-OH 
fragments were higher when longer lengths of consecutive amino acids were considered 
(Figure 2.8C). I identified specific examples of mRNAs with 5´-OH fragments upstream 
of regions encoding consecutive acidic residues including CBF5 and HSC82 (Figure 
2.8D). Analysis of other consecutive codons showed that they are not associated with 5´-
OH fragment accumulation (data not shown). These findings suggest a relationship 
between the electrostatic properties of a nascent peptide and mRNA cleavage events that 
yield 5´-OH fragments, possibly via a co-translational process such as no-go mRNA decay 
(Shoemaker and Green 2012). 
The eukaryotic 5´→3´ exonuclease Xrn1 specifically recognizes 5´-PO4 RNA 
substrates, but has greatly reduced activity on 5´-OH RNA in vitro (Stevens 2001). 
Consistent with this activity, xrn1∆ budding yeast accumulate several types of 5-PO4 RNAs 
(Harigaya and Parker 2012), and phosphorylation of the 5´-OH RNA products of tRNA  
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Figure 2.8. 5´-OH RNAs accumulate upstream of regions encoding consecutive 
polycharged amino acids. 
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Figure 2.8. 5´-OH RNAs accumulate upstream of regions encoding consecutive 
polycharged amino acids. 
A. Schematic of 5´-OH signals with respect to regions encoding specific peptide regions 
in B. 
B. The mean 5´-OH fragment coverage in rRNA-depleted total RNA was calculated 75 nt 
upstream (negative) and downstream (positive) of the start position of all mRNA sequences 
encoding at least 5 consecutive basic or acidic residues, including Arg (n=12), Lys (n=59), 
a mixture of Lys and Arg (n=280), Glu (n=105), Asp (n=102), and a mixture of Glu and 
Asp (n=642). A peak of 5´-OH fragments is present ~30 nt upstream of regions composed 
of Lys and Arg, but this signal is lower in regions encoding Lys or Arg alone (top panels). 
Coverage of 5´-OH fragments is elevated higher in regions encoding Glu than regions 
encoding Asp, or Glu and Asp (bottom panels).  
C. The mean 5´-OH fragment coverage was calculated 75 nt upstream (negative) and 
downstream (positive) of the start position of all mRNA sequences encoding varying 
lengths of consecutive basic and acidic residues.  5´-OH fragments were enriched upstream 
of regions encoding polyelectrostatic (both basic and acidic) resides (Arg, Lys, Glu, Asp; 
left panel) and were highest upstream of regions encoding only Lys and Glu (right panel). 
In both panels, regions encoding longer consecutive stretches (≥20) of polyelectrostatic 
amino acids had higher 5´-OH signals than regions encoding shorter stretches (≥5).  
D.  Representative examples of mRNAs (CBF5 and HSC82) with 5´-OH fragments that 
map to positions upstream of sequences encoding polyelectrostatic amino acid motifs. 
Regions encoding polyelectrostatic amino acid stretches are indicated by grey boxes above 




splicing is required for their turnover by Xrn1 (Wu and Hopper 2014). Given the high 
specificity of Xrn1 for 5´-PO4 RNA substrates in vitro, it is possible that other 5´-OH RNA 
fragments could be subject to a similar turnover pathway with a requisite phosphorylation 
event prior to Xrn1-mediated turnover. 
 
Identification of endonucleolytic cleavages produced during the unfolded protein response 
 During the unfolded protein response (UPR), misfolded or aggregated proteins 
accumulate in the lumen of the endoplasmic reticulum and activate the kinase-
endoribonuclease Ire1 (Ron and Walter 2007). Activated Ire1 endonuclease cleaves an 
intron from the HAC1 pre-mRNA (Gonzalez et al. 1999), and the cleaved exons are 
subsequently ligated by yeast Trl1 tRNA ligase (Sidrauski et al. 1996). After ligation, the 
mature HAC1 mRNA is translated, and Hac1 protein traffics to the nucleus where it drives 
expression of hundreds of stress response genes (Sidrauski et al. 1996). I mapped 5´-OH 
RNA fragments in cells treated with the N-linked glycosylation inhibitor tunicamycin 
(Tm), which causes protein misfolding and UPR activation. The primary 5´-OH RNA 
fragments captured from the HAC1 mRNA mapped upstream of a sequence encoding 
consecutive electrostatic residues (Figure 2.9A), consistent with the transcriptome-wide 
enrichment of 5´-OH signal upstream of mRNA sequences encoding polyelectrostatic 
residues (Figure 2.8B). The canonical Ire1 cleavage sites in the HAC1 pre-mRNA were 
identified at the 5´ end of the intron and the 5´ end of the 3´-exon (Figure 2.9B, all panels).  
In ∆xrn1 yeast, the HAC1 5´-OH RNA products of Ire1 cleavage increased with in vitro 
shrimp alkaline phosphatase (SAP) treatment, consistent with their phosphorylation in vivo 
– presumably by Trl1 5´-kinase (Sidrauski et al. 1996) – followed by Xrn1-mediated 
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degradation (Figure 2.9B, top panel). The increase in 5´-OH signal at the the 5´ end of the 
HAC1 3´-exon in the xrn1∆ strain treated with tunicamycin (Figure 2.9B, second panel) 
compared to the XRN1 strain treated with tunicamycin (Figure 2.9B, fourth panel) may be 
due to an increase in stability of the primary HAC1 transcript prior to cleavage. 
I compared 5´-OH mRNA signals in untreated cells and cells treated with 
tunicamycin, and found a 5´-OH fragment from the KAR2 mRNA (the yeast ortholog of  
BiP/HSP70) that was 17-fold more abundant in the presence of tunicamycin (Figure 
2.10A). Initially I attributed this signal to upregulation of KAR2 mRNA expression by the 
UPR transcriptional response (Normington et al. 1989), but I also identified six other ER-
related mRNAs with 5´-OH fragments that increased 5-fold or more upon tunicamycin 
treatment and were present in a sequence motif similar to the KAR2 cleavage site: 
5´-CCAUU|A-3´ (Figure 2.10A, lower panel; Figure 2.10B). One of these mRNAs is the 
UPR-induced thioredoxin peroxidase TSA1 mRNA (Kimata et al. 2005), where 5´-OH 
fragments accumulated at two such motifs upon tunicamycin treatment (Figure 2.10C). A 
shared motif within these mRNAs suggests that a site-specific endoribonuclease 
specifically cleaves certain mRNAs during UPR induction. 
 
Discussion 
 I developed a method to directly capture RNAs with 5´-OH termini using the unique 
substrate specificity of E. coli RtcB RNA ligase (Tanaka et al. 2011) (Figures 2.1, 2.2). 
This method is highly selective for the capture of 5´-OH products (Figure 2.3), and yields 
reproducible signals among several classes of cellular RNA. RNA fragments with 5´-OH 




Figure 2.9. HAC1 mRNA cleavage fragments accumulate with 5´-OH and 5´-PO4 
termini. 
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Figure 2.9. HAC1 mRNA cleavage fragments accumulate with 5´-OH and 5´-PO4 
termini. 
A. The majority of 5´-OH fragments from the HAC1 mRNA map upstream of codons for 
consecutive electrostatic amino acid residues. Their abundance was similar in DMSO-
treated cells (DMSO, top panel) and cells treated with 2.5ug/mL tunicamycin for 2 hours 
(+Tm, bottom panel) cells. 
B. Ire1 cleavage fragments from HAC1 mRNA are captured in 5OH-Seq libraries. Low 
levels of fragments resulting from intron cleavage were found in all conditions at the 5´end 
of the intron and the 5´ end of the 3´-exon (all panels). The fragments were most abundant 
in the xrn1∆ strain treated with tunicamycin and subjected to in vitro dephosphorylation 






Figure 2.10. Some 5´-OH RNAs increase with tunicamycin treatment and occur in a 
common motif. 
A. 5´-OH fragment abundance (CPM) in KAR2 mRNA was examined in cells treated with 
vehicle (DMSO, top) and tunicamycin (middle). A 5´-OH fragment increased 17-fold upon 
tunicamycin treatment (middle) and mapped to the sequence 5´-CCAUU|A-3´ (bottom). 
B. Consensus sequence motif in logo format derived from sequences flanking (10 nt up- 
and downstream) 5´-OH fragments that increased in abundance 5-fold or more upon 
tunicamycin treatment. A total of 10 instances of the motif were found among 23 mRNAs. 
C. Two 5´-OH fragments in the TSA1 mRNA increased 11.4-fold and 8.7-fold upon 
tunicamycin treatment (top and middle panel) and mapped to the consensus motif in B 
(bottom panel, arrows). 
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RNA fragments reported here collectively comprise a previously uninterrogated RNA 
class. 
I identified three categories of tRNA fragments with 5´-OH termini: those derived 
from cleavage at the boundary of the intron and 3´ exon, cleavage in the anticodon loop, 
and cleavage in the D-arm/loop (Figure 2.4). The first of these validates the method by 
demonstrating capture of a known 5´-OH terminus generated in vitro during the well-
characterized processing of an intron-containing pre-tRNA by the tRNA Splicing 
Endonuclease (SEN) (Trotta et al. 1997). A mechanism of anticodon loop cleavage is also 
known: Rny1 can cleave the anticodon loop during stress conditions (Thompson and Parker 
2009b), and related fragments have been previously captured by 2´,3´-cyclic phosphate 
cloning (Schutz et al. 2010). However, the most abundant tRNA cleavages observed in 
5OH-seq were in the D-arm and loop, which may represent a novel tRNA stress fragment 
generated simultaneously with the 5´-tRF fragment (Saikia and Hatzoglou 2015).  
 I identified a relationship between 5´-OH mRNA fragments and mRNA sequences 
that encoded consecutive basic peptide sequences (Figures 2.7, 2.8). In the RPS31 mRNA, 
a 5´-OH fragment accumulates upstream of codons encoding a polybasic peptide (Figure 
2.7A). Production of the fragment does not appear to be related to ubiquitin processing, as 
another ubiquitin fusion RPL40A does not have 5´-OH fragments near the site of ubiquitin 
cleavage (Figure 2.7B). A similar fragment in the RPS31 mRNA was also identified in 
ribosomal profiling experiments done in budding yeast (Guydosh and Green 2014). 
(Figure 2.7C). These experiments predominantly recover RNA fragments that are 
protected from ribonuclease digestion by ribosomes, but do so without relying on a specific 
5´ end chemistry (Ingolia et al. 2012). Additionally, several previous studies showed that 
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nascent peptides with specific electrostatic properties cause ribosome pausing and trigger 
co-translational mRNA decay. In non-stop decay (NSD), translation of the polyadenylate 
tails of mRNAs that lack stop codons leads to a nascent polylysine peptide (Ito-Harashima 
et al. 2007), which is proposed to interact with the negatively charged exit tunnel of the 
ribosome (Lu and Deutsch 2008) to trigger ribosome stalling and mRNA decay. Similarly, 
internal polybasic peptides trigger co-translational mRNA decay, and this process is 
dependent on the non-canonical release factors Dom34 and Hbs1 (Tsuboi et al. 2012). In 
addition, global measures of translation indicated that polybasic sequences cause ribosomal 
stalling, suggesting they interfere with ribosome elongation (Brandman et al. 2012). The 
presence of this RPS31 5´-OH fragment in ribosome profiling data suggests that it may be 
associated with ribosomes and may be a product of a ribosome-directed decay process 
driven by the polybasic coding region. 
Many studies have used synthetic reporter mRNAs to study the role of nascent 
peptides in determining decay of a translating mRNA (Tsuboi et al. 2012). However, there 
are no known physiological mRNA substrates of no-go decay (NGD), and the 
endonuclease activity responsible for mRNA cleavage during NGD is not known 
(Shoemaker and Green 2012). Detailed mapping of mRNA cleavage events during NGD 
showed that mRNA cleavage occurs around 20 nt upstream of a polybasic sequence 
(Tsuboi et al. 2012), which is consistent with the distance between 5´-OH fragments and 
other polyelectrostatic sequences (Figure 2.8). The 3´-fragments generated in NGD are 
degraded by Xrn1 (Doma and Parker 2006), which requires 5´- PO4 substrates (Stevens 
2001). Perhaps the  3´-fragments of NGD are generated by an endonuclease that creates 
5´-OH RNA products that are phosphorylated by a cellular 5´-kinase activity (e.g., the 
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tRNA ligase Trl1), promoting their decay by Xrn1. This scenario would be similar to 5´-
kinase-mediated turnover of spliced tRNA introns by Xrn1 (Wu and Hopper 2014). Thus, 
it is possible that many of the 5´-OH fragments I identified are products of NGD. Future 
studies will determine whether the production of 5´-OH fragments in mRNA sequences 
encoding highly electrostatic peptides (Figure 2.8) is dependent on NGD factors such as 
Dom34 and Hbs1 (Tsuboi et al. 2012). 
 I also identified 5´-OH fragments upstream of polyacidic and other 
polyelectrostatic sequences composed of a mixture of basic and acidic residues (Figure 
2.8). These signals were more prominent than any regions composed of any other single 
amino acid. Polyacidic stretches in the C-terminus of several human proteins are associated 
with ribosome frameshifting in these regions (Gould et al. 2014). However, it is not clear 
whether frameshifting is a consequence of the polyacidic nascent peptide, or whether it is 
a consequence of the propensity out-of-frame polyglutamate codons to encode new Met 
initiation codons. Notably, the 5´-OH fragment I identified 8 nt downstream of the MDH1 
stop codon (Figure 2.6B) is near the site of ribosomal stop codon read through in other 
fungi, which appends a peroxisomal targeting sequence (PTS) to the Mdh1 protein for its 
localization (Stiebler et al. 2014). If a similar phenomenon accounts for the MDH1 mRNA 
5´-OH fragment in S. cerevisiae, it suggests that production of 5´-OH fragments is a general 
feature of mRNA decay at sites of non-canonical ribosome elongation (i.e., frameshifting 
or read through). 
A potential artifact of mRNA purification with oligo-dT beads is the enrichment of 
A-rich 5´-OH RNAs independent of their non-templated 3´-polyadenylate tails. In 
particular, some codons for electrostatic residues (Arg, Lys, Glu) are A-rich, and might be 
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preferentially isolated by oligo-dT beads. I found that 5´-OH fragments upstream of 
polylysine stretches (encoded by AAA and AAG codons) were indeed increased in polyA 
libraries relative to rRNA-depleted libraries, but 5´-OH fragment levels upstream of other 
mixed polyelectrostatic sequences were present at similar levels in polyA selected and 
rRNA-depleted libraries. Furthermore, in polyA selected samples and rRNA-depleted 
samples, I detected no enrichment of 5´-OH signal upstream of polyasparagine residues, 
which are encoded by AAU and AAC codons and are well-represented in the yeast 
transcriptome (n=138). Therefore, I conclude that oligo-dT purification introduces minimal 
codon bias in the 5OH-seq signal. 
During activation of the unfolded protein response, the HAC1 pre-mRNA is cleaved 
by the kinase-endoribonuclease Ire1, producing 2´,3´-cyclic phosphate and 5´-OH RNA 
fragments (Gonzalez et al. 1999) that are substrates for ligation by tRNA ligase (Sidrauski 
et al. 1996). However, previous studies that identified 5´-PO4 mRNA fragments from 
dcp2∆ xrn1∆ yeast recovered HAC1 cleavage products at the sites of Ire1 cleavage 
(Harigaya and Parker 2012). Using 5OH-seq, I recovered HAC1 mRNA cleavage products 
at their highest levels in xrn1∆ cells after in vitro dephosphorylation (Figure 2.9B, top 
panel). The presence of these 5´-PO4 RNA fragments possibly indicates that the Trl1 5´-
phosphorylation step is rapid, but further HAC1 mRNA ligation by Trl1 is slow or often 
not completed. Corroborating this idea, fungal ligases have rapid 5´-kinase kinetics, but a 
slower ligation step (Remus and Shuman 2014). Similarly, the products of metazoan 
Regulated IRE1-Dependent Decay (RIDD) are degraded by Xrn1 (Hollien and Weissman 
2006), implying that a 5´-kinase phosphorylates 5´-OH products of Ire1 cleavage prior to 
their decay by Xrn1. 
	 88 
Previous studies indicated that HAC1 is the sole target of Ire1 cleavage in budding 
yeast (Niwa et al. 2005); however, a more recent study provided evidence that yeast Ire1 
can cleave known human RIDD substrates in vitro, and suggested that DAP2 and MFα1 
mRNAs may be endogenous targets of yeast RIDD (Tam et al. 2014). I identified 23 
mRNAs with 5´-OH fragments that increased more than 5-fold with tunicamycin treatment. 
Ten of these fragments were present in the consensus motif 5´-CAUU|A-3´, suggesting that 
the mRNAs are targeted by a site-specific endonuclease following UPR induction (Figure 
2.10B). An obvious candidate for this endonuclease is Ire1, but the 5´-CAUU|A-3 cleavage 
motif identified by 5OH-seq differs from the canonical Ire1 recognition motif for HAC1 
mRNA in budding yeast (Sidrauski and Walter 1997), as well as motifs in other RIDD 
targets in fission yeast and metazoans (Maurel et al. 2014). However, Ire1 cleavage 
specificity can vary with oligomerization state, and Ire1 may not necessarily cleave at the 
canonical motif during RIDD (Gaddam et al. 2013). Further study will determine whether 
these mRNAs are directly cleaved by Ire1, or are an indirect consequence of UPR 
activation. 
The ability to globally map 5´-OH RNA fragments will enable new studies of 5´-
kinase enzymes that phosphorylate 5´-OH substrates. For example, the human RNA 5´-
kinase CLP1 was first identified as a component of the CF IIm sub-complex of cleavage 
and polyadenylation specificity factor (de Vries et al. 2000), and has recently been 
implicated in quality control of RNA 5´-termini during transfer RNA processing (Weitzer 
and Martinez 2007b). Mutations in CLP1 cause severe neurodevelopmental phenotypes, 
and reduce its 5´-kinase activity in vitro (Schaffer et al. 2014; Karaca et al. 2014). Previous 
studies proposed that reduction in 5´-kinase activity causes accumulation of aberrant RNA 
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fragments (Hanada et al. 2013), but it is currently not known how accumulation of these 
molecules might lead to human neurodevelopmental defects or the spinal motor neuron 
deficits that develop in mice expressing kinase-dead Clp1 (Hanada et al. 2013). Turnover 
of tRNA fragments may be analogous to the turnover of tRNA introns in yeast, where 
phosphorylation of 5´-OH tRNA introns leads to their rapid 5´→3´ decay by Xrn1 (Wu and 
Hopper 2014). Application of the 5OH-seq method in cells harboring mutant CLP1 with 
reduced 5´-kinase activity might identify new 5´-OH RNA substrates of CLP1, providing 
insight into this class of neurodevelopmental disorders. In Chapter IV, I present the 
preliminary results of such an experiment. 
 
Summary 
 In this chapter, I described 5OH-seq, a novel method that uses the unique ligation 
chemistry of E. coli RtcB to capture 5´-OH RNAs prior to library preparation and high-
throughput sequencing. 5OH-seq is specific for 5´-OH RNAs, and I validated this by 
showing enrichment for RNAs with 5´-PO4 termini only after in vitro dephosphorylation.  
By performing 5OH-seq on polyA+ RNA from budding yeast, I identified several known 
and previously unknown 5´-OH RNAs. I discovered 5´-OH tRNA fragments from the D-
arm/loop, anticodon loop, and introns of tRNA.  I demonstrated that 5´-OH RNAs are 
enriched upstream of polycharged regions, potentially identifying the first in vivo targets 
of no-go decay. I also showed that a subset of 5´-OH mRNAs increased with tunicamycin 
treatment, which may signify that regulated Ire1-dependent decay (RIDD) occurs in yeast. 
Of all the findings in this initial 5OH-seq study, the confirmation of HAC1 mRNA 
fragments with 5´-PO4 termini rather than 5´-OH termini in xrn1∆ strains is the most 
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intriguing for follow-up studies. It suggests that: i) the kinase activity of Trl1 can be 
separated from the ligation activity, and ii) Xrn1 is responsible for the degradation of HAC1 
mRNA intermediates. In the next chapter, I directly test the hypothesis that the HAC1 
mRNA 3´-exon intermediate with a 5´-OH terminus is phosphorylated by Trl1 prior to 




KINASE-MEDIATED DECAY OF 
EUKARYOTIC MRNA CLEAVAGE PRODUCTS 
 
Introduction 
Many steps in RNA processing are initiated by RNA cleavage events that produce 
RNAs with 2´,3´-cyclic phosphate and 5´-OH termini. During the unfolded protein 
response (UPR), unfolded proteins in the ER lumen promote oligomerization of the 
transmembrane kinase-endoribonuclease Ire1, which cuts a cytoplasmic mRNA to create 
2´,3´-cyclic phosphate and 5´-OH products (Gonzalez et al. 1999). In budding yeast, Ire1 
cleaves an intron from the HAC1 mRNA and the exons are ligated by the multifunctional 
Trl1 RNA ligase (Sidrauski et al. 1996), whereas in metazoans the products of XBP1 
cleavage by IRE1 are ligated by the RTCB RNA ligase (Lu et al. 2014; Kosmaczewski et 
al. 2014). Although the HAC1 3´-exon is produced with a 5´-OH terminus following Ire1-
mediated cleavage, two transcriptome-wide sequencing studies captured the HAC1 3´-exon 
with a 5´-PO4 terminus in xrn1∆ yeast (Harigaya and Parker 2012, Peach et al. 2015) 
(Chapter II), indicating that the HAC1 3´-exon is normally phosphorylated after Ire1 
cleavage and then degraded by Xrn1. 
RNAs with 5´-OH termini must be phosphorylated to become competent for decay 
by 5´-phosphate-dependent exoribonucleases, and I have termed this process “kinase-
mediated decay” (KMD). Three previous examples of KMD suggest that it is a common 
mode of RNA turnover. In the first example of KMD, bacteriophage T4 cleaves “early 
genes” with T4 endoribonuclease RegB shortly after infection of E. coli, generating 3´ 
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RNA cleavage fragments with 5´-OH termini. Phosphorylation of the 5´-OH terminus by 
T4 polynucleotide kinase (PNK) yields a 5´-PO4 RNA intermediate, which is degraded by 
the host endonucleases RNase E and G (Durand et al. 2012). In the second example, the 
yeast SEN complex cleaves intron-containing pre-tRNAs in yeast, releasing an intron with 
a 2´,3´-cyclic phosphate terminus and a 5´-OH terminus (Knapp et al. 1979). Trl1 
phosphorylates the 5´-OH terminus enabling degradation of the intron by the 5´-phosphate-
dependent 5´→3´ exoribonuclease Xrn1 (Wu and Hopper 2014). In the most recent 
example of KMD, the Las1 endonuclease cleaves the ITS2 spacer of 27SB pre-rRNA in 
yeast, generating 26S pre-mRNA with a 5´-OH terminus. RNA/DNA 5´-kinase Grc3 
phosphorylates the terminus of 26S pre-rRNA, and the 5´-PO4 terminus promotes 
recognition and degradation by nuclear 5´→3´ exoribonuclease Rat1 to produce mature 
25S´ rRNA (Gasse et al. 2015). 
Insight into unknown endonucleolytic factors that cleave mRNA substrates may be 
gained by examining the termini of RNA cleavage products. In no-go mRNA decay 
(NGD), mRNA features that slow or stall ribosome movement are sensed by the non-
canonical release factors Dom34/Hbs1, which couple ribosome slowing to mRNA 
cleavage (Doma and Parker 2006; Parker 2012). However, the factors that catalyze NGD 
endonucleolytic cleavage are not known. Thus, while Xrn1 degrades the 3´ product of 
cleavage (Doma and Parker 2006), it is not known whether NGD products are created with 
5´-PO4 termini, or with 5´-OH termini that are subsequently phosphorylated. 
In this chapter, I establish the role of 5´-OH RNA kinase Trl1 and 5´-phosphate-
dependent 5´→3´ exoribonuclease Xrn1 in two KMD pathways for mRNA cleavage 
products in budding yeast. In the first example, I use a series of experiments to demonstrate 
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that Trl1 phosphorylates the 5´-OH terminus of the HAC1 mRNA 3´-exon cleavage 
fragment. The 5´-PO4 terminus promotes degradation by Xrn1, which in turn suppresses 
HAC1 mRNA splicing and UPR activation. In the second example, I present an experiment 
performed by Patrick Cherry, which shows that NGD fragments are generated with 5´-OH 
termini, and require Trl1 phosphorylation prior to their decay by Xrn1. These two pathways 
suggest that KMD may function broadly to degrade 5´-OH mRNA cleavage products. 
 
Materials and Methods 
 
Yeast strains and plasmids 
Plasmids used in this chapter were obtained from previous studies or created as 
indicated in Table 3.1 with further details of the (10x-tRNA) plasmid below. Yeast strains 
used in this chapter are described in Table 3.2. Plasmids were introduced into yeast by 
standard lithium acetate transformation. For plasmid shuffles, yeast were plated on 5-
fluoroorotic acid (5-FOA). The following yeast strains were a gift from S. Shuman: SPT05, 
SPT06, SPT07, SPT08 (Tanaka et al. 2011). 
 
Generation of (10x-tRNA) plasmid 
A sequence was designed that encodes the 10 intron-containing yeast tRNAs 
without introns (i.e, “pre-spliced”). The expression of this “tRNA block” is driven by the 
SUP4 promoter and terminated by RPR1. This sequence was ordered from IDT as a gBlock 
and recombined into pDONR221 in a Gateway BP reaction (Thermo Fisher). The product 








Table 3.1 Plasmids. 
 
Name Genotype Source 
(XRN1) (pGP564 2� LEU2), YEpXRN1 (Wu and Hopper 2014) 
(TRL1 URA3) (pRS416-TRL1 CEN URA3), TRL1 promoter (Tanaka et al. 2011) 
(TRL1) (pRS413-TRL1 CEN HIS3), TRL1 promoter (Tanaka et al. 2011) 
(RTCB) (pRS423-RTCB 2� HIS3), TPI promoter (Tanaka et al. 2011) 
(10x-tRNA) (pAG424-10X-tRNA 2� TRP1), SUP4 promoter Described in text 
(TRL1-D425N) (pRS413-TRL1-D425N CEN HIS3), native promoter Quick change of the (TRL1) plasmid 











Table 3.2 Yeast strains. 
 
Index Name Description 
SPT01 XRN1 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 trp1Δ  
SPT02 xrn1∆ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 trp1Δ xrn1∆::KanMx 
SPT03 xrn1∆ (XRN1) SPT02 transformed with (XRN1) 
SPT04 dxo1∆ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 trp1Δ dxo1∆::KanMx 
SPT05 
 
trl1∆ (TRL1 URA3) 
 
MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 
trl1Δ::kanMx 
SPT06 trl1∆ (TRL1) SPT05 transformed with (TRL1), plasmid shuffle on 5-FOA 
SPT07 trl1∆ (TRL1) (PGK1-sL) SPT06 transformed with (PGK-sL) 
SPT08 trl1∆ (RTCB) SPT05 transformed with (RTCB), plasmid shuffle on 5-FOA 
SPT09 trl1∆ (RTCB) (PGK1-sL) SPT08 transformed with (PGK-sL) 
SPT10 trl1∆ (10x-tRNA) SPT05 transformed with (10x-tRNA), plasmid shuffle on 5-FOA 
SPT11 trl1∆ (10x-tRNA) (TRL1-D425N) SPT10 transformed with (TRL1-D425N) 
SPT12 trl1∆ xrn1∆ (TRL1 URA3) SPT05 xrn1∆::HygMx 
SPT14 trl1∆ xrn1∆ (TRL1) SPT12 transformed with (TRL1), plasmid shuffle on 5-FOA 
SPT15 trl1∆ xrn1∆ (TRL1) (PGK1-sL) SPT14 transformed with (PGK-sL) 
SPT16 trl1∆ xrn1∆ (RTCB) SPT12 transformed with (RTCB), plasmid shuffle on 5-FOA 
SPT17 trl1∆ xrn1∆ (RTCB) (PGK1-sL) SPT16 transformed with (PGK-sL) 
SPT18 trl1∆ xrn1∆ (10x-tRNA) SPT12 transformed with (10x-tRNA), plasmid shuffle on 5-FOA 
SPT19 trl1∆ xrn1∆ (10x-tRNA) (TRL1-D425N) SPT18 transformed with (TRL1-D425N) 
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pAG424-ccdB (created by removing the GPD promoter from pAG424-GPD-ccdB (Alberti 
et al. 2007), which has the TRP1 gene and a 2µ origin). The pDONR221-10X-tRNA, 
pAG424-ccdB (empty vector) and pAG424-10X-tRNA (10x-tRNA) plasmids will be made 
available from Addgene. 
 
Yeast spot assays 
Yeast strains were spotted on –Trp, -Ura, and 5-Fluoroorotic Acid (5-FOA) SC 
plates in serial dilutions. Yeast were grown at 30ºC and imaged at 5-7 days. 
 
Yeast culture conditions and RNA preparation 
Single colonies were inoculated in selective drop-out media supplemented with 
relevant amino acids and incubated at 30˚C overnight with rotation. For UPR induction, 
overnight cultures were diluted to OD600 of 0.2, grown to mid-log phase, and treated for 2 
hours with tunicamycin (final concentration of 2.5 µg/mL, Sigma-Aldrich) or DMSO. For 
stem-loop reporter experiments, overnight cultures were pelleted, washed, resuspended in 
YEP with 2% raffinose and 2% galactose, and grown to mid-log phase. In both UPR and 
stem-loop experiments, cells were harvested by centrifugation and total RNA was isolated 
by hot acid phenol extraction. Total RNA was treated with TURBO DNase (Ambion) to 
remove genomic DNA. 
 
RT-PCR and qRT-PCR 
DNase-treated RNA was reverse transcribed with Protoscript II RT (New England Biolabs) 
using degenerate primers. HAC1 and PGK1 were PCR amplified from cDNA using 
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oligonucleotides listed in Table 3.3. Products were run on a 1.5% agarose TAE gel, stained 
with CYBR-Gold (Life Technologies) and imaged with AlphaImager HP (ProteinSimple). 
Densitometry was performed with ImageJ. cDNA was also subjected to quantitative real-
time PCR (qRT-PCR) using the LightCycler 480 SBYR Green I kit (Fischer Scientific) 




Primers against the 3´-UTR of HAC1 mRNA and snRNA U6 were end-labeled with 
PNK (New England Biolabs) and γ32P-ATP (Perkin Elmer). Labeled primers were purified 
by Illustra MicroSpin G-25 columns (GE Healthcare), precipitated with 100% ethanol and 
washed with 75% ethanol. Radiolabelled primers and DNase-treated RNA  
(5 µg) were denatured in TRIS, pH 8.0, 31 mM NaCl, 6.21 mM DTT at 90ºC for 3 minutes, 
folded at 55 ºC for 3 minutes, and then immediately cooled in liquid nitrogen. GoScript 
reverse transcriptase (1 U, Promega) was added in a final concentration of 533uM dNTPs, 
3.23 mM MgCl2, 6mM DTT, 80mM KCl, and 55 mM Tris pH 8.3. Primers were extended 
for 45 minutes at 42ºC and 15 minutes at 55ºC. GoScript RTase was inactivated by heating 
for 15 minutes at 65ºC. RNA was hydrolyzed with 10mM NaOH at 90ºC for 3 minutes. 
Formamide loading dye was added and ssDNA products were run on a 6% TBE 7M Urea 






Table 3.3. Oligonucleotides 
 
Name Sequence 
HAC1 3´-UTR ACCCTCTTGCGATTGTCTTC 
U6-67 GAACTGCTGATCATCTCTG 
HAC1 F CATGGGAGCTGCAGATGTT 
HAC1 R AAATGAATTCCAACCTGACTGC 
PGK1 F TCTTAGGTGGTGCCAAAGGTT 
PGK1 R GCCTTGTCGAAGATGGAGTC 
KAR2 F AAGACAAGCCACCAAGGATG 
KAR2 R AGTGGCTTGGACTTCGAAAA 







For stem-loop reporter northern blots, 5µg of total RNA was run on a 6% TBE 7M 
Urea gel. RNA was transferred to nylon membrane (Hybond N+, GE) and UV-crosslinked. 
The PGK1 3´-NGD probe was end-labeled with PNK (New England Biolabs) and γ32P-
ATP (Perkin Elmer) and incubated with the membrane in ULTRAhyb-Oligo Buffer 
(Thermo Fisher Scientific) at 42ºC overnight. The membrane was exposed on a phosphor-






Xrn1 and Trl1 are required for degradation of the HAC1 3´ exon. 
Previous studies showed that HAC1 3´-exon cleavage products can accumulate with  
5´-PO4 termini in dcp2∆ xrn1∆ (Harigaya and Parker 2012) and xrn1∆ yeast cells (Peach 
et al. 2015) (Chapter II). This suggests that a 5´-OH RNA kinase must phosphorylate the 
HAC1 3´-exon prior to decay by Xrn1. Using a radiolabelled primer complementary to the 
3´-UTR of HAC1 mRNA, I performed primer extensions on several samples and analyzed 
the 74 nt predicted HAC1 3´-exon product (Figure 3.1A). The bands representing the 
HAC1 3´-exon occur in one of three configurations in this assay. If the HAC1 3´-exon is 
present and has a 5´-OH terminus, it cannot be degraded by 5´-phosphate-dependent 5´→3´ 
exonucleases and thus appears as the full 74 nt product (Figure 3.1B, lane 1). If the HAC1 
3´-exon exists with a 5´-PO4 terminus and Xrn1 is present, it is degraded, and does not 
appear in the assay. Finally, if the HAC1 3´-exon exists with a  5´-PO4 terminus and Xrn1 
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is deleted, it is shortened 1 to 3 nt by 5´-phosphate-dependent 5´→3´ exonucleolytic 
“nibbling”, which has been previously reported for 5´-PO4 RNAs in xrn1∆ yeast (Muhlrad 
et al. 1995; Hsu and Stevens 1993). Thus, a HAC1 3´-exon with a 5´-PO4 terminus appears 
as a doublet slightly below the expected product (Figure 3.1B, lane 2). In the xrn1∆ strain 
(BY4741 background), the HAC1 3´-exon accumulates with a 5´-PO4 terminus in the 
absence of UPR induction (Figure 3.1C, lane 3), and the accumulation of the HAC1 3´-
exon with a 5´-PO4 terminus increases upon UPR induction with N-linked glycosylation 
inhibitor tunicamycin (Tm) (Figure 3.1C, lane 4). Normal degradation of the HAC1 3´-
exon is restored when XRN1 is expressed from the genome (Figure 3.1C, lanes 1, 2). or 
from a plasmid (Wu and Hopper 2014) (Figure 3.1C, lanes 5, 6). Rai homolog Dxo1 was 
recently shown to have distributed 5´→3´ exoribonuclease activity (Chang et al. 2012), but 
the dxo1∆ strain does not accumulate the HAC1 3´-exon, suggesting it is nonessential for 
degradation of the HAC1 3´-exon (Figure 3.1C, lanes 7, 8). Taken together, these findings 
indicate that the HAC1 3´-exon is phosphorylated, and that the degradation of the 
phosphorylated HAC1 3´-exon fragment is primarily accomplished by Xrn1-mediated 
5´→3´ decay (Figure 3.1C). 
E. coli RtcB does not have 5´-OH kinase activity, but can ligate HAC1 mRNA and 
intron-containing tRNAs in yeast via an orthogonal chemistry, catalyzing ligation of 2´,3´-
cyclic phosphate and 5´-OH termini without a 5´-PO4 intermediate (Tanaka et al. 2011). 
Given that RtcB can rescue Trl1 deletions, but does not replace its 5´-OH kinase activity, 
I compared HAC1 3´-exon accumulation in the presence (TRL1) or absence (RTCB) of 
cytosolic 5´-OH kinase activity using W303 plasmid shuffle strains (Tanaka et al. 2011). 
When Trl1 is present and Xrn1 is deleted, the HAC1 3´-exon fragment accumulates with a 
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5´-PO4 terminus (indicated by the lower doublet of nibbled 5´-PO4 fragments), and this 
accumulation increases upon Tm treatment (Figure 3.1D, lanes 3, 4), consistent with the 
BY4741 xrn1∆ strain. However, when E. coli RtcB replaces Trl1, and no cytosolic 5´-OH 
kinase activity is present, the HAC1 3´-exon never accumulates with a 5´-PO4 terminus, 
even following Tm treatment in the absence of Xrn1 (Figure 3.1D, lanes 7, 8). This 
indicates that Trl1 phosphorylates the 5´ terminus of the HAC1 3´-exon and that Xrn1 
degrades this fragment. In comparison to the BY4741 strains, all trl1∆ W303 strains 
accumulate a HAC1 3´-exon fragment with a 5´-OH terminus (indicated by the full length 
fragment which is immune to decay by Xrn1) in the absence of induction (Figure 3.1D, 
lanes 1, 3, 5, 7), and this fragment increases with Tm treatment (Figure 3.1D, lanes 2, 4, 
6, 8). This may indicate inefficient ligation of the exogenously expressed ligases Trl1 and 
RtcB. 
 
The 5´-OH kinase activity of Trl1 is required for degradation of the HAC1 3´-exon. 
I next sought to specifically test the role of Trl1 5´-kinase activity in the decay of 
the HAC1 3´-exon. In yeast, Trl1 is essential because it is required for the ligation of tRNA 
halves following cleavage by the TSEN complex (Greer et al. 1983). Similar to previous 
studies in C. elegans (Kosmaczewski et al. 2014), we constructed a plasmid that expresses 
all 10 intron-containing yeast tRNAs in their “pre-spliced” forms. This (10x-tRNA) 
plasmid allows us to bypass the essential tRNA splicing activity of Trl1 (Figure 3.2A). To 
validate the rescue of trl1∆ cells with “pre-spliced” tRNAs, we performed a plasmid shuffle 










Figure 3.1. Xrn1 degrades the phosphorylated HAC1 3´-exon cleavage product. 
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Figure 3.1. Xrn1 degrades the phosphorylated HAC1 3´-exon cleavage product. 
A. Diagram of HAC1 mRNA and the HAC1 3´UTR primer, which is extended with reverse 
transcriptase. The expected primer extension product length of the HAC1 3´exon cleavage 
product is 74 nt. 
B. Schematic of HAC1 3´-exon bands in the primer extension assay. A HAC1 3´-exon with 
a 5´-OH terminus escapes decay by 5´-phosphate-dependent exoribonucleases and appears 
as a single 74 nt band on the gel (Lane 1). A HAC1 3´-exon with a 5´-PO4 terminus is 
rapidly decayed by Xrn1 and does not appear on the gel (no band). A HAC1 3´-exon with 
a 5´-PO4 terminus is stabilized in the absence of Xrn1, but shortened by 5´-phosphate-
dependent exonucleolytic “nibbling”  (Muhlrad et al. 1995; Hsu and Stevens 1993), and 
appears as a 73 nt and 71 nt doublet slightly below the expected length (Lane 2). U6 primer 
extension serves as a positive control (67 nt). 
C. XRN1, xrn1∆, xrn1∆ (XRN1), and dxo1∆ BY4741 strains in log phase were treated 
with 2.5µg/mL tunicamycin (Tm) or DMSO for 2 hours. Radiolabelled HAC1 3´UTR 
primer was extended on DNase-treated total RNA isolated from these strains. Primer 
extension of U6 RNA (67 nt) was used as a loading control. Band intensity was quantified 
with ImageJ, and is displayed in the bar graph immediately below the gel image as 
percentage of HAC1 primer extension signal with a 5´-PO4 or 5´-OH terminus. The HAC1 
3´-exon accumulates with a 5´-PO4 terminus in the xrn1∆ strain (indicated by lower doublet 
bands derived from “nibbled” HAC1 3´-exon fragments). This accumulation increases with 
Tm treatment (Lanes 3, 4). The (XRN1) plasmid restores degradation of the intermediate 
in the xrn1∆ strain (Lanes 5, 6), and dxo1∆ has no effect on HAC1 3´-exon accumulation 
(Lanes 7, 8). 
D. trl1∆ and trl1∆ xrn1∆ W303 strains with expression of either Trl1 or RtcB ligase were 
treated and evaluated as in C. The HAC1 3´-exon accumulates primarily with a 5´-PO4 
terminus (indicated by the lower doublet bands derived from the “nibbled” HAC1 3´-exon) 
in the trl1∆ xrn1∆ (TRL1) strain and this accumulation increases with Tm treatment (Lanes 
3, 4). The trl1∆ xrn1∆ (RTCB) strain does not accumulate the HAC1 3´-exon with a  
5´-PO4 terminus (Lanes 7, 8). All strains accumulate the HAC1 3´-exon with a 5´-OH 
terminus (indicated by the single upper band) independent of Xrn1 presence or Trl1 or 
RtcB expression, and this accumulation increases with Tm treatment.   
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I measured the HAC1 3´-exon mRNA intermediate by primer extension in trl1∆ 
and trl1∆ xrn1∆ W303 yeast strains expressing the (10x-tRNA) plasmid alone or the (10x- 
tRNA) plasmid and a plasmid encoding kinase-dead TRL1-D425N (Sawaya 2003) (Figure 
3.2C). In the absence of Trl1 5´-kinase activity, the HAC1 3´exon accumulates with a 
5´-OH terminus (indicated by the single upper band) (Lanes 1, 3, 5, 7), and the 
accumulation increases when the cells are treated with tunicamycin (Lanes 2, 4, 6, 8). There 
is an increase in the 5´-OH HAC1 3´-exon fragment in Lane 4 compared to Lane 2; this 
may indicate increased stabilization of the HAC1 pre-mRNA in the absence of Xrn1 in the 
W303 strain, which in turn results in increased Ire1 cleavage. 
Taken together, my results thus far indicate that Trl1 phosphorylates the 5´-OH 
terminus of the HAC1 3´-exon, and the phosphorylated HAC1 3´-exon is then degraded by 
Xrn1. This represents the third example of KMD in eukaryotes, and the first shown to occur 
on eukaryotic mRNA cleavage fragments. 
 
Xrn1 5´→3´ decay of the phosphorylated HAC1 3´-exon is required to suppress aberrant 
HAC1 mRNA splicing and UPR activation 
Given the regulated decay of the HAC1 3´-exon intermediate, I next asked whether 
Xrn1 might also affect HAC1 splicing and UPR activation (Figure 3.3). In the absence of 
UPR induction, HAC1 mRNA splicing is significantly elevated in the xrn1∆ strain 
compared to the XNR1 replete strain (Figure 3.3A, B, Lanes 1, 3). Furthermore, HAC1 
mRNA is nearly completely spliced in the xrn1∆ strain after treatment with Tm (Figure 
3.3A, B, Lane 4). Expression of Xrn1 in the xrn1∆ strain restores HAC1 splicing to 











Figure 3.2. The HAC1 3´-exon mRNA cleavage product requires the kinase activity 
of Trl1 to promote degradation by Xrn1. 
A. Diagram of the 10x-tRNA plasmid used to rescue trl1∆ yeast strains. “Pre-spliced” 
forms of the 10 intron-containing tRNAs in yeast are encoded in tandem on a high-copy 
TRP1 plasmid. Expression of a single transcript is driven by a SUP4 promoter and 
terminated by the RPR1 terminator. 
B. Spot assays demonstrate rescue of trl1∆ with the (10x-tRNA) plasmid. Serial dilutions 
of trl1∆ (TRL1 URA3) (10x-tRNA) or trl1∆ (10x-tRNA) were spotted onto –trp, –ura, and 
5-FOA plates. Plates were photographed after 5-7 days of incubation at 30˚C. The trl1∆ 
strain complemented with the (10x-tRNA) plasmid is viable on –trp plates, but is slow 
growing compared to strains with Trl1 expression. The trl1∆ (10x-tRNA) strain does not 
grow on -ura plates but is viable on 5-fluoroorotic acid (5-FOA) plates, demonstrating loss 
of the (TRL1 URA3) plasmid and rescue of trl1∆ with the (10x-tRNA) plasmid. Spot assay 
data provided by Laura White. 
C. Primer extension with radiolabelled HAC1 3´UTR and U6 primers was performed on 
DNase-treated total RNA isolated from yeast strains where essential tRNA ligation is 
bypassed by the (10x-tRNA) plasmid. Band intensity of the HAC1 3´-exon fragment with 
a 5´-OH terminus was quantified with ImageJ, normalized to trl1∆ (10x-tRNA), and is 
displayed in the bar graph immediately below the gel image. Kinase-dead Trl1 (TRL1-
D425N) cannot restore normal Xrn1-mediated degradation of the HAC1 3´-exon. 
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cytosolic exoribonuclease, has little effect on HAC1 mRNA splicing (Figure 3.3, 4, Lanes 
7, 8). These results indicate that Xrn1 normally suppresses baseline HAC1 mRNA splicing. 
If the increase in HAC1 mRNA splicing leads to a rise in Hac1 protein levels, I 
would expect elevated transcription of Hac1 target genes indicating activation of the UPR. 
Indeed, in the absence of Xrn1, expression of the Hac1 transcriptional target KAR2 (Kohno 
et al. 1993) was elevated 4-fold above XRN1 cells without chemical UPR induction (Figure 
3.3C, Lane 3). This modest but significant elevation was reduced in the other strains tested.   
Following UPR induction, all strains induce KAR2 to similar levels, perhaps reaching a 
level of maximal upregulation. 
These results collectively demonstrate the multi-step process of kinase-mediated 
decay. HAC1 mRNA is initially cleaved by Ire1, generating a 3´-exon fragment with a  
5´-OH terminus that cannot be degraded by Xrn1. Phosphorylation by Trl1 5´-kinase 
activity creates a 5´-PO4 terminus, which allows Xrn1 to degrade the HAC1 3´exon 
intermediate. The decay of this intermediate prevents ligation by Trl1, which inhibits 
HAC1 splicing and UPR activation. Thus, KMD is required to control UPR activation in 
yeast.  
 
Trl1 phosphorylates no-go decay 3´-fragments prior to degradation by Xrn1. 
We asked whether KMD might play a broader role in 5´-OH RNA surveillance. 
RNAs with 5´-OH termini accumulate upstream of consecutive basic residues (Peach et al. 
2015) (Chapter II), which are known to trigger no-go mRNA decay (Parker 2012), 
suggesting that NGD 3´ fragments may be generated with 5´-OH termini. However, 
because Xrn1 is required for the decay of NGD 3´ cleavage products (Doma and Parker 
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Figure 3.3. Xrn1 suppresses HAC1 mRNA splicing and UPR activation. 
 
  * 
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Figure 3.3. Xrn1 suppresses HAC1 mRNA splicing and UPR activation. 
A. The indicated strains were grown to log phase and treated for 2 hours with 2.5µg/mL 
tunicamycin (Tm) or DMSO. RT-PCR across the HAC1 mRNA splicing junction was used 
to assess HAC1 splicing. Unspliced HAC1 is the upper band at 461 bp, and spliced HAC1 
is lower band at 209 bp. A minor intermediate band of an unknown species is indicated 
with an asterisk. Gel is representative of three biological replicates. 
B. Quantification of HAC1 splicing in A for three biological replicates. The calculation for 
HAC1 mRNA splicing percentage is: (spliced HAC1) / (spliced HAC1 + unspliced HAC1) 
× 100. White bars indicate DMSO (control) treatment and black bars indicate Tm 
treatment. 
C. KAR2 expression from the samples in A was evaluated by qRT-PCR. KAR2 expression 
is normalized to PGK1 expression for each sample, then compared to the normalized KAR2 
expression in the XRN1 strain for each of three replicates. 
B, C: **p<0.01, ***p<0.001, ***p<0.0001. Student’s t-test (2-tailed). Error bars are SEM. 
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2006) we asked whether Trl1 5´-kinase phosphorylates the 5´-OH terminus of NGD 
products prior to their degradation by Xrn1. 
To evaluate the decay of NGD fragments, we used a NGD reporter (Doma and 
Parker 2006) consisting of a long stem-loop inserted in the PGK1 gene under the control 
of the GAL1 promoter (PGK1-sL) (Figure 3.4A). This stem-loop causes elongating 
ribosomes to stall, leading to mRNA cleavage upstream of the stem-loop. Patrick Cherry 
expressed this reporter in four yeast strains and evaluated NGD 3´-fragment accumulation 
following induction (Figure 3.4B). PGK1-sL 3´ NGD cleavage fragments are degraded in 
strains expressing 5´-OH RNA kinase Trl1, but accumulate in the absence of Xrn1, 
confirming previous studies (Doma and Parker 2006). However, when Trl1 is replaced by 
the orthogonal E. coli RNA ligase RtcB, PGK1-sL 3´ NGD cleavage fragments accumulate 
at elevated levels in the presence or absence of Xrn1, indicating that Trl1 acts upstream of 
Xrn1. 
Thus, a PGK1-sL 3´ NGD cleavage fragment is generated with a 5´-OH terminus 
that must be phosphorylated by Trl1 prior to 5´-phosphate-dependent 5´→3´ degradation 
by Xrn1. KMD of NGD 3´-fragments is the second example of eukaryotic mRNA cleavage 




I have described two examples of kinase-mediated decay (KMD) in which RNA 
5´-OH kinase Trl1 phosphorylates a cleaved 5´-OH mRNA and promotes 5´-phosphate- 
dependent 5´→3´ decay by Xrn1 (Figure 3.5). In the first example, the 3´-exon of HAC1 
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Figure 3.4. Trl1 phosphorylates NGD 3´ fragments prior to 5´→3´ degradation by 
Xrn1. 
A. Diagram of no-go decay reporter PGK1-sL. A strong stem-loop inserted in PGK1 
mRNA causes ribosome stalling and triggers NGD. PGK1-sL fragments detected by 
Northern blot with a radiolabelled 3´-PGK1 probe are indicated below the reporter cartoon. 
B. Northern blot analysis with the 3´-PGK1 probe was performed on RNA isolated from 
yeast strains grown in YEP-galactose-raffinose to induce expression of PGK1-sL. PGK-sL 
3´ NGD fragments accumulate when XRN1 is deleted, or when Trl1 is replaced by RtcB, 
which does not have 5´-OH kinase activity. Experimental data provided by Patrick Cherry. 
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mRNA is phosphorylated by Trl1 prior to 5´→3´ degradation by Xrn1. KMD of the HAC1 
3´-exon suppresses HAC1 mRNA splicing and UPR activation in the absence of true 
stimulus (Figure 3.5A). In the second example, NGD 3´ cleavage fragments are generated 
with 5´-OH termini and must be phosphorylated by Trl1 to become competent substrates 
for 5´-phosphate-dependent Xrn1 degradation (Figure 3.5B). These two examples, 
combined with the two previous examples of eukaryotic KMD for processing tRNA introns 
(Wu and Hopper 2014) and 25S rRNA maturation (Gasse et al. 2015), help make the case 
that KMD is a fundamental, multi-purpose pathway of regulated RNA decay in yeast. 
The mechanism of NGD mRNA cleavage remains mysterious. The proposal that 
Dom34 is the NGD endonuclease is controversial (Lee et al. 2007; Passos et al. 2009), and 
the reduction in NGD cleavage in the absence of ribosomal small subunit proteins is likely 
due to reductions in overall levels of translating ribosomes (Bhattacharya et al. 2010). 
Other characteristics of NGD cleavage suggest that it may not be catalyzed by an 
endonuclease: NGD cleavage is inefficient, with only a small percentage of mRNA 
substrate cleaved (Doma and Parker 2006), and cleavage can occur in a variety of sequence 
contexts (Tsuboi et al. 2012). Patrick Cherry’s data show that NGD mRNA cleavage 
products have 5´-OH termini, suggesting that the NGD cleavage might be catalyzed by 
intrinsic phosphoester transfer promoted by stalled ribosomes. 
KMD is likely required for the decay of 5´-OH RNA cleavage products generated 
by many metal-ion independent endoribonucleases. For instance, in higher-order 
eukaryotes, Ire1 homologs cleave ER-proximal mRNAs during ER stress in a process 
termed Regulated IRE1-Dependent Decay (RIDD) (Hollien and Weissman 2006). The 
cleavage chemistry of Ire1 dictates that the 3´ mRNA fragments must have 5´-OH termini. 
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Figure 3.5. Models of kinase-mediated decay of mRNA cleavage fragments. 
A. (1) Upon sensing unfolded proteins in the ER, Ire1 cleaves HAC1 mRNA, leaving a 5´-
OH terminus on the 3´ exon. (2) The terminus is phosphorylated by Trl1. (3) Normally, the 
3´-exon is degraded by Xrn1. (4) However, in the absence of Xrn1, the RNA is available 
for ligation resulting in splicing of HAC1 mRNA and aberrant activation of the UPR. 
B. (1) When a translating ribosome stalls at a strong secondary structure in mRNA, 
endonucleolytic cleavage leaves a 5´-OH terminus on the 3´ NGD fragment. (2) 
Phosphorylation by Trl1 creates a substrate for degradation by Xrn1 (3). 
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However, these fragments are normally degraded by 5´-phosphate-dependent 5´→3´ decay 
by Xrn1, which requires that the 3´-fragments are first phosphorylated (Hollien and 
Weissman 2006). 
Under certain stress conditions including oxidative stress and nutrient starvation, 
yeast Rny1 and mammalian Angiogenin cleave the anticodon loop of some tRNAs 
(Thompson and Parker 2009b; Yamasaki et al. 2009; Fu et al. 2009). These stress-induced 
tRNA fragments (tiRNAs) can then repress translation and apoptosis (Ivanov et al. 2011; 
Saikia et al. 2014). The 3´-tiRNAs are produced with 5´-OH termini, but it is not known 
how they are degraded. If 3´-tiRNAs are decayed by nuclear 5´-phosphate-dependent 
exoribonuclease Rat1/XRN2, they must first be phosphorylated. 
A third example of potential KMD substrates are the targets of RNase L (Cooper et 
al. 2014). During viral infection of human cells, RNase L cleaves both viral and host RNAs, 
which function as ligands for RIG-I and MDA5 (Malathi et al. 2007; 2010). Although it is 
known that deletion of cytosolic exosome component SKIV2L limits the activation of RIG-
I-like receptors (RLRs) and the production of type I interferons (Eckard et al. 2014), it is 
not known whether cytosolic decay factors directly affect the RNase L cleavage fragments. 
The 3´-fragments of RNase L are produced with 5´-OH termini, and if they are degraded 
by Xrn1, would also require phosphorylation of the 5´-terminus. 
In humans, the UPR is a tripartite signaling system regulated by XBP1, ATF4, and 
ATF6 proteins. XBP1 mRNA, the human homolog of HAC1, is cleaved in the cytoplasm 
by activated IRE1α, which generates a 5´-exon fragment with a 2´,3´-cyclic phosphate 
terminus and a 3´-exon fragment with a 5´-OH terminus. The two exons are joined by 
RTCB, which first resolves the cyclic phosphate to a 3´-PO4 prior to ligation (Lu et al. 
	 115 
2014; Chakravarty and Shuman 2012). The RNA terminal phosphate cyclase RTCA may 
directly antagonize RTCB by converting the 3´-PO4 terminus back to a 2´,3´-cyclic 
phosphate. In Drosophila, loss of function mutations in Rtca enhances Xbp1 splicing and 
axonal growth (Song et al. 2015). Similarly, decreased Rtca expression in the adult mouse 
retinal ganglion cells promotes axon regeneration after optic nerve crush(Song et al. 2015). 
An exome screen of consanguineous families with children afflicted by severe 
neurodevelopmental deficits identified a single site homozygous mutation in CLP1 that 
reduces RNA 5´OH-kinase activity in vitro (Hanada et al. 2013; Karaca et al. 2014; 
Schaffer et al. 2014). Although patient-derived fibroblasts with the homozygous CLP1
R140H
 
mutation accumulate aberrant tRNA fragments, the affect on other RNAs was not assessed.  
Given that RTCA may directly oppose RTCB ligation of XBP1 by cyclizing the 3´-PO4 
terminus of the 5´-exon, perhaps CLP1 can oppose RTCB ligation by phosphorylating the 
5´-OH terminus of the 3´-exon. Phosphorylation of the XBP1 3´-exon by CLP1 would also 




In this chapter, I followed up on a mysterious finding: HAC1 3´-exons are captured 
with 5´-PO4 termini in xrn1∆ yeast (Harigaya and Parker 2012; Peach et al. 2015) (Chapter 
II), despite being generated with 5´-OH termini following Ire1-mediated cleavage. By 
analyzing HAC1 3´-exon accumulation and HAC1 mRNA splicing in yeast strains with 
Xrn1 and Trl1 deletions, I demonstrated the first example of kinase-mediated decay (KMD) 
of a eukaryotic mRNA. Even in the absence of ER stress, Ire1 cleaves HAC1 pre-mRNA 
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at low levels, generating a 3´-exon mRNA fragment with a 5´-OH terminus. 5´-OH RNA 
kinase Trl1 phosphorylates the 5´-OH terminus, yielding a 5´-PO4 RNA that is then 
degraded by 5´-phosphate-depedent 5´→3´ exoribonuclease Xrn1. KMD of the cleaved  
3´-exon of HAC1 is necessary to prevent HAC1 ligation and suppress activation of the UPR 
in the absence of true ER stress. 
KMD is also responsible for the turnover of no-go decay (NGD) 3´-fragments. Prior 
to this study, the nature of the 5´ terminus of the 3´-fragment was unknown. In this chapter, 
I shared Patrick Cherry’s data, which show that the 3´ NGD fragment from the PGK-sL 
reporter is generated with a 5´-OH terminus. Trl1 phosphorylates the 5´-terminus of this 3´ 
NGD fragment, enabling recognition and decay by Xrn1. Given that NGD occurs on a 
variety of mRNA substrates, this suggests that KMD functions as a broad surveillance 





ANALYSIS OF 5´-HYDROXYL RNAS IN MAMMALS 
 
Introduction 
 Cleavage and polyadenylation factor 1 (CLP1) is an essential mammalian 
polyribonucleotide 5´-OH kinase that is a component of both the pre-mRNA cleavage 
complex II (de Vries et al. 2000) and the tRNA splicing endonuclease (TSEN) complex 
(Paushkin et al. 2004). CLP1 phosphorylates synthetic siRNAs in vivo prior to 
incorporation into the RNA-induced silencing complex (RISC) (Weitzer and Martinez 
2007b). CLP1 also phosphorylates the 3´-exon and intron generated from cleavage of 
intron-containing tRNAs by TSEN (Weitzer and Martinez 2007b). 
Studies of consanguineous families with childhood neurological disease identified 
nine pedigrees with a single mutation in CLP1 (Schaffer et al. 2014; Karaca et al. 2014). 
Affected children with a  homozygous CLP1
R140H
 mutation develop motor-sensory defects, 
cortical dysgenesis, and microcephaly. They also demonstrate structural defects of the pons 
and cerebellum consistent with pontocerebellar hypoplasia (PCH). Studies of patient-
derived fibroblasts with the kinase-impaired CLP1
R140H
 mutation and a mouse model with 
a kinase-dead CLP1
K127A
 mutation showed differential accumulation of tRNA fragments 
including intron-containing pre-tRNAs (Schaffer et al. 2014), introns processed from 
tRNAs (Karaca et al. 2014), and 5´ exons (Hanada et al. 2013) when CLP1 kinase activity 
is compromised, though it is not known whether these fragments are causative of disease. 
 In Chapter II, I described the development of the 5OH-Seq method and its 
application to transcriptome-wide analysis of 5´-OH RNA in yeast. Given the severe 
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neurodevelopmental phenotypes causes by single site mutations in the CLP1 mammalian 
kinase, I sought to use 5OH-seq to identify additional targets of CLP1 in mouse and 
humans. Here, I demonstrate the utility of the 5OH-Seq method on three sets of mammalian 
samples with impaired CLP1 kinase function: human 293FT cells with CLP1 shRNA 
knockdown; patient-derived fibroblasts with homozygous and heterozygous CLP1
R140H
 
mutations; and mouse embryonic fibroblasts (MEFs) and spinal cords from mice with 
kinase-dead CLP1
K127A
 mutations. I show enhanced 5´-OH RNA accumulation around 
Poly-A sites in human cell lines with decreased CLP1 expression and identify a novel SeC 
tRNA anti-codon loop cleavage in spinal cords of mice but not in MEFs. These studies 
demonstrate the utility of the 5OH-seq in identification of new 5´-OH RNA fragments in 
mammalian studies. 
 
Materials and Methods 
 
Generation and validation of human cell lines 
Following standard protocols, 293FT cell lines were transduced with one of three 
vectors targeting CLP1 mRNA via shRNA (Table 4.1, shRNA #1-3) or a non-targeting 
control vector, along with packaging plasmids VSV-G and ∆8.9. Transduced cells were 
selected with puromycin. CLP1 shRNA knockdown cell lines were validated by qRT-PCR 
with CLP1 qPCR F/R and Actin qPCR F/R primers. CLP1 shRNA knockdowns were 
further validated by western blots with primary antibodies against CLP1 (ab133669, 
Abcam) and Actin (15939, Pierce) and fluorescent secondary antibodies (DyLight488, 
ab96875, Abcam). Patient-derived fibroblasts were a kind gift from the Lupski lab  
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Validation Primers  
Actin qPCR F GGATGCAGAAGGAGATCACTG 
Actin qPCR R CGATCCACACGGAGTACTTG 
Clp1 qPCR F AAATTCTGCACGGGAGGACC 
Clp1 qPCR R AGATGCCTCCACCTCAAAGC 
Clp1 F TGATGACAAGAAGCCAACCA 
Clp1 R TGTTAGTGCCAGGAGTGGTG 
  
Northern Probes  
SeC tRNA 5´ AGCCTGCACCCCAGACCACTGAGGAT 





(Karaca et al. 2014). Genomic DNA was amplified by PCR with CLP1 F/R primers and 
the CLP1 R140H as validated by Sanger sequencing with the CLP1 qF primer. 
 
RNA isolation and enrichment 
293FT shRNA cell lines and patient-derived fibroblasts were grown in high-
glucose DMEM (Thermo Fisher Scientific) supplemented with 10% FBS (Life 
Technologies) and 1% penicillin/streptomycin (Life Technologies). RNA and DNA were 
isolated from human cell lines using the standard procedures for TRIzol reagent (Ambion). 
From 293FT shRNA cell lines, PolyA+ RNA was enriched from total RNA using oligo-
dT(25) dynabeads (Ambion). Patient-derived fibroblast samples were split in half. One half 
was enriched for PolyA+ RNA with oligo-dT beads, the other half was depleted of rRNA 
using Ribo-Zero Gold rRNA Removal Kit (Illumina). Total RNA from MEFs and mouse 
spinal cords was received as a gift from the Martinez lab (Hanada et al. 2013). This total 
RNA was also depleted of rRNA using the Ribo-Zero kit. 
 
Library preparation 
5OH-Seq libraries from all samples were prepared essentially as described in 
Chapter II (Peach et al. 2015). PolyA-seq libraries were prepared from the 293FT shRNA 
cell lines according to the published protocol (Derti et al. 2012). All libraries were 
sequenced by Illumina HiSEQ 2000/2500 with single 50bp reads. Raw data from all 





5OH-Seq data was preprocessed as described in Chapter II with additional 
downstream analysis. For analysis of mouse tRNAs, I aligned 5OH-seq libraries to a 
custom tRNA database created using annotated tRNAs and including 15 nucleotides 
upstream and downstream to capture leader sequences and potential processing defects.  
To compare 5OH-signal density surrounding mRNA features, I analyzed 40 bins of 25 
bases to capture 500 nucleotides upstream and downstream of a given feature. I calculated 
the average 5OH-seq signal within each bin for each mRNA and summed these means. All 
Python, R, and bash scripts are available at https://github.com/hesselberthlab/5OH. 
 
Northern blot 
DNA oligonucleotides complementary to the 3´ and 5´ halves of SeC tRNA were 
end-labeled with PNK (New England Biolabs) and γ32P-ATP (Perkin Elmer). Total RNA 
(5µg) from mouse spinal cords was run on a denaturing 10% TBE-Urea gel (Thermo 
Fisher). RNA was transferred to positively-charged nylon membrane (Hybond-N+ 
Membrane, GE Healthcare Amersham) and fixed with UV light. Blocking and 
hybridization was performed in ULTRAhyb-oligo buffer (Thermo Fisher Scientific) at 
42ºC. Membranes were exposed on a phosphor-imager screen and imaged on a Typhoon 








Increased 5OH-signal surrounding PolyA sites in CLP1 knockdown cell lines 
CLP1 is a component of the pre-mRNA cleavage complex II, which processes 3´ 
ends of pre-mRNA to form the mature polyadenylated mRNA (de Vries et al. 2000). To 
assess whether decreased CLP1 expression would affect 5´-OH RNA formation near PolyA 
sites, our lab generated stable shRNA knockdowns of CLP1 mRNA in 293FT cell lines. I 
validated CLP1 knockdown by qRT-PCR (Figure 4.1A) and Western blot (Figure 4.1B).  
I performed 5OH-seq on RNA isolated from validated CLP1 knockdown cell lines and 
analyzed 5OH-seq signals 500bp upstream and downstream of PolyA sites (Figure 4.2, 
top). All three CLP1 shRNA knockdown lines had enhanced 5OH-seq signal density 
surrounding PolyA sites compared to the scrambled control. As an additional control, I 
analyzed PolyA-seq signal around the same sites (Figure 4.2, bottom). Depletion of CLP1 
had no effect on PolyA signal. 
 
No significant differences between patient and parent CLP1
R140H
 samples 
CLP1 kinase activity is decreased more than 50% in patients with a homozygous 
CLP1
R140H
 mutation compared to wildtype CLP1 (Schaffer et al. 2014). To test whether 
CLP1 might broadly phosphorylate 5´-OH RNA prior to 5´-phophate-dependent decay 
(discussed further in Chapter III), I applied 5OH-seq to patient-derived fibroblasts from 
individuals with heterozygous or homozygous CLP1
R140H
 mutations. I used the DESeq 




Figure 4.1. CLP1 shRNA knockdowns validated by qRT-PCR and Western blot. 
A. CLP1 shRNA cell lines were validated by qRT-PCR. CLP1 signal is normalized to 
ACTIN signal, and compared to the scrambled control cell line.  All CLP1 shRNA cell lines 
show at least 67% reduction in CLP1 mRNA levels compared to the scrambled control. 
B. CLP1 shRNA cell lines were validated by western blot with a primary antibody against 
CLP1.  All CLP1 shRNA cell lines (Lanes 2-4) show at least a 50% reduction in CLP1 






Figure 4.2. CLP1-deficient cell lines have increased 5OH-signal surrounding PolyA 
sites. 
5OH-seq signal (top) and PolyA-seq signal (bottom) was assessed within 500 nucleotides 
upstream and downstream of poly(A) sites. 40 bins of 25 bases were created upstream and 
downstream of known poly(A) sites. The average 5OH-seq signal within each bin for each 
mRNA was calculated and the sum of the means is plotted on the y axis. Position relative 
to the poly(A) sites is plotted on the x axis. CLP1 shRNA knockdown cell lines and the 
scrambled control have nearly identical PolyA-seq signals.  CLP1 deficient cell lines (blue, 
green, purple) have an elevated signal surrounding poly(A) sites compared to the scrambled 
control (red). This difference is particularly pronounced upstream of PolyA sites. 
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homozygotes. Using an FDR of 0.1, I was unable to identify significantly different sites of 
5´-OH RNA. 
 
5´-OH signal increases in kinase-dead Clp1 samples 
In the previous two experiments, CLP1 levels were decreased by shRNA 
knockdown or CLP1 functioning was decreased by a single amino acid change outside the 
ATP-binding pocket that decreases but does not abolish kinase activity. In contrast, a single 
amino acid change in the Walker A motif of CLP1 completely abolishes CLP1 kinase 
activity (Hanada et al. 2013). To assess the affect of a kinase-dead CLP1 mutation on the 




 Prior to sequencing, I run libraries on a TBE gel to visualize library content.  
Libraries from samples with kinase-dead CLP1 displayed more intensity compared to 
samples with wildtype CLP1, and this difference was particularly pronounced in samples 
from mouse spinal cords (Figure 4.3A).  
I assessed the 5OH-seq signal 500bp upstream and downstream of several key 
genomic features: Poly-A signals, start codons, stop codons, and transcription start sites 
(TSS) (Figure 4.3B). 5OH-seq libraries from MEFs had similar traces for all genomic 
features independent of CLP1 status (left panels). The 5OH-seq signals from CLP1
+/+
 
spinal cord RNA were similar to MEFs, with the 4-month time point having a slightly 
lower signal than the 20-day time point. RNA from the spinal cords of mice with kinase-
dead CLP1
K127A/K127A
 had greatly diminished 5OH-seq signal, and this change is 
independent of time. Thus, the CLP1 mutation has a clear effect on 5OH-seq signal in the  
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Figure 4.3. CLP1 kinase-dead mutants differentially accumulate 5OH-RNAs in 
mouse spinal cords. 
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Figure 4.3. CLP1 kinase-dead mutants differentially accumulate 5OH-RNAs in 
mouse spinal cords. 
A. 5OH-seq libraries were prepared from RNA isolated from MEFs or spinal cords of mice 
with wildtype CLP1 or kinase-dead CLP1. For quality control, 5OH-seq libraries were run 
on a TBE gel after PCR amplification and before size-selection and sequencing. Lanes 1-
8 are the libraries sequenced and analyzed in B. Lanes 9-12 are mock libraries prepared 
from pre-fragmented yeast RNA in the presence or absence of RtcB ligase or Reverse 
Transcriptase (RT). Lane 13 is a no template (nt) PCR control. 5OH-seq libraries from 
kinase-dead CLP1 samples (lanes 2, 4, 6, 8) showed enhanced intensity compared to 
wildtype CLP1 samples (lanes 1, 3, 5, 7). 
B. 5OH-seq signal was assessed within 500 nucleotides upstream and downstream of Poly-
A signals, start codons, stop codons, and transcription start sites (TSS). 5OH-seq libraries 
from MEF RNA have similar traces indicating no changes with CLP1 mutation or in 
different mouse backgrounds. Libraries from spinal cord RNA differ based on animal age 
and on CLP1 mutation status. 
CLP1 +/+: Wild-type CLIP1. CLP1 K/K: kinase dead CLP1
K127A/K127A
. SC: spinal cord. 
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spinal cords of affected mice. However, this is a general effect on mRNA and is present at 
all genomic features, rather than a feature-specific effect. Furthermore, these results do not 
support the hypothesis that CLP1 broadly phosphorylates mRNA prior to decay by Xrn1. 
 
Novel SeC anti-codon loop tRNA cleavage identified by 5OH-seq 
CLP1 phosphorylates the 3´-exon and intron of cleaved intron-containing tRNAs 
in vitro (Weitzer and Martinez 2007b), and mammalian cells with mutations in CLP1 
accumulate several types of tRNA fragments (Hanada et al. 2013; Schaffer et al. 2014; 
Karaca et al. 2014). I asked whether 5OH-seq could capture known or novel tRNA 
fragments in cells with kinase-dead CLP1. I aligned the 5OH-seq reads to a tRNA-specific 
genome and analyzed the summed signals for each tRNA species (Figure 4.4). 
Surprisingly, the strongest signal was found in the anticodon loop of selenocysteine (SeC) 
tRNA in spinal cord RNA, though this signal was independent of CLP1 mutation (Figure 
4.4B). During certain stress conditions, angiogenin can cleave tRNAs in the anticodon loop 
generating a 3´ stress-induced tRNA fragment (3´-tiRNA) with a 5´-OH terminus (Fu et al. 
2009; Yamasaki et al. 2009); however, such a cleavage in SeC tRNA has not been 
described (Figure 4.5A). To validate the fragment by Northern blot, I designed probes 
against the 5´ and 3´ halves of the SeC tRNA (Figure 4.5B). I captured the full-length SeC 
tRNA with both probes but was unable to validate either tiRNA half (Figure 4.5C).  
 
Discussion 
Patients with homozygous CLP1
R140H
 mutation suffer from pontocerebellar 
hypoplasia and severe neurological deficits (Schaffer et al. 2014; Karaca et al. 2014). 
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Figure 4.4. SeC 3´-tiRNAs accumulate in the spinal cords of mice. 
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Figure 4.4. SeC 3´-tiRNAs accumulate in the spinal cords of mice. 
A. 5OH-seq reads from MEF RNA (first four columns) and spinal cord RNA (last four 
columns) were uniquely aligned to a tRNA genome and normalized to counts per million 
aligned reads (CPMs). 5OH-seq CPMs for each tRNA species was summed and is 
displayed on the y axis. Samples with wildtype CLP1 (CLP1 +/+) are colored in black; 
samples with kinase-dead CLP1 (CLP1 K/K) are displayed in red. The predominant peak 
is a 5OH signal consistent with cleavage in the anticodon loop of SeC tRNA generating a 
3´-tiRNA. This signal is present in spinal cord samples for both time points and is 
essentially absent in both sets of MEF samples. 
B. Zoomed view of the boxed SeC tRNA plot from A. 
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Though CLP1 is a ubiquitously expressed gene, most tissues are unaffected by this single 
site mutation. It is therefore perhaps unsurprising that I did not identify significant changes 
in 5OH-Seq signal when comparing RNA isolated from patient-derived fibroblasts of 
CLP1
+ / R140H
 parents to CLP1
R140H / R140H
 patients. I conducted my experiments in a rich 
media and did not treat the cells with any cellular stressors. In one of the publications that 
first describes the CLP1
R140H
 mutation, the patient-derived fibroblasts are cultured in N3 
media supplemented with BDNF, GDNF, NT3 and CNTF to induce neuronal properties, 
termed “iNeurons” (Xue et al. 2013; Schaffer et al. 2014). The iNeurons with a CLP1
R140H
 
homozygous genotype show a stronger translocation of CLP1 to the cytoplasm and an even 
more pronounced tRNA accumulation phenotype when compared to the uninduced 
fibroblasts. It is therefore possible that a differential 5OH-seq signal would be generated 
upon iNeuron induction of these cells or upon cellular stressors that endogenous neuronal 
populations are selectively exposed to, such as oxidation. 
 When CLP1 kinase activity is completely abolished by the K127A mutation in the 
Walker A motif, there is an increased signal intensity on the gel of 5OH-seq libraries prior 
to sequencing; however, the normalized 5OH-seq signal does not corroborate this effect or 
correlate with the anticipated biology of KMD (Figure 4.4). One of the current limitations 
of the 5OH-seq method is the absence of an internal standard. I normalize the 5OH-seq 
signal by counts of UMI-corrected reads per million reads aligned (CPMs), a normalization 
method that is analogous to standards of other sequencing methods. However, a widespread 
signal could be erased by this normalization procedure. I anticipate that including a 
sequencing standard prior to library preparation (further described in Chapter V) could 
improve the identification of 5´-OH RNAs. 
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Figure 4.5. SeC tRNA Northern blot requires optimization. 
A. A cartoon of cleavage generating a 5´-OH tRNA fragment which is competent for RtcB 
ligation and 5OH-seq. Angiogenin is known to cleave tRNAs in the anticodon loop, and 
could potentially be involved in SeC tRNA cleavage. 
B. Location of the 3´ (green) and 5´ (red) northern probes in the SeC tRNA molecule. 
C. Northern blot with the probes shown in (C). Both the 3´ and 5´ probes anneal to the full-







































































SeC tRNA SeC 3´ tiRNA
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Analysis of 5OH-seq reads aligning uniquely to tRNA sequences revealed a 
cleavage in the anticodon loop of selenocysteine (SeC) tRNA (Figure 4.4). This signal was 
found reproducibly in RNA from mouse spinal cord samples and was independent of CLP1 
mutation. I was unable to validate this fragment by northern blot with probes designed 
against the 3´ or 5´ half of SeC tRNA (Figure 4.5).  However, given the strength of the 
signal in the 5OH-seq data, I anticipate that the SeC 3´-tiRNA fragment may be validated 
by: optimizing hybridization conditions of the probes, greatly extending phosphor screen 
exposure time, changing the probe design, or using a more sensitive method for RNA 
detection, such as double DIG-labelled LNA probes. 
Although anticodon-loop cleavage has been demonstrated in Met, Gly, Pro, Val, 
Arg, and Tyr tRNAs (Fu et al. 2009; Yamasaki et al. 2009), this study is the first to identify 
anticodon-loop cleavage in SeC tRNA. The SeC tRNA can only pair with the UGA codon 
when a selenocysteine insertion sequence (SECIS) is present in mRNA (Berry et al. 1993).  
When cells are grown in the presence of selenium, the SeC tRNA overrides the normal 
UGA stop codon and incorporates selenocysteine into the nascent peptide. Twenty-five 
genes encode selenocysteine-containing proteins (selenoproteins) in humans, with most 
selenoproteins performing catalytic redox reactions (Labunskyy et al. 2014). Cleavage of 
SeC tRNA may enable a cell to rapidly and specifically cease production of selenoproteins.  
It is possible that this regulatory mechanism controlling selenoprotein production is 
ongoing in differentiated cells, and disrupting CLP1 kinase activity either directly prevents 
the degradation of these 3´ tiRNAs by inhibiting 5´-phosphate-dependent decay, or 




 In the chapter, I investigated the role of CLP1 on the accumulation of 5´-OH RNAs 
by performing 5OH-seq on several mammalian samples with mutations in CLP1. In 293FT 
cells with stable expression of shRNAs directed against CLP1 mRNA, I showed a CLP1-
depedent divergence in 5OH-seq signal surrounding PolyA sites, confirming the 
importance of CLP1 in the pre-mRNA cleavage complex II for appropriate 3´-end 
formation. In RNA from spinal cords of mice, I identified a novel 5´-OH RNA generated 
by cleavage in the anticodon loop of SeC tRNA, which may link neural development to 
precise temporal regulation of selenoprotein expression. Further analysis of these 5OH-seq 
libraries may uncover additional 5´-OH RNAs that are differentially present in CLP1 




SUMMARY AND FUTURE DIRECTIONS 
This dissertation describes my two main contributions to the field of RNA decay: a 
method to directly capture and sequence 5´-OH RNAs (5OH-seq) and a unified theory of 
5´-OH RNA degradation by kinase-mediated decay (KMD). I developed the 5OH-seq 
method to enable transcriptome-wide analysis of the uncharacterized 5´-OH RNA end 
modification. In Chapter II, I applied the 5OH-seq method to Saccharomyces cerevisiae, 
a quintessential eukaryotic model organism. Surprisingly, 5´-OH RNAs are found 
throughout the yeast transcriptome with areas of distinct and dispersed cleavages. I 
identified several hotspots of 5´-OH RNA accumulation, including upstream of mRNA 
sequences encoding polycharged amino acids and within a specific 5´-CCAUU|A-3´ motif 
following tuncamycin treatment. In Chapter IV, I extended the 5OH-seq method to 
mammalian samples, and showed that 5OH-seq can identify novel 5´-OH RNA fragments 
in mammals, such as the selenocysteine (SeC) 3´-tiRNA in mouse spinal cord RNA. 
The widespread accumulation of 5´-OH RNAs led me to ask how this subset of 
RNAs might be degraded. Given the perplexing accumulation of 3´-exon HAC1 mRNA 
fragments with 5´-PO4 termini (Harigaya and Parker 2012; Peach et al. 2015), I 
hypothesized that 5´-OH RNAs could be phosphorylated by RNA kinases to enter the 
canonical Xrn1 5´→3´degradation pathway. In Chapter III, I showed that this process, 
which I termed “kinase-mediated decay” (KMD), is required for the degradation of 3´-exon 
HAC1 mRNA fragments and a NGD stem-loop reporter. I determined that KMD provides 
regulatory control of UPR induction in yeast by determining whether the HAC1 3´-exon 
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mRNA fragment is ligated and translated (UPR activation) or decayed by Xrn1 (UPR 
suppression).  
In this final chapter, I reflect on the applications of 5OH-seq and the implications 
of KMD. I propose the use of 5OH-seq for identification of endonuclease targets and rapid 
clinical diagnostic tools. I also suggest strategic improvements to the 5OH-seq method. In 
the second half of the chapter, I outline future directions for the study of KMD, including 
a discussion of the potential for KMD in regulating the mammalian UPR, and the 
possibility of KMD inhibition by an RNA phosphatase. 
 
Applications and Improvements of 5OH-Seq 
 
Targets of metal ion-independent endoribonucleases 
 The most pressing application of 5OH-seq is the identification of novel targets of 
metal ion-independent endoribonucleases. In Chapter I, I discussed the mechanism of 
metal ion-independent endoribonucleases, which cleave ssRNA to yield a 5´-fragment with 
a 2´,3´-cyclic phosphate terminus and a 3´-fragment with a 5´-OH terminus. Given the 
successful capture of tRNA halves by 5OH-seq in both yeast (Chapter II) and mammals 
(Chapter IV), I am particularly interested in finding novel targets of the endoribonucleases 
known to generate these fragments. 
 Under certain stress conditions, Rny1 in yeast and Angiogenin in humans cleave 
subclasses of tRNAs in the anticodon loop to generate 5´-tRNA halves with 2´,3´-cyclic 
phosphate termini and 3´-tRNA halves with 5´-OH termini (Yamasaki et al. 2009; Fu et al. 
2009; Thompson and Parker 2009b). These stress-induced tRNA fragments (tiRNAs) can 
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inhibit translation and apoptosis in mammalian cells (Emara et al. 2010; Ivanov et al. 2011; 
Saikia et al. 2014). In Chapter II, 5OH-seq enabled identification of an anticodon loop 
cleavage in tRNA
Ser
AGA in non stressed conditions in yeast, which likely represents a low 
level constitutive cleavage by Rny1, as has been previously suggested (Thompson and 
Parker 2009b). What is the nature of the tRNAs cleavage by Rny1?  Does Rny1 cleave in 
this region merely based on a non-specific cleavage in an accessible, hypomodified region 
of an abundant RNA species, or are there other structural components driving recognition? 
Other than the anticodon loops of tRNA, what are the other targets of Rny1, and are these 
cleavages functionally significant in mediating the effects of Rny1 by altering specific gene 
expression? 
I discovered an anticodon loop cleavage in SeC tRNA in RNA isolated from mouse 
spinal cords (Chapter IV). The tRNA
SeC
 cleavage fragment is a novel 3´ tiRNA that has 
not been previously described in tiRNA literature, which prompts several questions. Is the 
SeC 3´-tiRNA a neural tissue-specific tiRNA, and if so, is it a functional tiRNA or merely 
a marker of normal development? Is the SeC tiRNA produced by angiogenin? Furthermore, 
angiogenin plays a critical role in angiogenesis (Fett et al. 1985) and is particularly 
important in promoting the growth of solid tumors (Shimoyama et al. 1999; Katona et al. 
2005; Montero et al. 1998). Does angiogenin target mRNAs to specifically decrease 
expression of tumor suppressors? Is the ribonuclease activity important for the function of 
secreted angiogenin? 
In addition to answering the above questions, 5OH-seq can be used to find novel 
substrates of the other metal ion-independent endoribonucleases. Metazoans have evolved 
dozens of endoribonucleases (Yang 2011). While most have known substrates, many 
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uncharacterized endoribonucleases remain. It would be of particular interest to study these 
“orphan endos” – endoribonucleases without known substrates – to determine their targets, 
which may in turn lead to additional insight into their function. 
 
 
RIDD substrates in S. cerevisiae and mammals 
In plants, S. pombe, Drosophila, and mammals, activated IRE1α cleaves ER-
proximal mRNAs in a process termed Regulated IRE1-Dependent Decay (RIDD) (Hollien 
and Weissman 2006; Hollien et al. 2009; Kimmig et al. 2012; Hayashi et al. 2012). Most 
studies identifying RIDD substrates propose that an ER-localized mRNA must carry a 
consensus cleavage motif for IRE1α recognition (Maurel et al. 2014). This motif, 5´-
CN|GNNG-3´ and most often 5´-CU|GCAG-3´, is similar to the HAC1/XBP1 cleavage 
sites. In Chapter II, I showed that the 5OH-seq signals within 23 mRNAs increased at 
least 5-fold upon tunicamycin treatment compared to the DMSO control. Seven mRNAs 
had sites of 5´-OH cleavage that occurred in a common sequence motif 5´-CAUU|A-3´; 
however, this sequence does not match any known endoribonuclease motifs, and is highly 
divergent from the common RIDD motifs. The increase in cleavage of specific mRNAs in 
a tunicamycin-dependent manner certainly argues for the existence of RIDD in S. 
cerevisiae, though the divergence from a consensus motif necessitates less specificity in 
yeast Ire1 targeting. A recent study argued that RIDD substrates may not necessarily 
require the 5´-CN|GNNG-3´ motif (Gaddam et al. 2013). If the increased 5´-OH RNAs I 
identified following UPR induction with tunicamycin are indeed fragments of mRNAs 
cleaved by yeast Ire1, this not only demonstrates RIDD in S. cerevisiae, but also suggests 
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that 5OH-seq can be used to identify additional targets of IRE1α in human cells and other 
model organisms. 
 
Additional analyses of 5OH-seq data in yeast 
 In Chapter II, I describe a series of computational analyses of 5OH-seq data from 
key yeast libraries including: comparisons to RNA-seq (Levin et al. 2010) and S1/V1 
structure mapping (Kertesz et al. 2010) datasets; identification of discrete and clustered 
cleavages; enrichment analysis upstream and downstream of polycharged residues; and 
motif discovery. While this is a comprehensive series of analyses, it is certainly not 
exhaustive. Ribosome profiling data has a known triplet periodicity, and a recent 
publication demonstrated the same frame-dependent signals in 5´-phosphate sequencing 
data (Pelechano et al. 2016). Preliminary analysis demonstrated a frame-dependent signal 
for wild-type 5OH-seq libraries, but a more detailed examination of this periodicity may 
reveal a link with co-translational decay processes, such as NGD. 
An in-depth assessment of the effect of specific codons on 5OH-seq signal should 
also be performed. Given that polybasic stretches are known to trigger NGD, I limited the 
analysis in Chapter II to runs of specific groups of amino acids (i.e., polyK, polyE, acidic, 
basic, etc.). However, lysine is encoded by both AAA and AAG codons, but only stretches 
of AAA trigger ribosomal sliding (Koutmou et al. 2015). Thus, specific codons rather than 
the biochemical properties of the amino acid encoded may promote cleavage by altering 
translation speed. Though I saw enhancement of signal upstream of polybasic stretches and 
polyacidic stretches with runs of at least 5 codons, I may find that individual codons have 
a greater contribution on 5´-OH RNA generation. 
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Rapid microarray-based screening of 5´-OH RNAs 
 While the plummeting costs of DNA sequencing have enabled a shift to whole 
exome and whole genome sequencing, there is still a need for validated tools for rapid 
clinical diagnostics. Dozens of patent applications for microarray-based screening tools 
have been filed in the United States, and such screening tools are used to detect monogenic 
disease-related mutations as well as bacterial, viral, and fungal infections (Yoo et al. 2009). 
Future 5OH-seq experiments might reveal differential 5´-OH RNA signals between 
affected and unaffected populations for a given disease state. It may therefore be useful to 
develop a tool for quicker, less labor-intensive quantitation of select markers of RNA decay 
defects. 
 Assessing differential expression of subset of 5´-OH RNA targets could be 
accomplished by combining RtcB 5´-OH RNA ligation with microarray technology. A 
DNA/RNA adapter with a 3´-phosphate and a recognition site for MmeI could be ligated 
to 5´-OH RNAs by RtcB. The ligated RNA could be reverse transcribed by using an adaptor 
with an oligo(dT) sequence followed by 5 cycles of PCR with primers complimentary to 
the adapters. The DNA could be cleaved with MmeI to yield fragments 20 or 21 nucleotides 
3´ of the initial ligation site. This DNA could then be labelled with differential fluorescent 
dyes and applied to a chip with probes against candidate 5´-OH RNA sites. While this 
provides less information than the 5OH-seq method, this 5OH-Chip method would be 
compatible with high-throughput preparation methods and would allow rapid analysis of 




Improvement of the 5OH-seq method 
 There are key improvements that should be made to the 5OH-seq method to 
overcome two principal limitations. One of the limitations of the current 5OH-seq protocol 
is purely technical in nature. The linker oligo contains eight degenerate bases to account 
for PCR amplification bias, and the reverse transcription primer contains nine degenerate 
bases for random priming. To avoid priming of the linker oligo with the degenerate reverse 
transcription primer, I purify the linker by running the ligated sample on a TBE-Urea gel, 
manually excising and crushing a gel band, and eluting the RNA. This step prevents the 
method from being compatible with high throughput robotics and also adds several 
additional hours and reagents to the protocol. To decrease reverse priming, the linker could 
be added at a lower concentration or the UMI of the linker could be shortened. 
Alternatively, RNA could be reverse transcribed with an oligo-dT primer, the resulting 
cDNA could be fragmented, and an Illumina-compatible primer could be directly ligated 
to the 3´ end. This would prevent background amplification, and would limit the libraries 
to poly-adenylated species, eliminating the need for polyA enrichment or rRNA depletion. 
The second limitation of the current 5OH-seq protocol is the lack of robust metrics 
for quantitative comparisons. The 5OH-seq libraries are normalized by UMI-corrected 
reads per million aligned sequences, referred to as counts per million (CPMs). While this 
aligns related samples on a similar scale, it may prevent analyses across key datasets. If 
samples maintain similar relative levels of 5´-OH RNA cleavages, but there is a gross 
change in processing by genome-wide modification or deletion of decay factors, this 
change may not be detected. It would therefore be useful to normalize libraries to a “spike-
in” control of several 5´-OH RNAs with known concentrations. The External RNA 
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Controls Consortium (ERCC) recently developed a set of universal synthetic RNA spike-
in standards for RNA-seq (Jiang et al. 2011; Zook et al. 2012), and these standards are 
commercially available. Use of such standards enables absolute quantification of 5´-OH 
RNAs, a fundamental question that remains unanswered. These standards also enable 
quantification of experimental variability in the preparation and sequencing of the libraries, 
providing a much needed quality assurance metric in the 5OH-seq protocol. 
 
Future Studies and Considerations of Kinase-Mediated Decay 
 Within this dissertation, I coined the term “kinase-mediated decay” (KMD), which 
encompasses any pathway where phosphorylation of 5´-OH RNA precedes 5´-phosphate-
dependent degradation. Prior to this dissertation, there were two examples of KMD in 
eukaryotes: the decay of excised tRNA introns and the processing of the 5´ end of 28S 
rRNA. In Chapter III, I describe two new substrates that require phosphorylation of 5´-
OH RNA prior to 5´-phosphate dependent degradation: the 3´-exon of HAC1 after cleavage 
by Ire1 and the 3´ cleavage fragment during NGD. These are the first examples of KMD 
that is required for the degradation of mRNA fragments. Though these examples solidify 
KMD as a bona fide pathway for cytoplasmic decay of mRNA fragments, many additional 
questions remain.  Below I discuss six unexplored aspects of KMD, including implications 
for mammalian XBP1 mRNA splicing. 
 
Decay kinetics 
 My initial studies of KMD evaluated accumulation of 5´-OH RNAs at single time 
points in yeast with stable deletions of decay factors. While this allowed me to demonstrate 
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that KMD is required for 5´-OH RNA degradation, it does not address the kinetics of this 
reaction. Several questions regarding KMD kinetics should be addressed in future studies 
including: What is the general turnover rate of 5´-OH RNAs?  How quickly are 5´-OH 
RNAs phosphorylated after cleavage, and how soon after phosphorylation are these 5´-PO4 
RNAs degraded? This is particularly interesting for determining the window of opportunity 
for cellular action, such as the repression of translation by tiRNAs. 
 
Localization of KMD 
 Though the two examples of KMD described in Chapter III are performed by 
enzymes with cytosolic localization (Trl1 and Xrn1), it is not clear precisely where KMD 
of mRNAs occurs. Processing bodies (P-bodies) are foci containing translationally-
repressed messenger ribonucleoproteins (mRNPs) (Parker and Sheth 2007). The complete 
proteome of P-bodies is not known, but many components of 5´→3´ mRNA decay are 
present, including Xrn1 and decapping proteins Dcp1/Dcp2. In xrn1∆ yeast, the NGD 
reporter PGK-sL aggregates in distinct cystoplasmic foci and colocalizes with Dcp2, 
suggesting that NGD fragments accumulate within P-bodies (Cole et al. 2009). Does KMD 
of NGD fragments therefore occur within P-bodies?  Is Trl1 present in P-bodies or does 
phosphorylation of the mRNA fragment precede entrance to the P-body? Are other 5´-OH 
RNAs fated for degradation in P-bodies? mRNAs stored within P-bodies are not 
constitutively degraded; some mRNAs exit P-bodies and resume translation (Brengues et 
al. 2005). This raises a particularly intriguing question: can 5´-OH RNAs be temporarily 
stored and later religated either in cis or in trans to RNAs with 2´,3´-cyclic phosphate 
termini? 
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KMD between compartments 
In the four examples of eukaryotic KMD so far, there are only two kinase-
exoribonuclease pairs – the nuclear Grc3-Rat1 and cytosolic Trl1-Xrn1 – which raises 
several questions for future studies. These enzymes show little substrate specificity and are 
agnostic to RNA sequence. Are these kinases and exoribonucleases therefore 
interchangeable for KMD? For instance, expressing a mutant Rat1 with cytosolic 
localization restores the growth defects of xrn1∆ strains (Johnson 1997). Would this 
cytoplasmic Rat1 also rescue KMD of the known substrates in xrn1∆ strains? 
Phosphorylation and degradation occur within the same compartment (i.e., both steps are 
either nuclear or cytosolic) in the known examples. Is it possible for a 5´-OH RNA to be 
phosphorylated in the cytoplasm, and then transported to the nucleus for decay, or vice 
versa?  Can the human 5´-OH RNA kinases (CLP1 and NOL9) restore KMD in yeast with 
kinase-dead Trl1 and Grc3? 
 
Decay of trailing mRNA in 3´-end formation 
CLP1, one of the human 5´-OH RNA kinases, was first identified as part of the 
cleavage factor II (CFIIm) complex, and is thought to bridge cleavage and polydenylation 
specificity factor (CPSF) and CFIm (de Vries et al. 2000). Accordingly, depletion of CLP1 
in HeLa cells decreases pre-mRNA 3´ cleavage activity (de Vries et al. 2000). Curiously, 
although the yeast homolog is also required for 3´ mRNA end formation (Haddad et al. 
2012), the yeast Clp1 cannot phosphorylate 5´-OH RNA. Whether the additional kinase 
activity of human CLP1 affects 3´ cleavage, and in particular, the decay of the fragment 
downstream of cleavage is not known. In the torpedo model of RNA Polymerase II 
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transcriptional termination, 5´-phosphate dependent 5´→3´ exoribonucleases Rat1/XRN2 
rapidly degrade RNA downstream of the poly(A) cleavage site and ultimately dissociate 
RNA Pol II from its DNA template (Luo and Bentley 2004). Could CLP1 potentially 
phosphorylate the 5´ terminus of the 3´ fragment to facilitate rapid degradation by XRN2? 
Since this activity is clearly not required in yeast, could another factor in humans alter the 
5´-terminus following cleavage? 
 
Regulation of UPR by KMD in mammals 
In mammals, the IRE1α arm of the UPR is regulated by the non-canonical cytosolic 
splicing of XBP1 mRNA, the HAC1 homolog. In Chapter III, I showed that 
phosphorylation of the 5´ terminus of the HAC1 mRNA 3´ exon by Trl1 poises the exon 
either for ligation and UPR activation or for degradation by Xrn1 resulting in UPR 
suppression. While it is possible that XBP1 splicing could also be regulated by KMD, this 
seems unlikely for several reasons. First, in contrast to the single pathway of UPR control 
by HAC1 mRNA splicing in yeast, humans have two additional branches controlling UPR 
induction, PERK and ATF6.  Therefore, there has been less selective pressure on an 
intricate pathway to regulate XBP1 splicing by degradation of intermediates. Second, the 
intron of XBP1 is only 26 nt in humans, compared to the 252 nt intron of yeast HAC1, 
which greatly minimizes the distance between the cleaved exons. Indeed, a recent 
publication from the Walter lab proposed that the intron was expelled by a conformational 
RNA zipper that quickly aligns the cleavage sites for splicing by RTCB (Peschek et al. 
2015). Third, RTCB directly ligates the two exons rather than the distributed multi-step 
ligation yeast pathway of Trl1. While I have not yet performed a direct comparison of the 
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ligation efficiency of yeast Trl1 and human RTCB, I and others have shown that E. coli 
RtcB quickly and efficiently ligates ends, especially ends in close proximity such as 
complementary RNAs (Tanaka and Shuman 2011). Finally, though humans have 
conserved components of KMD, including at least two 5´-OH RNA kinases (CLP1, NOL9) 
and several 5´-phosphate-dependent exoribonucleases (XRN1, XRN2, DXO, and CPSF3), 
it is unclear whether cytosolic KMD is truly feasible. XRN1 is primarily cytosolic; 
however, NOL9 is localized in the nucleolus (Heindl and Martinez 2010) and CLP1 is 
primarily (~85%) located in the nucleus (Schaffer et al. 2014). There may not be a 
sufficient concentration of 5´-OH RNA kinase in the cytoplasm to rapidly phosphorylate 
this specific substrate prior to ligation by RTCB. 
Although I believe it is unlikely that XBP1 splicing and the human UPR is regulated 
by KMD, it remains possible that an unknown cytoplasmic 5´-OH RNA kinase could 
phosphorylate the XBP1 3´-exon for degradation. A prime target for future experiments 
testing either UPR-specific KMD or general cytosolic KMD in humans is NEDD4-binding 
protein 2 (N4BP2), which is located in the cytoplasm and has 5´-polynucleotide kinase 
activity (although it is not known whether this includes 5´-OH RNA substrates). 
Importantly, although XBP1 splicing is unlikely to be regulated by KMD, the possibility 
for general cytoplasmic degradation of mRNAs by KMD cannot be ruled out. 
 
RNA phosphatase 
 In signaling pathways, kinases and phosphatases act as molecular switches to 
modulate function of protein intermediates. A kinase transfers a phosphate to a serine, 
tyrosine, or threonine residue to alter confirmation of an affected protein. Phosphorylation 
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can activate or deactivate enzymatic activity, change protein localization, or alter binding 
sites for cofactors and protein partners. Phosphatases remove phosphates from the same 
residues and antagonize these changes. Perhaps RNA end modifications can be similarly 
regulated for precise, reversible control. If an RNA kinase can alter an RNA to enter a 
regulated decay pathway, is there a RNA phosphatase counteracting this fate and 
preserving the RNA? 
 mRNA capping enzymes were the first eukaryotic proteins described with in vivo 
RNA triphosphatase activity. The N-terminal domains of these mRNA capping enzymes 
have sequence similarity to the protein tyrosine phosphatase (PTP) family, and the cytosine 
of the conserved HCX5R, motif in CEL-1 is required for RNA triphosphatase activity in C. 
elegans (Takagi et al. 1997). The baculovirus protein phosphatase (BVP) from the 
Autographa californica nuclear polyhedrosis virus also contains a PTP domain and can 
further hydrolyze the 5´ terminus of RNAs from diphosphate to monophosphate in vivo 
(Takagi et al. 1998). Sequence similarity studies revealed that human PIR1, which contains 
41% sequence similarity to BVP, also has RNA 5´-triphosphatase and 5´-bisphosphatase 
activities (Deshpande et al. 1999). Together, these enzymes form a subgroup of PTP family 
members that recognize RNA as a substrate. None of these known RNA phosphatases can 
hydrolyze 5´-monophosphate RNAs to 5´-OH RNAs; however there are phosphatases that 
act on nucleic acids indiscriminately. Calf intestinal phosphatase is a standard molecular 
biology reagent that dephosphorylates 5´-PO4 RNA and DNA in vitro. In humans, there 
are four such alkaline phosphatases: placental (PLAP), placental-like (ALPPL2), intestinal 
(ALPI), and the tissue non-specific live/bone/kidney alkaline phosphatase (ALPL). 
Importantly, measuring alkaline phosphatase (ALP) levels is part of the standard panel of 
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“liver function tests”; elevated ALP is a marker of liver damage and certain cancers, 
especially osteosarcoma (Lange et al. 1982; Khan et al. 2015). If a phosphatase acts in 
direct opposition to the RNA 5´-kinases, it is either: i) not yet known, or ii) a broad-acting 
DNA/RNA phosphatase, such as the alkaline phosphatases. Future studies should 
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